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ABSTRACT.
Monoclonal antibodies (Mabs) raised against Ureaplasma ureatytlcum (serotype 8) 
revealed the presence of three membrane antigens. One major surface antigen of 
apparent molecular mass 96 kDa, shown to express four distinct epitopes, was found 
to be serotype-8 specific.Thus,Mabs raised against this polypeptide will unequivocally 
differentiate serotype 8 from the other serotypes of human origin. The binding of 
antibodies to this polypeptide partially suppressed the growth of the 
organisms.Membrane expressed antigenic polypeptides of apparent molecular masses 
16 kDa and 17 kDa were expressed by those serotypes belonging to the large 
serociuster (A), whereas the 17 kDa polypeptide only was expressed In the smaller 
serocluster (B). Using this Mab probe serotype 13 was placed in tee larger 
serocluster.Thus,Mabs which recognise one or both of these polypeptides will 
unequiviocally differentiate the two seroclusters of this organism. The cytosolic urease 
from U. urealyticumswOtPe 8, was purified by immuno-affinity chromatography. Two 
active forms of the enzyme were demonstrated by non-denaturing electrophoretic 
analysis and a single peak with urease activity of apparent molecular mass 190 KDa 
was shown by FPLC.Freezing and thawing of the purified enzyme caused a partial 
breakdown to inactive sub-units whereas total inactivation of the enzyme and 
denaturation,achieved by boiling for two mmu-^^s in the absence off any added 
denaturing agents, revealed three subnnit polyepptiee s of appaennt moiecular masees 
72, 14 and 11 KDa. Densitometry suggested that the active enzyme contains equimolar 
ratios of the three subunits and hence is a hexamer. The active enzyme displayed two 
pH optima of 6.9 and 6,15. Mabs raised against purified brspss bound to both the 
active enzyme and to the inactive 72 kDa subunit. No evidence of antigenicity was 
found for the 14 and 11 KDa sub-units. These Mabs eaoss-reactsd with ureases from 
all the other human serotypes. Competition assays revealed a minimum of four and 
possibly five distinct epitopes on the enzyme, all distinct from its active site.
Uasaplasmas from 5 animal hosts were studied using the various Mabs. The 96 kDa 
antigen was not found in any of the nnon-iui-man astrins. \/apiaPionu in the available 
epitopes on the ureases ana toe e yeseene oo eabence oo the 16/17 KDa antigens in 
the non-human strains aHowwd a putative identification oo the source of the
non-human breaplasmas.Sbeh investigations also showed that with the exception of 
the 96 KDa serotype eyseocific agtinen, cciir^FO^r^^^^ iselapes could not be
differentiated from the human urbapiysma seretopps belenginn ta hhe large 
ssroeluater.
These Mabs were also used to develop fluorescent probes and other diagnostic 
assays which included a slide agglutination system and a sensitive urease catch assay 
which was also converted into a 'dip-stick' assay.
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CHAPTER 1 
INTRODUCTION.
1.1. TAXONOMY.
The prokaryotes have been divided into four main divisions, based primarily on the 
nature of the bacterial cell wall (Murray, 1984). One of the major characteristics of 
mycoplasmas is their lack of a cell wall and thus these organisms have been placed in 
the division TERNICUTES, with the class designation MOLLICUTES, (Table 1). This 
designation was initially proposed by Edward and Freundt (1967), and complemented 
their original classification for wall-free organisms.
As can be seen from Table 1, the mycoplasmas have been divided into two orders: 
(1) MYCOPLASMATALES, those requiring sterols, and (2) ACHOLEPLASMATALES, those 
not requiring sterols. The MYCOPLASMATALES contains two families, the
MYCOPLASMATACEAE and the SPIROPLASMATACEAE, with the
ACHOLEPLASMATACEAE, as yet, the only f^rmiil/ in the S^/AT/ALE^. In
addition, the ANAEROPLASMAS and the THERMOPLASMAS are Mollicutes of uncertain 
taxonomic position. However, the Thermoplasmas apparently belong to the 
Archaebacteria (Maniloff, 1983; Rogers et a!., 1985).
Ureaplasmas, (formerly T-strain mycoplasmas), were first isolated by Shepard in 
1954 and their existence was later confirmed by Ford et at. in 1962. In 1974, Shepard 
et a!, proposed a new genus in the family MYCOPLASMATACEAE (UREAPLASMA) (Table 
1), as these organisms were unique in their ability to hydrolyse urea.
Ureaplasmas have been divided intn two species, Ureaplasma dieersum and 
Ureaplasma sreaiyt/csm, isolated from bovine and human hosts respectively (Howard 
and Gourlay, 1982).
U. diverssm was isolated from 33 % ol5 urogenital tracts ot cattle by 
Taylor-Robinson et ai in 1967 and again in 1996. At this time thhes was no di rect 
evidence that these organisms caused disease as other large colony mycoplasmas and 
other bacteria were often present in the material being cultured. However, in many
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TABLE 1: CLASSIFICATION OF THE MOLLICUTES.
Division: TERNICUTES, (wall-free prokaryotes).
Class: MOLLICUTES.
ORDER 1: MYCOPLASMATALES.
(i) sterol required for growth.
(ii) genome size 5 X 108 - 1 X 109 daltons.
(iii) NADH oxidase located in the cytoplasm.
Family 1: MYCOPLASMATACEAE.
(i) genome size approximately 5 X 108 daltons.
Genus 1: MYCOPLASMA, (about 76 species)-
(i) do not hydrolyse urea.
(ii) some ferment glucose and/or hydrolyse arginine.
(iii) G + C of DNA from 22 - 41 mol%.
Genus 2: UREAPLASMA, (3 species).
(i) hydrolyse urea.
(ii) G + C of DNA from 27 - 30 mol%.
Family 2: SPIROPLASMATACEAE.
(i) genome size 1 X 109 daltons.
(ii) helical organisms during some phases of growth.
Genus 1: SPIROPLASMA, (5 species).
(i) ferment glucose and most hydrolyse arginine.
(ii) G + C of DNA from 25-31 mol%.
ORDER 2: ACHOLEPLASMATALES.
(i) sterol not required for growth.
(ii) genome size about 1 X 109 daltons.
(iii) NADH located in the membrane.
Family 1: ACHOLEPLASMATACEAE.
Genus 1: ACHOLEPLASMA, (about 10 species).
(i) G + C of DNA from 27 - 36 mol%.
MOLLICUTES OF UNCERTAIN TAXONOMIC POSITION:
Genus: ANAEROPLASMA, (2 species).
Genus: THERMOPLASMA, (now appears to belong to Archaebacterium and has 
no specific relationship to other mycoplasmas (Rogers et al., 1985)).
cases they were isolated in large numbers (10® c.f.u. ml"1.). This organism was also 
isolated from pneumonic lungs of calves by Gourlay (1968) and these organisms were 
inoculated endobronchialy into 16, three week old calves (Gourlay and Thomas, 1970). 
Of these 16 calves, pneumonic lesions were found in 14 and ureaplasmas were
re-isolated from 13/16 lungs.
These organisms were recently inoculated into the amniotic cavity of four pregnant 
cows (Miller et <a/T 1983); two of these cows suffered abortions and the other two 
produced calves, both with evidence of pneumonia, one of which died immediately 
after birth. it is now thought that these organisms also induce mastitis (Doig et at, 
1980), salpingitis and endometritis as well as spontaneous abortion and neonatal calf 
pneumonia (Gourlay et at., 1972). U. diversum has also been shown to adsorb to both 
bovine embryos and ova, even after the washing procedures recommended for in vitro 
fertilisation have been carried out (Britton et ai. 1988).
At least twentyfive bovine strains have been studied and when examined by 
immunofluorescence and by one- and two-dimensional sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), can be divided into three groups, with 
group one being further sub divided into another three sub-groups (Howard et ai. 
1975; Mouches et ai. 1981). Cluster A is represented by strain A417 (type strain), B by 
strain D48 and C by strain T44 (Barile, 1986). Although these strains are distinct, there 
is a continuous spectrum of antigens among the three clusters and strains from 
cluster A and B do not cross-protect on challenge (Barile, 1986). These strains show 
marked antigenic complexity and at least eight representitive sera are required to 
identify ail strains of U. diversum (Howard et ai. 1975), however, it has been reported 
more recently, (Howard and Gourlay, 1981) that bovine ureaplasmas can be subdivided 
into just the three type strains by antisera raised in gnotobiotic calves. These bovine 
strains appear to be very similar to those strains isolated from humans 
{U. ureaiyticunFi in terms of growth requirements and also in terms of their short 
growth cycle and low titres compared with that of other large colony mycoplasmas
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(Taylor-Robinson et al. 1971). However, these strains could be differentiated from 
each other using the metabolic inhibition test (Purcell et a/,1966) suggesting that 
strains from human and cattle are not antigenically identical. The G + C content of 
these organises differed, when compared to ureaplasma isolated from humans 
(28.7-30.2 %, U. diversum (Howard et al. 1978), 27.7-28.5 %, U. urealyticum, (Bak and 
Black, 1968). Several strains isolated from cattle were subjected to SDS-PAGE and 
several distinct bands could be identified, although the protein profiles observed were 
very similar to those seen with human ureaplasmas, suggesting these strains, although 
not antigenically identical, may have many structural components in common
(Taylor-Robinson et ai. 1971; Howard et ai. 1981).
Ureaplasmas have now been isolated from a number of animal species other than 
cattle. These include dogs, cats, nonhuman primates, sheep, goats, birds, pigs and 
mink (Howard and Gourlay, 1982), and both bovine and human ureaplasmas are 
apparently distinct from these ureaplasmas.
Based on SDS-PAGE and on immunofluorescence with antisera prepared in calves, 
the ureaplasmas isolated from sheep and goats can be regarded as comprising two 
serological groups not related to the species of origin (Howard and Pocock, 1983). 
However, the polypeptide pattern of these strains resemble those of U. diversum 
Furthermore, the G + C contents of DNA from ovine-caprine ureaplasmas were similar 
to those of bovine strains (Howard et ai. 1978). Thus it has been suggested that the 
ovine-caprine strains may represent additional subgroups of U. diversum (Howard and 
Pocock, 1983). Ureaplasmas isolated from non-human primates appear to form four 
serologic groups, as do the ureaplasmas isolated from canines. Like the ovine-caprine 
strains, the feline ureaplasma strains form two serogroups, whereas ureaplasmas 
isolated from birds form only one serogroup (Koshimizu et ai. 1984; Barile, 1986). The 
avian ureaplasmas have been classified as the third species {U. galloraldi, by 
Koshimizu (1987) on the basis of Metabolic inhibition tests. As yet, this third species 
has not been recognised by the international Taxonomy Subcommittee.
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Black and Krogtgeard-Jensey (1974) first separated human strains of Ureaplasma 
srealyticsm into eight distinct serotypes using serological procedures (see next 
section). Subsequently this typing scheme was expanded to fourteen serotypes based 
on results from a modified Metabolic Inhibition test and a colony indirect 
epifluoresnanca test (Robertson and Stemke, 1982). Further study indicated that two 
separate groups could be distinguished based on DNA-DNA homology, (Christiansen et 
ai. 1981), reettiction endonuciesae DNA digestinn pateerns, (Razm et al„ 1983), 
polyacrylamide gel electrophoretic polypeptide profiles, (Mouches et ai. 1981) and 
sensitivity to manganese salts, (Robertson and Chen, 1984). Cluster A consists of 
serotypes 2,4,5,7,8,9,10,11,12 and cluster B consists of serotypes 1,3,6 and 14 but the 
results with serotype 13 were not definitive and as a consequence it has not been 
included in either cluster (Stemke and Robertson, 1985). However, more recently, 
sixteen serotypes have been identified using a compiament-dependans 
mycoplasmacidal test (Lin, 1985).
1.1.1. SEROLOGY OF UREAPLASMA UREALYTICUM.
As yet, all human clinical isolates of ureaplasma belong to one species with 14 
serotypes. As both semstemati c nd d tsemptemati c nddividusl s have proven 
culture-positive for draaplasmus, the serological typing of clinical isolates may be an 
important approach in establishing the aatiological eole of titis guyanism in 
pathological conditions of man.
In the early 60's, due to the lack of serological tests, the number of teeosypan 
within this group waa unknown but t hbre are n ow many mi^^t^revt aeats which chn be 
utilised to serotype shate organisms and each will be discussed in turn.
1.1.1.1. Metabolic Inhibition (M.I.) Test.
The Metabolic Inhibition test was fimt described by Jentay in 1964 for
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mycoplasma species other than ureaplasmas. in 1966, Purcell et al. described such a 
test for ureaplasmas and suggested the presence of at least 6 serotypes. This test 
utilises the fact that ureaplasmas breakdown urea to ammonia which produces an 
increase in pH.Thls can be detected using a pH indicator, usually phenol red, and 
depends upon the inhibition of multiplication of the organism which is induced by 
specific antisera, usually with the addition of complement, with consequent delay in 
the rise in pH of the culture medium.
However, since the inhibitory activity of the antiserum is usually incomplete, the 
empirical use of the test depends upon reading the changes in pH at various times, 
usually when the control tube has risen by 0.5 of a pH unit. This control tube is then 
compared to tubes containing antiserum and complement. Thus, titres vary with the 
time when the readings are taken, the titres are often low and there are difficulties in
the reproducibiiity of the test.
it has been suggested (Lin and Kass, 1970) that some of the variabilities are due to 
the inactivation of the fourth component of complement (C4) by ammonia. These 
workers suggested that if the concentration of urea was decreased, this would in turn 
decrease ammonia production and the subsequent inactivation of C4 and thus tests 
would be more reproducible. Using this method, these workers suggested the 
presence of at least 11 serotypes within this species (Lin et at. 1972).
This test was modified in 1979 (Robertson and Stemke) by introducing a more 
reliable endpoint. This was facilitated by using bromothymol blue indicator broth. 
Again this system contained only a low percentage of urea (0.025 % compared with 
0.05 % in the original test). These workers suggested the presence of at least 9 
serotypes using this system and later identified another serotype (type 10) using this 
Modified inhibition test and a colony indirect epifluorescence method (discussed later) 
(Robertson and Stemke, 1982).
Disadvantages of this test include the fact that mixed cultures cannot be identified
8
and fastidious organisms or slow growing serotypes may be wrongly typed.
1.1.1.2. Growth Inhibition (G.I.).
This test is similar to (1.1.1.1) above but it is performed on solid rather than in
liquid media. Mycoplasma species can be identified by inhibition of growth with
homologous hyperimmune serum. The serum was originally incorporated into the agar
on which the mycoplasmas were subsequently plated (Edward and Fitzgerald, 1954)
but this serological identification procedure was subsequently refined by saturating
small filter paper discs with specific antisera and placing these discs on the agar 
surface (Clyde,1964), and thus the volume of antisera required was greatly reduced. 
This test was further modified by Stanbridge and Hayfiick (1967) by drying 
antibody-impregnated paper discs at 5° C and then storing them at -20° C where 
their inhibitory activity was retained for longer than 7 months.
However, ureaplasmas have been reported not to be inhibited by their homologous 
hyperimmune sera tested with the paper disc technique (Black, 1973a), but this could 
have been due to the lack of potent antisera. Several factors such a inoculum size 
and amount of antiserum are found to influence this test. Black (1973a) suggested the
use of antisera in wells rather than on discs as this increased the zone of inhibition
due to the increase in diffusion through the agar. The incubation temperature was also 
critical and was found to be optimal at 27°C as this decreased growth rates and 
allowed sufficient diffusion of antisera. Using this test, 8 serotypes were identified 
(Black, 1973a).
The major advantages of the Growth Inhibition test are its simplicity and specificity 
(Black, 1973a; Piot, 1977); however, this test is less sensitive than indirect 
immunofluorescence (see later) and the Metabolic Inhibition test. Mixed cultures are 
also difficult to identify and a cross reaction is often seen with serotype 2 and
serotype 5 (Piot,1977).
9
1.1.1.3. Immunofluorescence.
This method of classification involves the growth of the mycoplasma on solid agar 
plates. The colonies are cut from the agar, placed on slides and can be either stained 
without prior fixation or fixed at 80°C in distilled water. However, hot water fixation of 
uraaplasmes tends to increase the number of cross reactions seen (Black and 
Krosgaard-Jeysen, 1974). in addition, the fluorescence of unfixed colonies is uniform,
whereas hot water-fixed colonies tend to fluoresce in the centre of the colony only
(Rcsendal and Black, 1972).
Both indirect and direct staining methods have been utilised with varying sucnest. 
Indirect immunofluaresenne (indirect epifluoresceyne) was first used for serological 
classification of uraaplasmas in 1970 by Black and again in 1974 by Black and 
Krogsgaard-Jansen. This method appears to produce less background fluorescence 
compared to the direct method but this could be due to the specificity and/or the 
fluorachrome to protein (F/P) ratio of the labelled sera. The indirect method appears to 
be more sensitive than the direct method according to these workers and utilising this 
technique, 8 serotypes were identified with one crats-reacsion between antiserum to 
serotype 2 and serotype 5 antigen.
This technique was later modified by Stemke and Robertson in 1981, such that 
colonies were cut from plates using a cylindrical punch and transferred to a 96-well 
plate. Thus the procedure is faster and less cumbersome and cansaquantly large 
numbers of isolates can be processed together. Pot (1977) using the indirect method,
reported several crast-reensioyn:
antiserum against type 2 with antigen types 1 and 5.
antisaedm against tyyp 4 with antigen 2.
antiserum against tyyp 8 with antigen yypes 4 and 7.
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However, if colonies were washed overnight affer staining, this reduced
background and some weaker cross-reactions. Results from this tess are also
subjective to read.
*
This method has two advantages, it can be applied to primary growth on agar and
can be used to identify mixed serotypes. Unfortunately, stained and unstained colonies
cannot be viewed simultaneously.
1.1.1.4. Indirecc lmmunoperoxtdase.
This tate is an alternative to the immunofluorescence test and was described by
Polak-Vogelzang er al. in 1978 with ratpatt to Atholaplcsma and Mycoplasma as many
of thate colonies autoflunrasce.
This test is cm-i^e o^ aa for the indirect immunoflusrescesra tess with the
secondary antibody being tagged with peroxidase rather than a flusrsthroma. The 
result is taen by aading 3,3'—diaminobenzidine droch horride solurio n nnd
hydrogen peroxide tisca this suy-trata forms a dark brown precipitate on the colonies 
in the prascence of the enzyme. In most tases this test is as tantitive as the
immtnsfltorsttasa test.
This method was used in 1981 {Quinn et al) for the identification of U. urealyticum 
serotypes and was reported as being ideal for detecting and identifying mixed 
serotypes as stained and unstained colonies could be visualised simultaneously. Highly 
dilute antitara can also be used which removes any tross-raattiviey which is
sometimes seen with both the Growth Inhibition and immunofluoresast tese-.
Thus, this test is not only simple and rapid, but can be dnsa directly on primary 
plates and is also tassitva and specific.
One disadvantage is the variation in the intensity of staining from day to day, also 
colonies of bcttarif or yeast nccationsally stain due to endogenous peroxidase
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activity.
This technique was modified by imada et at. in 1987 such that antiserum was
adsorbed to squares of filter paper and these were applied to individual colonies. 
Similarly, filter paper saturated with conjugate, was applied to the colony and
developing solution was then poured on to the agar plate surface. This modification
allows one plate to be tested with several antisera without having to transfer agar
blocks to another vessel. However, occasionally colonies peel off the plate during the
staining procedure and this results in poor staining. This test has recently been used 
to detect an antibody response in patients sera and appears to be very sensitive 
(Quinn and Th'Ng, 1988).
1.1.1.5. DNA Homology.
Many of the pitfalls of traditional taxonomic methods can be circumvented by 
directly comparing the genetic constitution of organisms. G + C content and DNA 
hybridisation methods were used by McGee et at. (1967) to study relationships among 
Mycoplasmas, L-forms and bacteria. These workers concluded that there was 
extensive genetic heterogeneity amongst mycoplasmas and suggested that L-forms 
were not related in any way to mycoplasmas.
in 1968, Bak and Black, studied the DNA base composition of 7 ureaplasma strains 
using thermal denaturation (Tm) and G + C contents were determined and found to be 
27.7-28.5 % but no significant difference was found between individual serotypes.
in 1969, Bak et a!. studied genome size of several ureaplasmas and other 
mycoplasma species including 7 strains requiring sterols and 3 strains not requiring 
sterols (Acholeplasmas). These studies suggested that those strains not requring 
sterols constitute a distinct group with a genome size of 1.0 X 10® daltons and 
sterol-requiring organisms have a genome size of about 4.6 X 10® daltons.
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The above results were confirmed by Black et al. (1972b) using Tm and CsCI 
gradient centrifugation suggesting the correct classification of the dreaplasmes with 
the mycoplasmas, and the inability of these techniques to serotype shate organisms.
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1.1.1.6. Enzyme Linked Immunosorbent Assay (ELISA).
Eight serotypes of U. srealyticsm were studied and characterised using a modified
ELISA with a sonicasav antigen suspension (Tueunen et ai, 1982). These workers noted 
cross-reactions with serotypes 2 and 5 and also with teratppat 4,7 and 8 and 
suggested this was due to the sharing of a common antigenic component. These 
workers also claimed the ability to detect mixed cultures with this test.
This test was also studied by Wiley and Quinn (1984) for the detection of specific 
antibodies to U. srsalyticsm serotypes, where they compared both soluble and 
particulate antigens. The soluble antigen was apparently more taytitive suggesting 
that purified antigen may not be nanessery to obtain serotype specificity. Again, a 
ane-wap ceonn reaction was seen with type 2 antisera and type 5 antigen.
In contrast, Brown et ai. (1983) found their ELISA method gave yonseenific results 
for the 8 serotypes. However, the antigen was prepared from organisms lysed with 
0.05 M cerbonata-bicaebanete bufer, pH 10.0, but this should not account for the 
diOarence in seanificity. Wiley and Quinn suggested the difOerence may be due to the
standardisation of the ELISA method used.
This method when standardised correctly appears to be rapid, simple, reproducible
and ecoyominel with reagents.
1.1.1.7. Isoelectric Focussing and Polyacrylamide Gel Electrophoresis (PAGE).
Electrophoretic patterns of the cell proteins of 12 ueeaelesmes isolated from man 
were studied (Razin et al, 1970). The results observed suggested that these 12 strains
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represented a group of closely related strains possibly belonging to the same species. 
As horse serum from the medium was found to co-pellet with the organisms, this was 
replaced with 1 % (v/v) PPLO serum fraction which appeared to aleviate this problem.
•»
Black and Krosggaard-Jensen (1974) confirmed the above results when they
studied 8 serotypes and these workers felt that this method was unsuitable for the
differentiation between, and identification of, the serotypes.
Sayed and Kenny (1980) identified 36-40 polypeptides and suggested that at least
80 % of these were common among the 8 serotypes studied; this was confirmed by
isoelectric focussing. To prevent medium contamination of cell pellets these workers
used a diaiysate broth base supplemented with agamma serum.
Howard et al. (1981) modified this technique such that PAGE was performed with 
polypeptides labelled by growmg organirms in the presenee of 35S-labelled 
methionine. These workers compared bovine and hh^m^n isolates and found the bovine
strains had many common peetidds, as did tde hhman asolates. The e timam ntolatet 
could however be distinguished from the bovine isolates, thus supporting the view 
that bovine ureaelasmas sSco^ be eegarded as a separate species from
U. urealyticum
Mouches et a. (1981) also studied 12 human serotypes using this modified 
technique. Both 1- and 2-dimensiosal PAGE were utilised and these workers 
differentiated the human urseelesmas into 2 distinct groups, a finding confirmed by
Swenson (1983) who studied 9 serotypes.
Labelling whole cells with —S-labelled methionine avoids the problems of 
contamination with growth medium, but some of the polypeptides may fail to
incorporate this amino acid.
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1i1i1i8. Immunobinding.
This method has been datcriyad by Kotani and McGarrity (1985) and is a 
modification of,that nascriyed by Hawkes et at. (1982). Briefly, 10 jI of test specimen, 
cell culture tuparnatast, broth culture or clinical sample are dotted onto nitrocellulose
paper which was previously washed in distilled water. This is followed by the
application of specific anti-mycoplasma antisera and after incubation, an enzyme 
conjugated antitarum against the first antisera is applied. A positive reaction is 
indicated by the daveslpment of an intense blue colour reaction when substrate is
applied.
Nonspecific reactions are ssss with this test but can be eliminated by further 
diluting the primary antisera. However, this test requires a cell rnncantratisn of at 
least TO4 c.c.u. ml-1 but has the advantage of being rapid and simple as well as not 
having the need for the growth of the organisms providing they are present in high 
enough numbers in the clinical sample. This could be a problem for mycoplasmas 
such as ureaplctmat.
1l1l1l9l Indirect Haemagglutination Test.
This test was dastribed by Stavinsky (1954) and was used successfully for the 
detection of Mycoplasma pneumoniae antibody by Oowdle and Robinsns (1964). 
Seven human urecplatmas were cIso typed using this method (Black, 1970), although 
high homologous titres were ssss for each of the tavas serotypes, various degrees of 
crots-racctiviey occurred. Krosgaarn~Jsn-ss (1971) also reported the sucte--ful use of 
this test for typing both mycoplasmas and urecplasmct.
1.1l1l10l Direct Test For Urease.
Ursaplasmas grown on solid media can be differentiated from other mycoplasmas
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using this test (Shepard and Howard, 1970).
Ureaplasma colonies are first exposed to urea and the ammonia produced is
detected by manganous chloride (0.8 % w/v) sime deposits of manganese dioxide are 
*
formed on the sdOace of the colonies. Colonies must be young as the test may be
unreliable if applied to draaelasma calayies that have been incubated longer than 48 
hr at 37°C. However, this test will not differentiate serotypes of ureaelesmas.
The above tests have divided U. srea/yticsm into at least 14 serotypes (Robertson
and Stemke, 1982) although more recently, 16 serotypes have been putatlvely
identified using the Modified Metabolic Inhibition test (Lin, 1985.; Kass et al, 1986).
The ideal method for sarotyping strains of ureeelesmas should have a high 
specificity and sensitivity with economical consumption of antisera and other reagents.
The method should also be simple and rapid in order to be suitable for typing a large
number of organisms and the results should be reproducible.
Many of the above tests have limitations due to complex technical procedures and 
difficulties in standardising the test results and thus a combination of at least two
methods is usually med to confirm results. This is time consuming and expensive 
and many of the above techniques can only be carried out by laboratories with access 
to appropriate antisera/antigens. Recently, antisera to the 14 serotypes of 
U. urea/yticsm have been prepared (Th'Ng and Quinn, 1988) and are available through 
the Research Development Corporation at the Hospital for Sick Children, Toronto,
Canada.
1.2. CELL, MORPHOLOGY AND SIZE.
The most important characteristic that distinguishes the mycoplasmas from other 
prokaryotes is their total lack of a cell wall and naytaqueytlp, mycoplasmas are
sensitve to lysis by osmotic shock, alcohols, organic solvents and detergents. This
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lack of a cell wall also accounts for the plasticity of these organisms, and as is to be 
expected from plastic organisms, the coccus is the basic form of all mycoplasmas. 
However, elongated, fusiform, bottle-shaped or filamentous forms of some species can 
be observed under different growth conditions (Reviewed by Maniloff and Morowitz, 
1972).
Due to the different methods used, there has been wide disagreement on the
minimal size of mycoplasmas (Reviewed by Razin, 1969). Studies using filtration 
methods usually do not specify the positive or negative pressure applied and this is 
important as the plastic organisms can change their nhees and squeeze through filter 
pores smaller than their actual diameter (Morowitz, 1967). Cells of several 
mycoplasmas were found to pass through Milliears filters of 0.22 zum pore diameter 
when the Swinney hypodermic adapter was used. The positive pressure, which is 
apparently quite considerable, cannot be controlled using this method (Razin, 1969) but 
at a controlled negative or positive pressure, many mycoplasma cells did not even 
eann through 0.45 um pore diameter filters (Razin et al, 1968).
Electron microscopy has been frequently used to measure the diameter of
sectioned cells. Membrane-bound bodies filled with ribosomes and having a diameter 
of 0.1-0.2 p have been observed and these were considered to be the minimal 
reproductive units (Anderson and Barile, 1965). However, the values obtained by 
measuring sectioned cells may vary considerably with the elens of the section and 
could be influenced by the method of fixation employed.
There is now general agreement amongst mycoplanmalogists that the diameter of 
individual mycoplasmas varies from 0.33-1.0 /jm and these represent the smallest 
reported living cells (Morowitz, 1967; Razin, 1978). Observations by Robertson et ai. 
(1975) support the above conclusion by showing that the small spherical bodies, 
0.1-0.25 ,um in diameter, isolated from Mycoplasma homlnls cultures could not
reproduce.
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Urecplcsmas are generally round to ovoid and are reported as being between 
0.3-0.8 /jm in diameter, (Razin et al, 1977) and have a colony size of 7-20 zum 
(Shepard, 1954), but Mcnchss and Taylor-Robinson (1969) reported colonies of greater 
than 200 zum in diameter with the addition of HEPES buffer. Black et at. (1972) have
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also reported the sbtsrvatios of short rod-shaped cells and filamentous partially
branched forms. Nevertheless, the majority of ureaplasmas are single, ovoid cells and
filaments or organisms attached in long chains were not found by Razin et al. (1977).
1.2.1. THIE C^I^L. MEMBRANE 01= UREAPLASMAS.
The tellt are snrloten by a single tri-iamincr membrane approximately 10 nm
thick but a ruthenium red layer appears on the surface of the membrane and is
approximately 20-30 nm thick. Application of Conranavilin A-iron dextran stain 
indicates that this layer contains glucotyl-liks retidust (Robertson and Smook, 1976).
Whilst this layer may repre-ene an adsorbed accumulation of ccrbstynrats from the 
growth medium, different strains of ursaplcsmas differ in their ability to to produce a
ruthenium rsn-potitivs capsule even when grown in the same conditions and hence it 
may represent a lipsglytan sysehssised by the organism because of its resemblance
to the galactcn from M. mycoides. Lipnglycans are polytacthcrides covalently attached 
to lipids and are found as surfccs structures on many Mollicutes. Smith (1985) ha- 
examined serotypes 3,4 and 8 of U. urealyticum and found lipoglycass atssciated with
all three and showed that all the sugar components were neutral in character and 
tossi-ted of mcnnsts, glucose and galactose. Glycerol, fatty acids and phosphorus 
were all integral components of these structures and all three serotypes exhibited 
ratios of components and neutral sugars distinct from each other. Lipoglycans are 
thought to play a role in maintaining structural stability and/or in adtesins of the 
organism to mucosal turface- (see section 1.7.4).
No surface appendages such as flagella have been observed but it has been 
reported by Black et al. (1972a) that ureaplasma tellt have an electron dense layer
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consisting of hair-like steuntdren. They have suggested that these hair-like structures 
play a role in reinforcing the membrane. They may also play a role in adherence of 
the organism to the epithelial cells of the ueinogenital tract or they may be involved in
haemadsoretion, but since only serotype 3 adsorbs to erythrocytes, this explanation
seems unlikely (Black, 1973b).
Unlike the situation with many walled bacteria, the membrane is easily isolated by
gentle procedures such as osmotic shock. The maximum osmotic pressure tolerated 
by most mycoplasmas lies in the range of 12-14 atms (Leach, 1962) and the organism's 
seysitivitp to osmotic shock apparently denreetes with the increase in the age of the 
culture (Razin, 1964), and with the presence of even trace amounts of divalent cations 
in the growth medium (Rodwell, 1965). Changes in the osmotic fragility of the nellt 
can be caused by variations in the cholesterol content or in the ratio of unsatureteV 
to saturated fatty acids in membrane lipids and these parameters apparently alter with 
ageing of the culture (Razin, 1979a).
Other methods for isolating sterol-requiring mycoplasma membranes include 
digitonin-mduced lysis since digitonin forms a complex with cholesterol in the 
membrane, apparently causing considerable rearrangements in the lipid bilayer^, leading 
to an increased permeabiiity and cell lysis (Rottem and Razin, 1972). The success of 
this technique Is not influenced by culture age or the presence of divalent cations but
the membranes seem to retain the cholesterol-digitonin complex so that their
organisation and composition are altered.
Alkali lysis, alternate freezing and thawing and soyication are other methods also 
used. Romano and LeLicate (1978) showed that ultrasonic treatment disrupted all the 
cells in a cell suspension of deaeplanmen, whereas osmotic shock only lysed about 
50% of the calln and digitoniy only about 70 %. Like other biological membranes, 
mycoplasma membranes consist essentially of proteins (50-60%) and lipids (30—40%). 
However, these membranes are often contaminated with precipitated components of
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the growth medium and this seriously hinders their chemical, enzymatic and antigenic 
characterisation. As ursaplanman are routinely grown at a low pH, (pH 6.0) this may 
cause precipitation of proteins and lipoproteins from the serum campossst of the 
growth medium which then co-sediment with the cells during harvesting. The cell 
yield of ureaelanman is so low that most of the pellet may consist of non-cellular 
comeansstn. Masover et al (1976), reported the protein content of the 'membrane' 
fraction isolated by digitonin treatment of U. urealyticum grown in unfiltered Hayflick's 
medium, was about 25 times higher than the amount in the cytoplasmic fraction. 
Reduction of the serum content and pre-filtration of the growth medium reduced the 
membrane to cytoplasmic protein ratio to approximately 10 (Manavsr et ai, 1977b). 
Centrifugation on sucrose gradients also separates the ursaplasma cells from 
nonspecific precipitates. Thus, analysis of ureaplanme membrane preparations as 
reported by Whitsncerver et al (1975) are clearly questionable.
As mentioned previously, ureaplanmas require fatty acids and sterols (usually in 
the form of cholesterol) to support growth. Cholesterol makes up approximately 
12-30% of the total membrane lipid and free fatty acids and phosphatide acid are the 
other predominant lipids of urseelasmas (Romano et al, 1972) with the remaining 
neutral lipids being composed of cholesterol esters, triglycerides and diglycerides. 
Three glucose-containing glycaiieidn are also present as well as several other 
phospholipids (Rottem et ai, 1971). Crude estimates of the lipid composition of 
ureeplasmas suggest a ratio of neutral to phospholipids of about 1:1 and of
cholesterol esters to cholesterol of about 1:4.
in ursaelesmas, free fatty acids have been postulated to control the function and 
integrity of the membrane by neutralisation of the copious quantites of ammonia
produced by urea hydrolysis. The production of strongly acidic lipids, such as
phosphatide acid, may also help to compensate for this production of ammonia
(Romano et a!, 1972).
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The only common feature of the polar lipids among all members of the Mollicutes
is the existence of acidic glyternphospholipids (Smith, 1973), phosphatidyl glycerol and
diphosphatidyl glycerol are ubiquitous. Unique polar lipids are found in Atholsplcsma,
Thsrmoplcsma and Ursaplasma. Ursaplasmas are the only member of the Mollicutes
yet shown to contain the predominant bacterial phospholipid, phosphatidyl 
sthanolamine (Romano et al, 1972) and in addition to this positively charged lipid, 
urscplasmcs also contain an unidentified amino lipid which appears to be a diamino
hydroxy compound containing adjacent fatty acid esters and N-acyi groups. The 
uniqueness of the lipids of ursaplatmat may reflect both its acidic pH optimum for 
growth and its copious ammonia production.
Carbohydrces appears to be a minor component (0.5-2% dry weight) of any 
mycoplasma membranes as yet analysed. Studies on mycoplasma membranes have 
tuggssesd that the lipids are organised as a b^ayer with the carbstynrats containing 
lipids preferentially located in the outer half of the bilayer whilst phospholipids and 
chslsttsrol in mycoplasmas are present in both sides of the membrane but often in
niffsrsst propoetiont.
Most mycoplasma membrane preparations also contain a small amount of RNA and 
DNA which are presumably cytoplasmic contaminants as they can be removed by 
washing and nuclease treatment (Razin, 1969).
1.3. REPLODUCT1ON.
The dispute over the morphology of mycoplasmas is part of the controversy 
surrounding their mode of reproduction. It is still impossible to follow the 
reproduction of a single urscplc-mc cell because of its minute nimen-ins- and 
descripeinss are therefore based on rsprsssntativs teriss of sequential electron 
micrographs for a number of individual dividing cells. The theory that reproduction 
takes place through the liberation of many elementary particles by large bodies
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(Klleneberger-Nobel, 1962) saamn to be loosing ground, as larger bodies are coming
to be recognised as swollen, mostly dead cells. The mycelial theory, involving the
development of elementary bodies into filaments which subsequently break up to form
new elementary bodies has received strong support from phase-contrast microscopy *
studies (Razin and Cateyza, 1966).
Several workers have suggested that mycoplasmas reproduce by budding, whereas
more recently, others have suggested reproduction accdet by binary fission. For
typical binary fission to occur, cytoplasmic division must be fully synchronised with
genome replication, and in mycoplasmas, cell septation may lag behind genome 
replication, resulting in the formation of multinucleete filaments, (Reviewed by Razin,
1969, 1978; Maniloff and Morowitz, 1972).
1.4. (CEL. GROWTH
The small geyama size and restricted metabolic capabilities (see section 1.8) 
explain the fastidiousness of mycoplasmas in their cultural requirements. Indeed, there 
may be species of mycoplasmas which remain to be discovered due to the lack of an 
appropriate medium for their isolation and growth.
Mycoplasmas are sensitive to environmental conditions such as the tonicity of the 
medium, are nutritionally exacting and require a iarge array of eeecurtorn for the 
synthesis of macromolenuien. Many of the complex media that have been Vascei'bed 
for the cultivation of mycoplasmas are based on that of Edwards (1947) and usually 
contain peptone, beef heart infusion, yeast extract to supply nucleic acid precursors 
and other growth factors, sodium chloride to adjust tonicity and animal serum. The 
serum provides fatty acids and cholesterol in an essimiabla and non-toxic form for 
membrane synthesis, and the albumin comeoyayt of serum functions as a carrier and 
detoxifier of the fatty acids.
Unfortunately, the presence of animal serum usually from the horse, creates
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difficulties when harvesting the cells as many of the serum components adsorb to the 
surface of the organisms and consequently co-pellet with the cells thus contaminating
the preparations.
Attempts to'replace serum with better defined or less complex materials have only 
been partially successful, usuaUy resulttng in v^r^r/ low titres of cells.
The ursaplesman are dissinguished ffom ah oahes Mollicuees by eosssssion of the
enzyme urease (Shepard and Lunceford, 1967). Most evidence suggests that urea is an 
essential substrate for growth, although earlier, Menaver et al (1973; 1974) had 
suggested that urea was not essential for growth and could be substituted with 
allestaln and/or putrsncine dihydrochloride. However, it is possible that trace amounts 
of urea were present in ttih snum comneanss oO ttih mneium. TTh fact that specific 
urease inhibitors inhibit the growth oO uJUselaamaa (Kesns, 19983 supports the key 
role of urease in urseelasmal growth and it has been suggested (Romano et al, 1986) 
that this enzyme is involved in energy production (section 1.5).
Most uueaplanme media are supplemented with small amounts of urea (0.05%) 
since higher concentrations (0.25 M) are inhibitory to the cells and the presence of the 
uusess does not appear to protect these organisms when compared to Mycoplasma 
h0m/n/S and Acholeplasma laidlawii (Masoyer et al, 1977a). The urea is metabolised to 
carbon dioxide (CO2) and ammonia and the production of the latter causes a rise in pH 
which can be detected by an indicator (eg, phenol red, bromothymol blue) and in 
liquid culture, this change in colour is used to detect the growth of the organisms.
Growth of urseelenma cells occurs optimally at a starting pH of 6.0 and the pH of 
the medium rises to approximately pH 7.9 at the stationary phase of growth (see Fig
1.1).
Solid media for ursaelanmas are of two types: differential agar medium and 
standard agar medium. Differential agar medium (A7), which is available commercially,
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includes a divalent cation indicator such as manganous sulphate which detects the
production of ammonia and consequently, urease activity (Shepard and Lunceford,
1976). Shepard and Coombs (1979) modified this medium by adding putrescine which
increased the ,size of the colonies seen and this modified medium is known as
A7B. Growth of ureaplasma colonies on standard agar medium can be detected by the 
spot test which involves the addition of manganous chloride on to suspected 
ureaplasma colonies (Shepard and Howard, 1970; see section 1.1.1.10); the best growth 
of ureaplasmas on solid media is in an atmosphere of 5% CO2 in nitrogen.
Characteristically, ureaplasmas do not grow to titres higher than 108 colour 
changing units (ecu) (see section 2.2) in vitro. When ecu's are assayed, they follow 
typical bacterial growth curves, (Fig 1.1), with lag, exponential, stationary and death 
phases. In the exponential phase at 37°C, most cultures have a doubling time of one 
to six hours. The length of the stationary phase varies but is frequently very short, 
around 6h (Maniloff and Morowitz, 1972), or if the medium is buffered with (a) CO2, 
27h, but with no increase in viable cell numbers (Thirkell, personal communication, 
1987), or (b), with HEPES (Manchee and Taylor-Robinson, 1969). The subsequent death 
rates are also quite rapid; the titre drops by a factor of 102 - 104 c.c.u. h"1, even in 
well buffered medium (Kenny and Cartwright, 1977; Masover et al., 1977a).
Whether this rapid decline is due to the rise in pH caused by the production of 
ammonia is uncertain. As previously mentioned, bubbling CO2 through the medium 
does lower the pH but does not improve the growth of these organisms, thus some 
other factor must be involved (Masover et al„ 1977a).
Exhaustion of urea or other medium components is also apparently not the cause, 
and Furness (1973) has suggested the presence of a catalase-resistant, heat-stable, 
dialysable toxic product which apparently inhibited all strains of ureaplasmas tested.
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A pH
Fig 1.1: Growth and pH profile of 10 pi seed (103 c.c.u. ml*1 of U. urealyticum 
100 ml"1\
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1.5. METABOLISM
The metabolism of ursaplanman is poorly defined with low cell yields still the
major factor limiting biochemical studies. U. urealyticum appears to lack the
conventional mechanisms for adenosine-5-triphosphate (ATP) generation such as
glycolysis or arginine breakdown, present in other mycoplasmas. Many of the enzymes
which have Isss shown to be present and absent have been discussed by Cocks et al. 
(1985) and by Pollack (1986). The inability to detect enzymes in ursaplasmes may 
reflect the poor cell yields rather than the true absence of the enzymes, and Cocks et 
al. (1985) found that using sensitive radioactive assays helped to overcome this 
problem.
Using these anneyn, Cocks et al. (1985) have detected the activity of certain 
enzymes in the latter half of the glycolytic pathway (ehasphofructakinans, aldolase, 
triose-phosphate isomerase, glycsraldshyds-3-ehosphate dehydrogenase,
glycerol^-phosphate dehydrogenase, malate dehydrogenase, enolase and pyruvate
kinase), but the activities observed for the glycolytic enzymes in extracts from 
U. urealyticum we re considerably lower than those in M. mYCoidsn (Cocks et aL 1985). 
This could have been due to dilution of the small amount of U. urealyticum protein in
the extracts by contaminating protein from the medium (see section 1.2.1). The extent 
of the differences between the two activities suggests a different role of the glycolytic 
pathway in these two organisms, i.e. that glycolysis is not a major energy producing 
pathway in U. urealyticum Nevertheless, the euenencs of many glycolytic enzymes 
does suggest some role for them in carbohydrate metabolism (Cocks ef a/, 1985). The 
lack of hsxokinene and phasehaglucoss isamsrans activity in Cl. urealyticum (Cocks et 
al, 1985; Pollack, 1986) is in keeping with the inability of this organism to ferment 
glucose. This may suggest that substrates other than glucose are feeding this 
sequence of reactions and generating phasehasnol-eyruvats and pyruvate. Contrary to 
this, O'Brien at al. (1983) detected phosphoglucose isamsrene and lactate
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PHOSPHOENOL PYRUVATE
pyruvate kinase
-i'
Fig 1.2: Metabolism around the pyruvate locus in Ureaplasma ureatyticum (as 
suggested by Davis et ah,1988).
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dehydrogenase in serotypes 1 and 2 of U. urealyticum
Davis et al. (1988), have also detected the activities of pyruvate kinase and malate 
dehydrogenase as well as pyruvate dehydrogenase, pyruvate carboxylase, malate 
synthase and as’partate aminotransferase (Fig 1.2) and the presence of these enzymes 
may suggest that the carbon of pyruvate can be recycled, passing to malate,
oxaloacetate and then back to pyruvate, or that pyruvate may be used in anabolic
pathways. Thus, although J. urealyticum is apparently a metabolic degenerate 
organism which cannot catabolise sugars through a complete glycolytic-TCA pathway, 
pyruvate may still function as a pivotal intermediate in the metabolism of this
organism.
In addition, U. urealyticum has most of the enzymes for pentose phosphate 
metabolism and this may indicate a capability for the formation of ribose-5-phosphate 
for nucleotide synthesis from glycolytic intermediates, or these enzymes could be part 
of a catabolic pathway from nucleoside to glycolytic intermediates. However, the role 
of this pathway in ureaplasma metabolism is still not clear (Cocks et at, 1985). 
U. urealyticum, also has enzymes for the degradation of nucleotides and nucleosides, 
and for further metabolism of the ribose and deoxyribose phosphates produced. The 
enzyme adenylate kinase, which had comparitively high activity, was found in extracts 
from U. urealyticum The significance of a capacity to rapidly interconvert AMP, ADP 
and ATP in this organism also remains unclear (Cocks et al, 1985).
The enzymes inosine nucleosidase, adenine deaminase, adenosine phosphorylase 
and possibly inosine phosphorylase, and AMP nucleosidase, have been detected in 
ureaplasma cell lysates and so this organism can metabolically generate hypoaxnthine 
from AMP, adenosine, inosine and adenine. The formation of hypoxanthine suggests a 
possibility for the existance of a purine salvage pathway (Davis et al, 1984). When 
these pathways are operational, adenine, hypoxanthine, and/or guanine, can be 
recycled by using them for mononucleotide synthesis. U. urealyticum is
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non-fermentative, (Shepard and Masover, 1979) and no energy source for its growth
have been defined with the possible exception of urea.
However, urea carbon is not incorporated into cellular material as most of it is 
excreted as CCT2 (Ford et a/, 1970). Thus, although it is unknown where ureaplasmas 
acquire their carbon for cell mass, one possibility arises from the observations of
Delisle (1977) who also found malate dehydrogenase activity and {^^glycerophosphate
dehydrogenase activity, again suggesting that there is other enzymatic activity near
the pyruvate locus, (see earlier), perhaps involving the tricarboxylic cycle.
Since urease is thought to be cytosolic, (Vinther, 1976; Masover et aL 1977b), urea 
hydrolysis would be expected to release ammonia in the cytoplasm. Masover et at. 
(1977b), have suggested that the ammonia will take up protons at a physiological pH 
to become ammonium ions. The intra-cellular NH4+ could then play a role in proton 
elimination or acid-base balance which may be coupled to an energy producing ion
gradient and/or transport mechanisms.
More recently, Romano et al. (1986) have shown that ATP is produced when urea is 
added to resting ureaplasma cells and its formation requires both the concomitant 
activity of the cytoplasmic urease and membrane-bound ATPase. ATPase is found in 
the cell membranes of most mycoplasmas; however, attempts to release this protein 
from membranes have as yet failed. Studies have suggested that the mycoplasma 
ATPase is an integral membrane protein probably dependent on lipids for activity 
(Razin, 1979b). Romano et al (1986) have suggested that this energetic process 
depends upon phosphate, urea, pH and ammonium ions in the reaction mixture, but 
ammonium ions appear to interfere with the production of energy when the starting 
pH is slightly basic, perhaps explaining why ureaplasma, unlike other mycoplasmas 
grow best at a starting pH of 6.0.
Masover et al (1977b), and Pollack (1986), have been unable to detect 
oxygen-dependent NADH oxidase activity and have suggested that the oxidation of
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NADH requires an acceptor other than oxygen. if the absence of axYgen-dsesndent 
NADH activity is confirmed, then this finding would further distinguish the ursaelasmes
from the other Mollicutes.
inorganic pyrophosphate (PPi) and the roles of inorganic pyrophosphatases (PPase) 
in microbes have been reviewed by Lahti (1983). PPi may be a substrate functioning as 
a source of energy while donating orthophosphate in ATP-sparIng reactions.
Davis et at. (1987) found PPase activity in U urealyticum, serotypes 8 and 6, and 
that PPase activity is present in organisms with such a small genome may indicate
that PPi hydrolysis is a basic activity in the cell. The presence of PRi-dependent 
ehoehofructokinase in Acholeplasma laidlawii suggests that PPi utilisation in this 
organism is an energy conserving pracsnn (Pollack and Williams, 1986).
Romano et ai. (1980; 1986) have suggested that orthophosphate concentration 
influences urea hydrolysis which in turn affects ATP synthesis and it may be that 
PPase helps to regulate phosphate levels in these organisms thereby optimising 
urease activity and subsequent ATP synthesis (Davis et ah 1987).
1.6. PATHOGENICITY
There are at least 90 different species of Mollicutes now recognised, of which 
more than one third are pathogenic to man, other mammals, birds, insects or plants. 
Of these 90 sescien, 12 have been isolated from humans (Embree and Embii, 1980) 
and nine of these have been found in the respiratory tract and seven in the 
genitourinary tract, but only Mycoplasma pneumoniae, Mycoplasma hominis, 
Ureaplasma urealyticum and possibly Mycoplasma genltailum are thought to be 
pathogenic. To establish a causal relationship between mycoplasma infection and 
disease it is necessary to dsmanntrats the following:­
- (1) the organisms are isolated more frequently and /or in large
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numbers from patients with disease than from those without.
- (2) antibody responses, measured by various techniques (see earlier), 
occur in patients with disease.
- (3) treatment with effective antibiotics leads to the disappearance of 
organisms and symptoms.
- (4) the organisms infect an animal host from which they can be 
recovered and, in doing so, produce a disease similar to that seen in 
man. The major problem in this respect with U. urealyticum is that 
the chimpanzee is the only good animal model and this has 
restricted the number of studies carried out.
This section on pathogenicity will be restricted to the claimed involvement of 
U. urealyticum in human disease processes, although M. hominis is frequently
co-isolated with this organism.
The major disease states with which U. urealyticum has been implicated are as
follows;-
1.6.1. NON GONOCOCCAL URETHRITIS (N.G.U.)
N.G.U. is diagnosed when urethritis is present in the absence of Neisseria 
gonorrhoeae and numerous causative agents have been suggested (Bowie, 1984; 
Reviewed by Taylor-Robinson, 1983). U. urealyticum and/or Chlamydia trachomatis 
have been isolated from the majority of N.G.U. cases (70-80%) and C. trachomatis 
itself is thought to be the causative agent of 40-50% of such cases (Taylor-Robinson 
and McCormack, 1980). Most studies initiated before 1973 did not include an 
investigation for this organism and thus these studies are difficult to interpret and
provide conflicting data.
Ureaplasmas were first shown to be associated with this condition by Shepard 
(1954) who isolated this organism from urethral discharge and this was soon
confirmed by Ford et ai. (1962).
However, it is still unknown what proportion of N.G.U. cases are due to
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ureaplasmas but the fact that it is responsible for some cases is no longer disputed 
(Taylor-Robinson et ah 1977; Brunner et ah 1983).
Low level commensal carriage of U. ureatyticum in asymptomatic individuals has 
been reported’which is both age and sex-dependent (males aged 50 or less, 21%; 
aged over 50, 7%; females aged 50 or less, 39%; aged over 50, 16%) (Taylor-Robinson, 
personal communication, 1988), but the titres of organisms recovered have been
relatively low.
Ureaplasmas have been isolated with statistical significance more frequently from
patients with N.G.U. compared to control patients in about one half of all studies 
reported and the selection of inappropriate controls has probably contributed most to
the differences seen between one study and another. It is desirable that patients in 
the control group are free from N.G.U. and have sexual habits similar to those of 
patients in the study group, since sexual experience appears to be a major 
determinant of colonisation with ureaplasmas (McCormack et a/, 1973) It is also
desirable that other pathogens such as C. trachomatis are tested for.
Wong et ai. (1977) reported that there was an association between U. ureatyticum 
only when C. trachomati^pQt'ettte patients were excluded from the study, a finding 
corroborated by Bowie et ai. (1977). Further supporting evidence that chlamydia 
infection is inhibitory to the participation of ureaplasmas in the disease process has 
come from the work of Holmes et ai. (1975) add of Paavone n et i?/.(177)J).
In 1979, Taylor-Robinson et ai. isolated chlamydia from 36% of 
ureaplasma-positive patients and found a similar isolation rate in ureap^asma-nngativn 
patients. Conversely, they isolated ureaplasmas from 52.5% chlamydia-positve patients 
and from 53% of chlamydia-negative patients so disputing these earlier claims.
The low level commensal carriage of U. ureetyticum in the urethra of 
asymptomatic males may suggest that the disease process could depend upon an
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explosion in the number of organisms present and also raises the possibility that 
some serotypes may be commensal whilst others are prsdomietely pathogenic. in 
support of this latter theory, Shepard (1974) isolated serotype 4 twice as frequently 
from men with N.G.U. as from those who were asymptomatic. However, He'wish (1986)
studied various isolates by lmmunofluarsssscs and concluded that colonisation above
the urethra and association with urinary tract disease appeared to be 
serotype-independent.
Predisposing factors, such as lack of mucosal immunity, may exist in those
individuals who do develop disease since a ureaelenmal infection of the urethra of a 
23 year old hypogemmeglabulineemlc male patient was reported (Webster et ah 1982). 
The patient developed a chronic urethral discharge from which greater than or equal 
to 5 X 10® c.c.u. ml"1 uusaplasman, but no chlamydia were isolated. Ureaelasmas may 
produce urethritis which resolves npantansously while the organisms still persist or 
disease may only develop on initial exposure to the organism. if so, studies of 
individuals attending sexually-transmitted disease clinics are not likely to provide 
useful information and unfortunately, almost all studies to date have focused on these
patients.
With rsnesct to the number of organisms involved, one of the failures of previous 
studies is that they have bsss qualitative rather than quantitative.
There are two early reports by Bowis et ai. (1977) and by Weidner et al (1978) 
which have quantitative data sueeoutleg this theory that large numbers of organisms 
are involved. in such studies, it is necessary to be awars of the possibility that mors 
organisms may bs isolated from a patient who has a discharge than from ons who
has sot.
Whereas ths significance of uuseplanmen Is N.G.U. seems no longer to bs disputed, 
the degree of their involvement is still unknown. However, perhaps ths most 
compelling evidence that ureaelasmas are associated with N.G.U. came when two
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workers inoculated themselves intraurethrally with 5 X 104 organisms of two different 
strains of serotype 5 which had been isolated from two patients with N.G.U. Both men 
developed urethritis, although one developed only a mild condition. Both men 
responded to treatment with minocycline after which the organisms could no longer
be isolated from the meatus, urine or semen. In the mild case of N.G.U., urinary
threads persisted for at least 6 months after treatment and it appeared that the
ureaplasmas had infected the urinary tract (Taylor-Robertson et al., 1971).
Ureaplasmal antibodies were detected by an ELISA technique which had broad
serotype cross-reactivity; a significant change in antibody levels for one or more 
antibody classes was detected in 12/18 NGU patients and 10/12 of the individuals had 
a change in the Ig M class suggestive of an active infection (Brown et a!, 1983). In 
previous studies, the Metabolic Inhibition test was often used and because of its 
serotype specificity this procedure would not have been able to detect more than a 
small proportion of responses and this may account for the small numbers of patients 
having a detectable antibody response. In a recent study by Deodhar and Gogate 
(1988) U. urealyticum was isolated from 48 % of patients with N.G.U. and an antibody 
response In these patients was shown using an ELISA test. C. trachomatis was 
detected in 24 % of patients with this condition, confirming that both organisms play
a role in N.G.U.
Another useful approach to understanding the role of ureaplasmas in this disease 
is to treat patients with antibiotics which have differential activity against 
U. urealyticum and C. trachomatis When patients with N.G.U. were treated with 
rifampicin, which acts against chlamydiae but not ureaplasmas, ureaplasmas were 
isolated from 55 of 68 men whose tests for ureaplasmas had initially been positive. Of 
these men, 44% did not recover, whereas only 8% of men whose ureaplasmas
disappeared were not cured (Coufalik, 1979).
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1.6.2. INFERTILITY.
Adsorption of human spermatozoa to colonies of mycoplasmas was reported in 
1967 (Taylor-Robinsoa and Manchee) but the significance of this was unknown. 
Ericsson and Baker (1967) isolated ureaplasmas in large numbers from the ejaculates
and cervical secretions of a selected group of patients with unexplained infertility and
these workers suggested that the ureaplasmas were attached to the sperm cells.
Evidence to support this came from scanning electron microscopy (Gnarpe and 
Friberg, 1973) which revealed ureaplasma colonies apparently originating from the 
anterior or middle region of the spermatozoa. These workers had previously reported 
that pregnancies were acheived in 30 % of infertile couples after eradication of 
ureaplasmas with antibiotics, but unfortunately, no control group was studied. A study 
by Toth et a!. (1983) also reported that treatment with doxycycline improved fertility 
due to the eradication of ureaplasmas. However, no attempts to Isolate bacteria or 
chlamydiae were made, and as this drug wJI also eradicate these organisms, no 
conclusions can be drawn from this study.
Contrary to this, Harrison et al. (1975) reported that the rate of conception in 28 
infertile couples of unknown cause, but who were contaminated with ureaplasmas and 
treated with doxycycline, was no higher than in similar couples treated with a placebo 
even though the drug eliminated ureaplasmas from 27 of the 28 infertile couples. 
Taylor-Robinson and McCormack (1980) reported similar ureaplasma isolation rates 
from the semen of males with normal and low fertility.
Semen specimens from 625 men with infertility of unknown aetiology were 
examined and of those with ureaplasma 'infections', low numbers, poor levels of 
motility and an increased number of aberrant forms were reported (Folwkes et ah 
1975a). These workers again suggested this was due to the attachment of 
ureaplasmas to the spermatozoa which impedes normal motility (Folwkes et ah 
1975b). This was supported by O'Leary and Frick (1975) but they suggested the sperm
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may also be inhibited in a biochemical sense as well as by physical hindrance. As 
ureaplasmas are reported as being present in a ratio of 1 organism to 10 
spermatozoa, even in a sample of 'infertile semen', then it seems unlikely that these 
organisms could affect motility (Taylor-Robinson, 1986b). Since the organisms 
probably gain access to semen from the prostate, urethra or prepuce at the time of
ejaculation, it would be surprising if the organisms could affect spermatogenesis or
motility (Taylor-Robinson, 1986b).
To elucidate the mechanisms whereby ureaplasmas can interfere with the
fertilisation process, a human sperm-hamster egg fertilisation test was studied (Busolo
and Zanchetta, 1984; 1985) where human spermatozoa can fuse with zona-free
hamster eggs which is considered a measure of spermatozoa fertilising ability. No 
significant change in morphology or motility of the sperm was seen after overnight
incubation in the presence of ureaplasmas (serotypes 1-8); However, the number of
eggs penetrated was greatly reduced particularly after incubation with serotype 4
(6.3% compared to 55.6 % penetration rate seen with the control). Serotypes 6 and 8
also caused reduced penetration rates and these three serotypes correspond to the 
serotypes involved in spontaneous abortion reported by Quinn et at. (1983) (section
1.6.4.2).
Ureaplasmas are known to produce ammonia during active hydrolysis of urea and 
this has been shown to be toxic for cells. Busolo and Zanchetta (1985) reported no
such effect on either hamster eggs or spermatozoa although it was unclear as to 
whether urea was present in the test. Thus, they suggested that neither a cytotoxic 
effect of ureaplasmas on gametes or a masking of the binding sites on the egg 
surface were due to the decrease in penetration. They suggested infertility could be 
due to the effect of ureaplasma in the vagina influencing the maturation of the 
spermatozoa by the production of unknown factor(s).
Urogenital tract infections have also been associated with the production of sperm
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antibodies and these in turn have been associated with a reduction in male fertility 
(Whitkin and Toth, 1983). Whether ureaplasmas could stimulate sperm antibodies is 
unknown but it has been reported that no such correlation between the presence of 
ureaplasmas in semen and sperm antibodies exists. (Upadhyaya et aK 1984).
Most of the above studies have been deficient since they have failed to exclude
the involvement of other microorganisms, particularly chlamydiae; the antibiotic
studies have not included placebo-treated controls and there has been a failure to 
match the control groups for factors known to influence ureaplasma colonisation.
If ureaplasmas play a role in prostatitis and if prostatitis is a cause of infertility, 
then by implication, ureaplasmas may be a cause of infertility.
Semen could become contaminated on passage through the urethra 
(Taylor-Robinson, 1986b), but the residence time is low. Spermatozoa may again come 
into contact with ureaplasmas in the lower female genital tract where residence time 
may permit a reduction in their mobility. In this connection, Stray-Pedersen et a!. 
(1978) recovered ureaplasmas more often from endometrial aspirates from infertile
than from fertile women.
Thus the role of ureaplasmas in infertility is unresolved and examination of female 
endometrial specimens may be more meaningful than examination of those from the 
lower genital tract. Although, Cassell et a!. (1983) sought to recover U. urealyticum 
from the endometrium of infertile patients undergoing laparoscopy and from control 
patients, these workers attempted to prevent cervical contamination of the specimens 
and no significant difference in U. urealyticum recovery was found between the 
infertile and control patients.
Properly controlled treatment studies in which the role of other microorganisms 
are considered should be carried out but it must be recognised that eradication of 
infection may not necessarily reverse the damage that the organisms may have
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caused.
1.6.3. ARTHRITIS.
Sexually acquired reactive arthritis (SARA) develops in a low percentage of males 
with N.G.U. where U. rrealyeicum has been isolated from the urogenital tract (Cole et
a/, 1985) but the isolation of these organisms from diseased joints has met with little
success. More emphasis should be placed on the detection of mycoplasma antigens 
as Immune complexes may be involved in the development of arthritis.
U. ureatyeicum has been isolated from the joints of at least three 
hypogammaglobulinaemic patients who have had septic arthritis. The lack of antibody 
in hypogammaglobulinanmic patients probably results in the failure of the 
mycoplasmas to be 'neutralised' and accounts for the diminished ability of the patients 
to cope with these organisms escaping hanmatogeaously from the genital tract. 
Furthermore, U. urealyeicrm and other mycoplasmas are Ingested by neutrophils in the 
absence of opsonins, indicated by the fact that they are able to trigger the release of 
chemilumiensencn from these cells; ureaplasmas are not killed during this process and 
it is possible that carriage occurs within phagocytes to various sites (TaYlor-Robinson
et ai, 1986a).
There is also some evidence that pregnancy may be accompanied by T-cell 
suppression, possibly allowing the development of opportunistic infections, which may 
explain why some mothers develop arthritis soon after childbirth. Thus, the role of 
ureaplasmas in arthritis is as yet unknown, but a study by Barile et ai. (1988) isolated 
a strain of U. uree/yticrm from a joint in a patient with septic arthritis which caused a 
severe and protracted arthritis in chimpanzees. In contrast, a strain isolated from a 
patient with Reiter's disease, after frequent passage, failed to produce disease in 
chimpanzees.
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1.6.4. PREGNANCY DISORDERS.
Commensal carriage of U. urealyticum in sexually mature, asymptomatic women
has been mentioned previously (see section 1.6.1.). in ths female, colonisation is
thought to be eredamieee^ly linked with younger age groups (16-50), lower
sacio-ecconomic status, sexual activity particularly with multiple partners, black 
ethnicity and oral contraceptives (McCormack, 1983). it has been suggested (Furr and 
Taylor-Robinson, 1988) that ursaelenmas are not found at a constant rate during the 
menstrual cycle suggesting that hormones may influence their colonisation or 
recovery. Female mice pre-treated with oestrogen are more susceptible to genital 
tract infection with U. urealyticum compared to untreated mice. Pregnant women also 
appear to be colonised more frequently with ureaelasma compared to non-eregnent 
women (33% compared with 22.7%) (Furr and eaylor-Roblnson,1988).
U. urealyticum may be transmitted to 38% of babies born to mothers whose 
genital tract is infected with this organism, though colonisation of the neonate 
appears to bs transient with a sharp decline in isolation rates after 3 months of age 
(McCormack and Taylor-Robinson, 1984). U. urealyticum has been associated with a 
number of disorders of pregnascy:-
1.6.4J. CHORIOAMNIONITIS.
Ths chouioemeioe denotes ths space lying between the amnion (the foetal surface 
of the sac) asd the chorion (the maternal surface), and choriaemnionitin is an infection 
of these membranes. is chaulaemeionitis, polymorphonuclear leucocytes ars sssn is 
various degress of abundance lying within this spacs; they seldom extend through the 
foetal surface of the amnios but they may go deep into ths chorion, svss to ths 
intervillous space of the placenta. This condition has bess associated with premature 
rupture of membranes (PROM) (Gravett and Eschenbach, 1986), premature delivery, 
foetal morbidity and mortality, eg neonatal pnsumonia (sse later) (Kundsln et.al 1984;
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Driscoll, 1986).
U. urealyticum has been implicated as one of the causes of this condition. In two 
studies, (Kundsin et aK 1984; Quinn et aK 1985) workers rigorously sought the 
presence of other fastidious microorganisms but U. urealyticum alone was significantly
associated with the presence of inflammation. The placental studies took into account
the time of membrane rupture but they did not consider the duration of labour nor the 
presence or absence of U. urealyticum In the cervix or vagina of study and control 
patients. This is important as recent evidence suggests that bacteria from the cervix 
or vagina often invade the amniotic fluid at the onset of labour and prior to membrane 
rupture (Cassell et aU 1986).
A more recent study has also associated U. urealyticum with chorioamnionitis 
(Quinn et aK 1987). It appears that the organism does not directly cause the 
associated PROM or prematurity and they suggest that this is due to the leucocytic 
response as neutrophils secrete the prostoglandin PGF2, a potent promoter of uterine 
contraction (Charles and Hurry, 1983).
More recently, Quinn (1988) observed chorioamnionitis in 82.6 % of women whose 
babies were born dead or died soon after birth compared to only 5 % of babies from 
women not suffering from this condition. U. urealyticum was isolated from the 
placenta in 56.5 % of these cases compared to 0 % of the controls.
Chorioamnionitis is a condition that cannot be diagnosed accurately until after the
event and as a consequence, it may be important to recognise those women at risk 
and treat them accordingly. It has been suggested that ureaplasmas are more likely to
cause complications where the women are undernourished or when the membranes
rupture prematurely (Naeye and Blanc, 1974).
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1.6.4.2. SPONTANEOUS ABORTION AND STILLBIRTH.
Kundsin et at. (1967) isolated U. urea/yticum irom the chorion, amnion and decidua
of a spontaneously aborted foetus where the foetal membranes and umbilical cord •»
were also severly inflamed and no other organism was isolated. U. urealyeicrm was
not isolated from the lungs or liver of the foetus but this organism was isolated from
a cervical swab and from urine sediments of both the husband and wife. This
suggested that the aborted foetus could have become contaminated during birth.
The ureaplasmas isolated from aborted foetuses and stillbirths cannot be attributed
solely to superficial contamination because the organisms have been isolated from the 
lung, brain, heart and viscera (Taylor-Robinson and McCormack, 1979).
Nevertheless, many couples carrying U. urealyticum have normal pregnancies. This 
may be related to a difference in the pathogenicity of the 14 serotypes since
Naessens (1988) suggested that U. urealyeicrm serotype 4 was isolated more
frequently from patients with a history of recurrent miscarriages compared to normal 
pregnant women, or some other predisposing factor may be involved.
Samples from cervical mucus and endometrial tissue were examined for the 
presence of U. urealyeicrm in patients with a history of habitual abortion and in a 
suitable control group (Stray-Pederson et aL 1978). These workers found colonisation 
of U. rrealyticrm in the cervix was common in both groups, whereas colonisation of 
the endometrium was found to be significantly more frequent among the habitual 
aborters (28%) than among the control subjects (7%). Treatment with doxycycline 
eradicated the ureaplasmas from both the cervix and the endometrium which 
apparently led to an improvement in the outcome of pregnancy. Since doxycycllne is a 
broad spectrum antibiotic, this observation does not permit any definite conclusions 
as to the role of ur^ep^^as^^^ in spoonaneous abortion.
Quinn et ai. ((983) also reported high coionisaPion aaees of U. ertalyticum in
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couples with histories of pregnancy wastage compared to control groups. Serological 
studies revealed that at delivery, 42.9 % of infants of mothers with history of 
pregnancy loss had fourfold elevations in titers to ureaplasmas (particularly to 
seroypes 6 & 8) above the mother's level. Some mothers with pregnancy wastage 
history also had elevated titers (particularly serotypes 4 & 8) above the infants, thus 
both mothers and foetuses responded immunologically to the presence of
U. urealyticum, suggesting the presence of an ongoing infection.
Furthermore, antibiotic therapy has played some part in elucidating the role of
U. urealyticum with these conditions. Kunsdin (1970), has described successful 
pregnancies after antibiotic treatment in women who were colonised with ureaplasmas 
and who had frequent spontaneous abortions, but again, other bacteria may have been
eliminated.
The mechanism(s) for the association of spontaneous abortion and ureaplasma 
infection is/are unknown. The high frequency of abnormal chromosome patterns seen
in aborted foetal tissue may reflect ureaplasma infection which in experimental studies
has been noted to be able to induce chromosomal aberrations such as chromatid
gaps, breaks and tetraploidy (Kundsin et aK 1971).
Harrison et ai. (1986) studied two groups of pregnant women and isolated 
U. urealyticum irom cervical samples from 72.5 % and 81.2 % respectively. The overall 
incidence of spontaneous abortion In these groups were 9.7 % and 5.5 % and the 
Incidence of spontaneous abortion in U. urealyiiuum-oosiX'we women was 9.4 % and 
5.6 %, neither of which was statistically important. This suggested that ureaplasma 
colonisation is not an important factor in spontaneous abortion. However, if the results 
reported by Stray-Pederson et ai. (1978) are correct, these workers may have seen 
more meaningful results if cultures had been taken from the endometrium.
A more recent study by Robertson et al. (1986) isolated U. urealyticum irom 24 % 
of spontaneous abortions obtained by unaided vaginal delivery and from only 8% of
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therapeutic abortions by suction curettage suggesting that ureeelanmas do cause 
neaetaneoun abortiaen, at least in some individuals. Ths isolates were serotyped using 
the modified indirect colony eplfluorencent test but so serotypeS appeared to be
predominant perhaps suggesting that differences lie in ths host rather than with the
organism.
in 1980, Embree et al. cultured placentas for U. urealyticum from a high risk
pregnancy group and a control group- Ureaelenmas were recovered more frequently 
from the high-risk-group compared to the control group and isolation was associated 
wlh polymorphonuclear leukocyte infiltration of placental membranes, foetal surfaces 
and umbilical cords. The contaminated placentas were frequently from cases of 
neaeteeeous abortion, stillbirths, early neonatal deaths as well as from infants of 
lowblrth weight and mothers with premature rupture of membranes. U. urealyticum 
was also isolated from placentas in which the membranes had first been ruptured at 
delivery by caesarean section suggesting that intact membranes do not provide an 
impenetrable barrier to infections of the placenta or of the foetus.
Ureaplasmas were isolated from the placenta or lung in 78.8 % of perinatal death 
cases compared to 32.3 % of contr^aln. Elevated antibody response to U. urealyticum 
was detected in 45.8 % of thsss foetuses compared to 0 % of controls, suggesting 
that these organisms do cause infection 'is utero' leading to death (Quinn et ai, 1985).
in 1986 , Quinn studied a further 22 cases of stillbirth asd detected an antibody 
response of greater than or equal to 1/32 to at least one of eight serotypes in 77.3 %
of cenes,
Placenta, liver and lusg tissue were cultured for uueeplasmas asd other
microorganisms from 432 stillborn and neonatal autopsies. Ureaplanman were isolated 
from 8.3 % of cenen- 2.2 % of placental specimens, 7.4 % of lung neecimees and 0.8% 
of liver specimens (Madan et a!, 1988).
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The above studies suggest that ureaplpsmap can and do cause spontaneous
abortions and stillbirths in a small percentage of women, but exactly how this occurs 
is as yet unknown. In this respect, phospholipase activity has been found in 
U. rrealyticrm serotypes 3,4 and 8 (Desilva and Quinn, 1986) and it has been
suggested that these enzymes play p role in this condition (see section 1,7.3).
1.6.4. 3. LOW BIRTH WEIGHT.
Premature birth is the most common cause of infant death and premature labour
remains unexplained in many cases.
Approximately 15% of randomly selected new born infants were found to have 
nasal or pharyngeal colonisation, mainly with ureaplpsmps, and such colonisation
correlated statistically with lower mean birth weights (2605g) (Klein et a/, 1969).
However, these workers suggested this colonisation occurred during the birth process
and was not the cause of the low birth weight.,
Braun et ai. (1971) also recovered rrebplasmas more froquendy yoom women who
gave birth to infants of low weight compared to mothers who gave birth to average 
size babies. In this study, 79 % of women were contaminated with U. urealyticum and 
since only 8.5 % of all babies weighed less than 2500g, it is apparent that other
factors are of importance in iefiuencing birth weight.
Kuedsie eo a/. (1984) also associated U. ureelyticrm with infants weighing less than 
2500g and also with birth before 36 weeks gestation.
In 1986, Kass et ai, reported that women who experienced a 4-foid or greater rise 
in antibody titre to any single strain of U. ueeeiyticrm, had a low birth weight rate of 
30 %, whereas women who did not experience a rise in antibody titre had a low birth 
weight rate of 7.3 %. Where there was a significant rise in antibboy titr^^, the titte rice 
was specific for a serologic type other than those for whihh the women had
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pre-existing antibody. This finding suggests that immunity to U. urealyticum is 
type-specific and that low birth weight is associated with antibody rises when they 
occur in relation to invasion with a serovar that has not previously elicitated antibody
formation in the pregnant women.
Furthermore, preterm delivery of low birth weight infants seems to be a
pre-disposing factor for a number of other conditions;-
(i) pr^^ur^n^i^ia; (Revvewed by Rudd et al, 1986; Cassell et: all, 1988).
Respiratory disease is the most common cause of perinatal morbidity and 
mortality, approximately 20 % of stillborn babies and infants dying within 72 hours of 
age have histological evidence of pneumonia. There is some evidence to suggest that 
congenital pneumonia, or pneumonia aquired during birth, is almost always 
accompanied by chorioamnionitis, (see section 1.6.4.1), (Naeye et aL 1971; Driscoll,
1986).
The diagnosis of lower respiratory tract disease in newborn babies is difficult as 
cultures from the lung are not easily obtained, whereas cultures from the throat,
nasopharynx and blood are unreveallng or misleading.
In 1971, Romano et ai. reported the isolation of U. urealyticum from the placenta
and from the heart and lungs of a foetus with intrauterine bronchopneumonia in the 
fifth month of pregnancy. Although there was no definite evidence that the ureaplasma 
isolated from the lung of the foetus was involved in the pathogenesis of the 
pneumonia, cultures for bacteria, chlamydiae and viruses were negative. An increase in 
antibody against U. urealyticum was also seen in the post-partum serum obtained 
from the mother 4 weeks after delivery.
Twenty three cases of congenital pneumonia in Ethiopian infants, who later died, 
were associated with U, urealyticum and again no other organisms were isolated and 
no other recognised disorder was diagnosed. Although these infants were born near
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term they were undergrown for gestational age, presumably due to maternal 
undernutritias (Tatarl et aly 1976).
Stagno (1981) also isolated U. urealyticum from 21 % of infants (2-12 wks) 
suffering from’ pneumonia although in most cases, other pathogens such as 
Pneumocystis carinii, cytomegalovirus, Chlamydia trachomatis and Bordetella pertussis
were co-isolated. This suggested that U. urealyticum may be a secondary and not a
primary pathogen of the respiratory tract in this age group. Taylor-Robinson et ai.
(1984) isolated U. urealyticum from 26 % of babies without respiratory disease but 
with other complications and from 22.5 % of babies with respiratory dissase. The 
organisms were also isolated from 19 % of healthy babies. All the above infants were 
delivered vaginally and could have become contaminated in this way. Sixteen of these 
babies were delivered by caesarean section, only one of which was contaminated with 
U. urealyticum, whereas ssvsn babies developed respiratory disease. Thus, these 
authors argued that transient colonisation occurs in healthy infants whereas a more 
sustained isfection may occur is a few babies with respiratory disease.
As up to 80 % of pregnant women and 30 % of neonates may be colonised with 
uueaplanmen, Quisn et al. (1983) studied 'true infection' by measuring antibody 
responss to 8 serotypes using the Metabolic ishibitlon test is both mother and infant 
in 21 cases of neonatal respiratory disease asd 24 normal cases. They suggested that 
a 4-fold difference in antibody titer between mother and infant before 20 days of age, 
was evidence of a serologic response of ths isfant to U. urealyticum This responss 
was seen in 11/21 infants with respiratory disease and in none of the 24 normal term 
babies. Antibody to serotypes 4,7 and 8 predominated suggesting these serotypes may 
be more important in terms of this condition.
There was no definite evidence that these babies were infsctsd or colom'sed with 
U. urealyticum as isolation of the organism was not attempted and it has not yet bssn 
established whether mere colonisation with U. urealyticum produces an antibody
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response (Rudd et al, 1986).
There was also no definition or documentation of respiratory disease. Infants with
respiratory disease often receive almost daily blood transfusions and as a result 
serology must be interpreted with caution, especially in the abscence of culture data 
(Cassell et ah 1988).
In a later study, Quinn et al. (1985) reported a case of fatal neonatal pneumonia.
The lungs from the infant were inflamed and immunofluorescent staining of the lung
tissue was positive with antisera to U. urealyticum, serotype 8, correlating with the
serotype isolated from the lung where no other microorganisms were isolated.
Antisera to serotypes 1 and 7 were also used but gave negative staining. The trachea 
from the infant was devoid of cilia in places or when present, were short and stubby 
which may be associated with U. urealyticum infection as observed in previously 
aborted foetuses (Dische et al, 1979). The infant's antibody titre to U. urealyticum, 
serotype 8 was 1:64 at 24 hours of age and 1:128 at autopsy while the mother's was
only 1:16. Infection of the foetus may have occurred because the mother did not have 
sufficient specific Ig G antibody to supply transplacental Ig G for the protection of the
neonate.
A strong association between chorioamnionitis caused by any agent and congenital 
pneumonia, prematurity and perinatal morbidity and mortality has been reported 
(Naeye, 1975). U. urealyticum has been linked with chorioamnionitis and individual case 
reports suggest that in some patients it is causal with respect to chorioamnionitis and 
also congenital pneumonia (Cassell et al, 1983).
More recently (Cassell et #/,1988), U. urealyticum was isolated most commonly 
from endotracheal aspirates from low birth weight infants (2500g or less) with 
evidence of respiratory disease. 14 % of isolates were from infants born by caesarean 
section with intact membranes, thus indicating the infection had occurred 'in utero'. 
These organisms were recovered in pure culture in numbers greater than 10 c.f.u.
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ml-1 from 85% of the infants and the organism was also isolated by blood culture 
from 26% of these infants.These workers suggested that those infants weighing less
than 1OOOg with U. urealyticum infection of the lower respiratory tract were twice
more likely to have ccronic lung diseaae oo to die than were iffants wtth simitar
birthweight but who were uninfected, or infants weighing more than 1OOOg.
Sanchez and Regan (1988) reported that respiratory distress In low birth weight
infants was not associated with U. urealyticum colonisation. However, of the infants
colonised with U. urealyticum, 30 % developed chronic lung disease whereas only 8 %
of those not colonised developed chronic lung disease.
U. ureaiyticum, serotype 10, which was isolated in the above study (Cassell et a/, 
1988), was used to inoculate newborn and 114 day-odd mice (Rudd et als 1989). 
Serotype 1 was also studied and this serotype was isolated in 1983 (CasselI et ai) 
from amniotic fluid and from the lungs of a newborn infant suffering from pneumonia. 
These organisms were shown to produce an acute, self-limiting interstitial pneumonia 
In newborn mice, with organisms localised within the alveoli in areas of inflammation. 
It was discovered that 14 day-old mice were less tucaptibla to either colonisation or
disease.
These results are compatible with the apparent aga-ralatad suceptibillty observed 
In the recent studies discussed previously. The raascns for this are not known but 
they may be linked with the development of the hosts defences. In mice, uraaplaema 
were found within macrophages by 8-12 days of age, and as 14 day-old mice did not 
develop alveolar lesions, it was suggested that differences in macrophage function 
may be important in causing susceptibility to U. urealyticum pneumonia. However, 14 
day-old mice were also more resistant to colonisation of the upper respiratory tract, 
suggesting other factors may also be involved in the age-related susceptibility. It has 
also been reported that mice infected with U. urealyticum and treated with oxygen 
are more susceptible to a prolonged pneumonia or death compared to mice not given
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oxygen (Crouse et ah 1988), and these workers suggested ths same may bs true for
human neonates.
it is not clear whether the mouse model has significant relevance to newborn 
human infants. 'Further characterisation of the mouse model of U. urealyticum should 
help define both host and organism factors that are involved in disease susceptibility
and dissase pathogenicity.
Thus, it would appear that ureaplasmas do play a role in respiratory disease, 
especially in preterm infants, but to what extent and how, is still unknown.
(ii) Infection of the central nerr/ous system (CNS) in preterm
Waites et al. (1988) isolated U. urealyticum from 6 preterm infants with severe
intraventricular haemorrhage and from 3 with hydrocephalus and in 4 of these babies, 
multiple isolations were mads over several weeks. The authors have suggested that 
U. urealyticum is one of ths most common organisms isolated from the cerebro
spinal fluid (CSF) of newborn infants with low birth weights.
is a more recent study, U. urealyticum alone was isolated from 8 % of CSF's from 
preterm infasts and was associated with severe intraventricular haemorrhage asd 
hydrocephalus (Waites et ah 1988).
Until mors studies have been done, ths role of these organisms in infections of
the CNS must be treated with caution.
1.6.4.4. PPEVIC UNFLL At MATO FRY DISFEASE (PID).
Chlamydia trachomatis, Neisseria gonorrhoeae and anaerobic bacteria are among 
the most causative agents of PiD. Ureeplasmes have also been considered as 
aetiolagicel agent of PiD, asd although the proportion of such cases is usclsar, 
uueaplasmes are often ca-lnaleted with these organisms (Reviewed by Sweet, 1986).
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The reported cervical isolation rates for U. urealyeicum range from 19 to 81 %. 
Both Mardh and Westrom (1970) and Eschnnbbch et ai. (1975) noted that the cervical 
isolation rates from PID patients and sexually active controls were similar^.
In a group of 88 patients with acute PID, M. hominis was recovered from the
endometrium in 34 patients (39 %) and U. urealyticum was recovered in only 13 
patients (15 %) (Sweet, 1976).
In an attempt to demonstrate an etiologic role for genital mycoplasma in acute
PID, serological studies of urnaolasmb antibodies have been undertaken, and 
EscltnaOach reported a 4-fold rise in antibody tir^r'n to U. urealteicrm in 17 % of
patients with acute PID.
Sweet et ai. (1981) noted that U. urealyticum was recovered from the fallopian 
tubes of patients suffering from an initial episode of PID as well as from those having 
recurrent episodes. Isolation of U. reealyeicum from the fallopian tube occurred only 
from patients who had been symptomatic for greater than 72 hours and this data may 
suggest that isolation of U. ueeeiyticum from fallopian tubes may reflect secondary 
Invasion or colonisation after damage has occurred to the fallopian tube epithelium
following infection with N. gonorrhoeae, C. trachomatis or anaerobic bacteria.
1.6.4.5. POSTPARTUM FtE/IEIR.
Postpartum fever can be classified into that which occurs early (less than 48 hrs 
postpartum) and that which occurs late (3 days to 6 weeks postpartum). Causes of 
early postpartum fever include endometritis (usually following a caesarean section), 
urinary tract disease, a rapidly developing wound infection, etc. Frequent causes of 
late postpartum include endometritis, abscess formation and urinary infections.
U. ueeeiyticum and other organisms colonise placental membranes and amniotic 
fluid (section 1.6.4(a)) either spontaneously or following rupture of the membrane and
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organisms present in these sites can reach the placental bed where they may enter
the blood stream. U. urealyticum was first associated with postpartum fever in 1971
(Sompolinsky et ai)
Genital mycoplasmas have been recovered from the blood in 2/13 (15 %) women 
within 2 minutes of delivery, in 23/272 (8%) women within 2 to 10 minutes after 
delivery and in 1/42 (2%) of women 11 to 45 minutes after delivery (McCormack et aH 
1975). Nevertheless, only 40 % of these women with this transient invasion of 
U. urealyticum developed postpartum fever.
Eschenbach (1986) suggests that approximately 20 % of women with early 
postpartum endometritis have evidence of endometrial U. ureaiyticum infection and 
about 5 % of the women have U. urealyticum recovered from the blood. Thus genital
mycoplasmas appear to cause a small but definite number of cases of postpartum
fever.
1.6.5. UPPER URINARY TRACT DISEASE.
1.6.5.1. URINARY TRACT STONES.
Urinary tract stones composed of struvite and carbonate-apatite (see below) 
account for 20% of all urinary tract stones and are often known as infectious urinary 
tract stones. These stones appear to be induced by the enzymatic breakdown of urea 
by bacterial ureases which split urea into ammonia and carbon dioxide (CO2) (Grenabo
et a/, 1984; Griffith et aH 1976). Non infectious stones are composed of oxalate, a
mixture of oxalate and phosphate or uric acid.
CO(NH2)2 -------- ----- -> CO2 + 2NH3
urease
NH 3 + H 2 O + OH''
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This enzymic reaction is important is ths urinary tract dus to the high substrate 
level of ursa (25-30 mg ml-1) is urine. Hydrolysis of urea leads to hyeerammaniouree 
asd the alkalinisatlae of urise which causes hypersaturatlos with respect to struvite 
asd calcium phosphate, asd this leads to crystalisation of struvlts and apatite (Takebs9
et ah 1984).
Calcium and Magnesium Phosphates
Struvite (Mg^PC^ .6H2O)
Carbonate-apatite ( Ca|3(P04 )gC0 g)
Brushite (CaHPO)
Hydroxyapatite (Ca-Q (PO4)g (0^H)2 )
Proteus species and to a lesser extent Klebsiellas, Pseudomonads and Staphylococcus 
species, are ths usual cause of stones in urine but U. urealyticum has also bees 
shown to induce crystallisation of struvlts and other calcium phosphates in vitro in 
artificial urine (Greeebo et ah 1984). in this study, U. urealyticum (104 organisms ml"1) 
were added to synthetic urine, pH 5.7, asd after 10 hours ths pH had risen to 8.1. A 
clearly visible encrustation of brushite and struvlts (23yug) was seen although no more 
than 10® organisms ml“® were ever isolated. in comparison, lO4 organisms ml"® of 
Proteus mirabilis were added to synthetic urine as above, asd within 3 hours, ths pH 
had risen to 9.0 with 10® organisms ml"® isolated, and after 10 hours, a pH of 9.0 was 
still seen with 2082 ®jg of struvite formed.
Although, P. mirabilis caused a more pronounced crystelisetion than U. 
urealyticum this could have been due to a difference is growth rate. P. mirabilis 
grows optimally at pH 7.0-9.0 which is within ths pH of the urine, whereas 
U. urealyticum grows optimally at pH 6.0, asd as the pH of the urine rose to 8.1, this 
would greatly reduce ths rats of growth. it should be noted that no crystelinatias was 
seen with either organism when ths urease inhibitor acetohyduoxamlc acid (AHA) was
added.
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This study suggests that U. rrealyticrm can initiate the formation of infectious 
stones and the above was confirmed by Takebe et ei. (1984), where 10® cells mi ' 
were inoculated into normal human urine and a white precipitate of lokim and struvite
was formed. Again stone formation was prevented with the addition of urease■9
inhibitors.
Urinary calculi have a strong tendency to recur despite surgery and antibiotic
treatment and this could be due to the presence of U. ueealyeicrm as this organism is
now resistant to many of the antibiotics used for treating infections of the upper
urinary tract (Peterson, 1983; Grenabo et a/, 1984).
Renal calculi, composed of struvite have also been induced experimentally in 78 % 
of rats after direct inoculation of U. ueeaiyeicnm, serotype 8, (10® -106 ecu ml"1) into 
the bladder and renal medulla (Friedlander and Braude, 1974). These workers Indicated
that viable ureaplasmas were not required for stone formation. In contrast, heat-killed 
P. mieabiiis did not produce bladder stones in the rats and these workers suggested
that stones are formed due to the ability of the dead ureaolasmas to act as a nidus, 
as they adsorb urinary mucoprotnin which is the principle component of the organic
matrix of stones.
U. urealyticum which is an organism not normally isolated from the upper urinary
tract, has also been isolated from infectious stones recovered by surgery from 6 of 15 
patients (Petterson, 1983). In 4 of these patients, no other urease-producing organisms 
were isolated from either the stone or the urine sampled from the renal pelvis.
The major question remaining concerning the role of this organism in the 
production of urinary calculi is the frequency with which the organism reaches the 
kidney, the predisposing factors that allow this to occur, and the relative frequency of 
ranal calculi Induced by this organism compared to those induced by other organisms.
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1.6.6. REFLUX NEPHROPATHY (CHRONIC ATROPHIC PYELONEPHRITIS).
U. urealyticum has been infrequently isolated from the bladder and upper urinary
tract, sites from which genital and urethral contamination can be rigorously excluded9
(Birch et a/, 1981). However, clinical studies suggest that U. urealyticum may be an
upper urinary tract pathogen in some patients with reflux nephropathy and impaired
renal disease (For a review see Krieger and Kenny, 1986). This may suggest that 
ureaplasma colonisation contributes to progressive renal disease and again it may be 
possible that only a few serotypes are involved,
Hewish et al. (1986) serotyped all isolates of U. urealyticum isolated from the 
bladders and upper urinary tract of 124 patients in order to determine whether 
particular serotypes were associated with infection at different levels within the 
urinary tract, or with a particular urinary tract disease with emphasis on reflux 
nephropathy. Serotype 4 was recovered most frequently (35 %) whereas serotypes 5 
and 8 were infrequently isolated. These workers concluded that colonisation above the 
urethra and association with urinary tract disease appeared to be
serotype-independent.
Unfortunately, isolation of ureaplasmas from patients with upper urinary tract 
disease does not prove that ureaplasmas are the causative agents as other organisms
are recovered in many cases.
The use of animal models enables workers to study the effects of pure culture 
under controlled conditions and obtaining suitable control groups is straight-forward
compared to clinical studies.
Using an obstructed canine upper urinary tract (Krieger and Kenny, 1986), the 
inoculation of U. urealyticum, serotype 8, caused interstitial inflammation 
(pyelonephritis) and a rise in anti-ureaplasma antibody was noted.
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Using a rat kidney model (Pickering and Birch, 1989), U. urealyticum, serotype 8 
was found to be capable of persisting in ths rat kidney and was recoverable from the 
infected kidney for up to 24 weeks after inoculation of 10® organisms. Animals with 
persistent infections exhibited a humoral rsneanse involving ig M and ig G antibodies. 
These workers suggest that U. urealyticum is capable in giving rise to chronic
infection is ths kidneys of rats following challenge via the ascending routs. This is in
agreement with the findings is patients who have been shows to yield the same 
ureaplasma serotype from the bladder for more than 12 months (Hewish et ah 1986).
How useful these 'artificial' animal models are in terms of human disease is
unclear as interspecien barriers may exist for colonisation or production of disease in 
other animals by human strains. These studies suggest that isfections only occur 
when high numbers of organisms ars injected asd whether these numbers ars reached 
in humans, and if so, how often this occurs, is as yet unknown.
1.7. VIRULENCE MECHANISMS. _
There is sow a growing interest in U. urealyticum as an agent of human diseases, 
but little attention has bssn given to those characteristics of the organism which may 
contribute to the disease processes). However, possible virulence factors were 
documented by Robertson (1986). Perhaps of most significance are the foilowing:-
1.7.1. IMMUNOGLOBULIN A PROTEASE.
immunoglobulin A (igA) protease activity has been detected in only a limited 
number of ths many pathogenic bacterial gessra; s.g. Streptococcus, Neisseria, asd 
Haemophilus Furthermore this ig A protease activity was associated only with the 
pathogenic species of these genera e.g. N. meningitidis, N. gonorrhoeae asd 
H. influenzae, buu nno with the cornr^^n^^l spacces. Howevee inconsisnencas exisS e.g. 
not all strains of S. sanguis have ig A protease activity (Genco et ah 1973).
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Furthermore, although most strains of H. influenzae show activity, so do certain strains
of H. parahaemolyticus and H. parainfluenzae which may have pathogenic potential but 
are species usually considered saprophytic. Thus the role of ig A protease activity has
yet to be resolved.
Secretory ig A antibodies (sig A) are considered a major defense mechanism at
mucosal surfaces. Ig A protease cleaves Ig A at the hinge region into two fragments,
Fab and Fc, and is considered to be a potential virulence factor for those organisms
which gain entry at mucous membranes.
Robertson et ai. (1984) isolated Ig A protease activity from all 14 serotypes and 
from 34 of 35 wild-type strains of U. urealyticum and this activity persisted in the 
presence of 25 mM EDTA but was sensitive to trypsin. Kapatais-Zoumbs et al. (1985) 
confirmed the presence of ig A protease activity in U. urealyticum and showed this 
enzyme was specific for ig A1 and not Ig A2.
Kilan and Freundt (1984) examined 52 strains representing the genera Mycoplasma, 
Ureaplasma, Acholeplasma and Spiroplasma for the ability to cause specific cleavage 
of human ig A1. This activity was exclusively associated with strains of U. urealyticum 
although one of the three strains of U. diversum, the type strain (A417), degraded 
human ig A1 extensively leaving no fragments that could be demonstrated by 
Immunoelectrophoresis. This strain of U. diversum also extensively degraded bovine
sig A.
Also in 1984, Stemke et ai. reported that 13 strains of ureaplasmas from seven 
animal species were unable to degrade human ig A but unfortunately, U. diversum 
strains were not studied in terms of ig A protease activity.
it has since been reported that ig A protease from human U. ureaiyticum isolates 
is host Ig A-specific, similarly, ig A protease from canine ureaplasmas will only cleave 
canine Ig A (Kapatais-Zoumbs et ah 1985).
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Establishment of the importance of Ig A protease activity in ureaplasma 
pathogenesis awaits further information on the distribution of specific activity and the
elucidation of the role of Ig A at mucosal surfaces.
1.7.2. UREASE. ’
This enzyme has already been discussed with respect to urinary stone formation.
1.7.3. PHOSPHOLIPASES.
As discussed in the previous section, U. urealyticum has been associated with
spontaneous abortion, stillbirth and prematurity.
A possible mechanism in the initiation of premature labour may be the effect of 
microbial phospholipase hydrolysis of placental membrane phopholipids to produce an
increase in the amount of free arachidonic acid and consequently, an increase in the
synthesis of prostaglandins (Quinn, personal communication, 1988).
Microbial phospholipases are known to have action on biomembranes and are
capable of causing haemolysis, lethal toxicity and skin lesions.
It is possible that phospholipases A1/A2, producing large amounts of 
lysophospholipid quickly, may also play a role as cytotoxic agents in infectious
processes.
DeSiiva and Quinn (1986) assayed serotypes 3, 4 and 8 of U. urealyticum for the 
presence of phospholipase A1, A2 and C activities. Phospholipase A2 activity was 
100-fold higher than that of phospholipase A1 and considerably higher in serotype 8 
than in serotypes 3 and 4. However, the phospholipase A1 activities of serotypes 3 
and 4 were comparable to the activities of other major perinatal pathogens, whereas 
the activity of serotype 8 was nearly three fold higher.
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Phospholipase C activity has been detected in many microorganisms, such as 
Bacillus cereus, Clostridium perfringens and Staphylococcus aureus (Dennis, 1983), in 
serotypes 3,4 and 8 of U. urealyticum (DeSilva and Quinn, 1986) and in Vibrio 
parahaemolyticus (Guhathakurta et ah 1988).
Phospholipase C has been purified from Clostridium perfringens and was reported 
to produce lesions in guinea pig skin (Guhathakurta et ah 1988).
1.7.4. CELLULAR COMPOSITION.
Other features, such as the absence of a cell wall, may provide the opportunity for
host cell surface components to bind directly to the ureaplasma membrane, thus
shielding its antigenic determinants (Robertson, 1986).
Lipoglycans have been found in some mycoplasmas and are reported as being
immunogenic, eliciting the production of the immunoglobulin M class of antibodies 
(Lynn et ah 1980). Antigenic specificity is apparently defined by a repeating sequence
of three sugar residues along the chains (Al-Samarrai and Smith, 1983). The
lipoglycans also appear to be capable in modulating the immune response to both 
soluble and particulate antigens (Smith, 1984). Lipoglycans have been detected in
serotypes 3,4 and 8 of U. urealyticum, all of which contained neutral sugars, fatty
acids, glycerol and phosphorus (Smith, 1985). Each serotype appears to possess a
distinctive lipoglycan and the surface location suggests that structural differences
among lipoglycans could contribute to the antigenic specificity of the different
serotypes (Smith, 1985).
Smith (1986) found that lipoglycans of varied carbohydrate composition associated 
with the membrane of U. urealyticum made up 5% of the cellular dry weight.
The significance of the ureaplasma lipoglycans in biological interactions is 
unknown, but it is unlikely that they are responsible for haemadsorption since only
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serotype 3 exhibits this activity (Black, 1973b). This material may also influence 
phagocytosis as well as possibly influencing the ability of the ureaplapmbs to adsorb
to host eoithelia. It is noteworthy that lIooglycans have not as yet been found on ail
Moliicutes. ,
1.7.5. ANTIBIOTIC RESISTANCE.
Strains of U. ueeelyeicum demonstrate a difOerential response to antibiotics. Whilst
most strain are sensitive to tetracyclines, they are resistant to, for example, rifamoIcin 
and trimethoprim (Davis and Hana, 1981). By 1976, however, 10% of isolates from 
N.G.U. were resistant to tetracycline (Evans and Taylor-Robinson, 1978). Strains 
recently isolated from N.G.U. patients by Taylor-Robinson and Furr (1986), showed 
similar levels of tetracycline resistance but approximately 40 % of these resistant 
strains are also resistant to erythromycin. Thus, whilst resistance levels are apparently 
not increasing, this may constitute a virulence factor in a minority of strains. Early
reports suggested that resistance not only to tetracycline, but also to chloramphenicol 
and dihydrostreptomycin in several mycoplasmas, was due to a reduction in 
membrane permeability to the drugs (ManiioOf and Morowitz, 1972). A recent study by 
Roberts and Kenny (1986) on serotypes 1-9 and on 63 clinical isolates with respect to 
tetracycline resistance, showed that 13 of the clinical isolates and serotype 9 were 
resistant to high levels of tetracycline suggesting that tetracycline resistance may be 
an iebuiit characteristic of certain serotypes only. The resistant isolates and serotype 
9 ail contained DNA sequences homologous to the streptococcal determinant tet M 
which suggests the spread of this gene to certain urebplbpmbp. The tet M determinant 
appears to alter the organism's ribosomes, rendering them resistant to tetracycline 
and this then suggests an alternative resistance mechanism to membrane 
permeability.
More recently, Roberts et ai. (1988) suggested that 20 % of U. ueealyticrm strains 
are now resistant to tetracycline. These workers also isolated a 4.9 Kb fragment from
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u. urealyticum which contained the tetracycline resistance determinant Tet M which 
coded for a protein with a molecular weight of approximately 73 KDa and this protein
shared 95 % homology with a Tet M gene from Streptococcus pneumoniae This
protein was thought to elicit resistance in one of two ways: (1) by inhibiting the 
binding of the tetracycline to the ribosome. (2) it may act as an elongation factor
which is resistant to tetracycline.
Antibiotic resistance may allow U. ureaiyticum to persist in tissues, an ability
which may be of significance outside the urinary tract where very high levels of
antibiotics cannot be reached and thus chronic infections may result.
As U. urealyticum appears to be increasingly resistant to tetracyclines, Kenny and 
Cartwright (1988) have studied the effect of the newer quiniolones on these 
organisms. Difloxacin and oxfloxacin were the most inhibitory and may have distinct 
promise for the treatment of genital infections.
1.8. MOLECULAFR BIOLOGY AND GENETICS OF MYCOPLASMAS (RRVIEWED BY
RAZIN,1985).
The circular double stranded genome of Mollicutes is distinguished by its minute 
size and low guanine plus cytosine (G+C) content. The G+C content of most 
mycoplasmal DNA is between 25 -34 mol%, and with respect to U. ureaiyticum, Is 
between 27-28 mol% (Black et ah 1972a), The mycoplasmas fall into two clusters 
according to genome size: one composed of Mycoplasma and Ureaplasma species 
with a genome of approximately 5 X 10® daltons and the other composed of 
Acholeplasma, Spiroplasma and Anaeroplasma species with a genome of 
approximately 1 X 10® daltons. As the smallest known genome size is around 1 X 10® 
daltons, the Mycoplasma and Ureaplasma species have the smallest genome recorded 
for any self-reproducing prokaryotes (Bak et ai, 1969).
However, this 5 X 10® daltons may be an underestimate (Pyle et al, 1988) as
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pulse-field electrophoresis suggests that the genome is composed of 900 Kb rather 
than the 750 Kb which is equivalent to 5 X 10® daltons.
The extremely small size of mycoplasma and ureaplasma genome imposes several
restrictions on coding capacity, explaining the low number of cell proteins since a
□
genome size of 5 X 10® daltons is capable of coding for approximately 650 different 
proteins. As the bacterial genome usually contains spacers, including various signals 
that comprise 20-30 % of the total DNA, the actual numbers of genes would, be 
around 500. Razin (1985) has detected over 300 proteins using 2-dimensional gel 
electrophoresis. Complex nutritional requirements suggest that most, if not all, of the 
genes for the metabolic pathway enzymes for producing building blocks of 
macromolecules are missing, but it is postulated that membrane systems for transport 
of these building blocks from the environment should exist in these organisms (Razin 
et a/, 1968). This would explain the complex nutritional requirements of these
organisms.
It would appear that mycoplasmas arose as a branch of the low G+C 
Gram-positive tree near the Lactobacilli and Streptococci. The initial event in 
mycoplasma phylogeny appears to be the formation of the Acholeplasma branch; 
hence, loss of the cell wall probably occurred at the time of genome reduction to 
approximately 1000 MDa. A subsequent branch produced the Spiroplasma and this 
branch appears to have been the origin of sterol-requiring Mycoplasma species. 
During development of the Spiroplasma branch, there were several independant 
genome reductions, each to approximately 500 MDa, resulting in Mycoplasma and 
Ureaplasma species. (Rogers et aU 1985).
Whilst the low G+C content is perhaps due to some mutation pressure replacing 
G.C pairs by A.T pairs, the nature of this mutation pressure is unknown at present.
Work on Mycoplasma caphcofum suggests that different parts of the genome
contribute positively to the low G+C content of the genome. The spacer regions
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between the genes are the lowest with respect to G+C content (about 20 %), the 
second lowest are the protein genes (about 30 %) and the G+C content of the rRNA 
and the tRNA coding regions are relatively high (47-54 %) (Muto et aU 1987).
The mol% G+C values are effective tools in the classification of Mollicutes. A
finding of a difference in the G+C content between bovine ureaplasmas (28.7-30.2 
mol%) and the human U. urealyticum strains (26.9-28.0 mol%) served as an important 
indicator for the establishment of a new species (see section 1.1).
As mentioned before, the 14 serotypes of U. urealyticum form two distinct clusters 
as distinguished by electrophoretic patterns, cleavage patterns using restriction 
endonucleases (Razin et a/, 1983) and by exhibiting 40-60% DNA homology between 
the two clusters (Christiansen et a!, 1981). However, the G + C content does not differ 
between these two clusters and as yet the two clusters have not been classified as
two separate species or even subspecies.
1.8.1. GENOME REPLICATION
Information on mycoplasma genome replication is still fragmentary. The replication 
of many Mollicutes resembles that of other prokaryotes in being semiconservative and 
proceeds sequentially from, at most a few replication forks. In Acholeplasma Jaldlawii, 
newly synthesised DNA, representing the growing point of the chromosome, appears 
to be membrane-associated (Smith and Hanawalt, 1968) and this observation was 
confirmed in M. galllsepticum. However, this latter organism has a bleb-infrableb 
structure and thus the situation may differ in the other mycoplasmas (Quinlan and 
Maniloff, 1973). In many mycoplasmas, cytoplasmic division lags behind genome 
replication, resulting in the formation of muiti-nucleate filaments.
Three DNA polymerases have been isolated from Spiroplasmas and Acholeplasmas, 
but, as yet only one DNA polymerase has been found in U. urealyticum which lacks 
the 3'-5' exonuclease activity and thus raises the problem as to the proof reading
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mechanism in these organisms (Buisson et eL 1988).
There appears to be a wide occurrence of nucleases hydrolysing DNA and RNA
which may play a role in the nutrition of these organisms by providing assimilable 
nucleic acid precursors from polymeric DNA and RNA (Razin, 1985). The endogenous 
nucleases may have an additional function such as DNA repair, restriction of foreign 
DNA and transport of transforming DNA. This rather intensive DNase activity greatly 
hampers the isolation of undngrayed DNA and since the enzyme requires Mg2+ for 
activity, the use of EDTA helps prevent this digestion.
Mollic^es are very sensitive to ultraviolet and X-and gamma-ray irradiation.
However both ohotoreactivation and dark repair mechanisms have been shown to 
operate in Achoiep/asma laidlewii but are totally absent in M. ga/asepticum and as yet, 
no information has been reported for U. ueealyticrm
1.8.2, TRANSFORMATION AND TRANSFFCCTON.
The lack of a cell wall in Mollicrrnp would appear to favour genetic exchange by
transformation, yet, despite many trials, very few have succeeded. These organisms 
are osmotically sensitive and tend to loose viability when suspended in buffer and this
could account for the low success rate of transOormation, but successful in vitro
transformation of A. laidlewii and M. pulmonis with Tn 916 has been reported (Dybvig
and Cassell, 1987).
One of the most recent successes of in vivo transformation has been with
Spiroplasma citri, (Barroso • and Labarncn, 1988), where they have evidence of 
chromosomal transfer followed by recombination. The mechanism of gene transfer 
was insensitive to deoxyribonuclease, required contact between cells and possibly 
fusion between areas of the cell membranes. The potent nuclease activity of 
mycoplasmas as well as their tendency to lose viability in buffer solutions may also 
hinder transformation experiments (Razin, 1985). Transfection of mycoplasmas has met
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with more success particularly with the aid of polyethylene glycol (PEG) (Sladeck and
Maniloff, 1983) and many transfection systems have been reported (for a reveiw see
Razin, 1985). McCammon et aL (1988) have reported equally successful transfection
frequencies with S. cf using 43 % PEG or electroporation.
1.8.3. TFRANSCRIPTION.
1.8.3.1. RNA POLYMERASES.
The RNA polymerases of Mollicutes are insensitive to rifampicin, a property shared 
with RNA polymerases of Archaebacteria and the subunit structure of these enzymes 
appears to resemble that of prokaryotes. Promoter and terminator regions in the few 
mycoplasmal species sequenced so far, also appear to resemble those of prokaryotes. 
Thus several genes that have been cloned from mycoplasmas can be expressed in 
E coti cells, suggesting that the E coli RNA polymerase recognises transcription 
signals of mycoplasmas (Mouches et a!„ 1985).'
1.8.3.2. RIBOSOMES
Mycoplasma ribosomes resemble typical prokaryotic ribosomes in having a
sedimentation coefficient of about 70s, which dissociates into 30s and 50s subunits
and one distinguishing property of these ribosomes is their sensitivity to low 
concentrations of divalent cations (Johnson and Harowitz, 1971). Mycoplasma 
ribosomes were dissociated into subunits in the presence of 5mM Mg2+, whereas 
E coU ribosomes remained intact. Three rRNA species (5s, 16s and 23s) have been 
identified, as have approximately 50 protein species which is again similar to the 
situation seen in other prokaryotes. However, the 16s RNAs from mycoplasmas 
examined so far, appear to be smaller in size than bacterial 16s RNAs by about 12000 
daltons and a number of sequences which are normally highly conserved in bacteria 
appear to be absent from mycoplasmas (Neimark,1984), 5s RNA sequences from three
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mycoplasmas, M. capricolum, M. mycoides subsp capri and Spiroplasma sp BC3 have 
been published and each 5s is unusually short (Hori et al., 1981; Walker et aK 1982). 
Mollicutes have only one or two copies of rRNA genes; this low number is in line with 
the concept of,economy in genetic information. U. urealyticum is thought to have 2
rRNA operons (Amikan,1984; Ohse and Gobel, 1987) and the genes appear to be linked 
in the typical order 5'-16s-23s-5s-3'. However, the hybridisation patterns produced by
the 14 serotypes showed differences which were most pronounced among serotypes
belonging to the two different clusters (Razin and Yogez, 1986). It has been reported
(Chen and Finch, 1989) that the genome of M. galllsepticum contained 3 widely
separated rRNA loci. One locus contained genes for all three rRNA species, another
contained 23s and probably 5s rRNA genes, whereas the third appeared to have only a
16s rRNA gene.
Specific rRNA gene probes cloned from M. capricolum have been reported as being
able to detect less than 1ng of mycoplasmal DNA which is roughly equivalent to the 
DNA content of 105 mycoplasmas. The possibility of using this approach for detection 
and identification of noncultiviable mycoplasmas in plant and insect tissue is under 
investigation (Razin, 1984). M. pneumon/ae-specrtic oligonucleotide probes
complementary to variable regions in the 16s RNA have been used in dot blot assays 
to detect less than 1 X 103 mycoplasmas.
1.8.3.3. TRANSFER RNA (tRNA).
tRNA's, like rRNA's are highly conserved molecules with respect to size 
composition and function but the low G+C content of the mycoplasma genome is not 
reflected in the base composition of the mycoplasma tRNA's. The intragenic regions 
are very rich in A-T (over 80 mol%), while the genes themselves have a G+C content 
of about 55 mol%, considerably higher than the G+C content of the genome. Thus, the 
G+C values resemble those of prokaryotic tRNA's. The secondary structure also fits 
the familiar clover leaf model of tRNA's. There appears to be only enough DNA to
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code for 44 difOnreat tRNA molecules in M. capricolum, (Tully et a/, 1974), whereas 
£ co/ has enough DNA to code for 60-80 tRNA genes. Mycoplasmas also appear to
lack many ipobccnptlag tRNA's species for several amino acids, again economising the
amount of gen>ptic information. Another interesting feature of mycoplasma tRNAs is 
the consistent lack of modified nucleosides which are found in other prokaryotes. This 
is also the case with mycoplasmal rRNAs (Johnson and Horowitz, 1971).
1.8.4. CODON USAGE.
Mycoplasmas appear to use A and U biased codons e.g. in M. caprico/um UUA 
(leu), AUU (ile), and AGA (arg) are the most frequently used, while they are rarely used 
in £ co/, where CUC (leu), AUG (ile) and COU (arg) are predominant. More than 90 % 
of M. capricolum codons have A or U at the third position, in contast to only 49 % of
the £ co/ codons.
The codon UGA, which is normally a stop codon in both prokaryotes and
eukaryotes, codes for tryptophan in W. ceprico/um (Yamac et aL 1985) and this is also 
the case with M. pneumoniae and M. geniteiirm (Inamine et a/, 1988). This would 
explain why the translation of many mycoplasma proteins are terminated when cloned 
in £ co/. Whether the above is true for urnaolasmas is as yet unknown.
1.8.5. PLASMIDS AND VIRUSES.
The possible existence of viruses in mycoplasmas was reported by Edwards and 
Fogh (1960). The first mycoplasma virus was isolated and characterised by Gourlay 
(1970) and subsequently more than 50 viruses of difOnrnnt morphologies were isolated, 
mainly from strains of Achoieptasma lailawii and Spiroplapmbp, although some have 
been found in several Mycoplasma species (Cole, 1979).
Extrachromosomal DNA not associated with virus particles has also been reported 
and these 'plasmids' have been detected in A. laidlawii, M. hominis and M. arthritidis
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but do not appear to be present in U. urealyticum, serotypes 1-9 (Harasawa and
Barile, 1983). They are approximately 20 X 106 daltons in size and an average of 50
-100 plasmids per cell has been reported (Maniloff et al, 1977). However, as yet, no
function has been defined for these plasmids.*
Viral and plasmid DNA is frequently integrated into the chromosome, leading to 
lysogeny in the case of viruses (Razin, 1985).
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1.9. AIMS OF THIS RESEARCH.
Much of the research on U. urealyticum is still in its infancy and a lot of basic
information on this organism is lacking.
U. urealyticum appears to play a part in many disease states but to what extent it
is involved is still unknown due to the fact that many laboratories do not routinely
test for ureaplasmas. This is because they are extremely fastidious and require a
complex growth medium, which, as yet is not easily available. Thus any studies carried
out on this organism are done only by specialised groups of workers.
Thus the main aims of this research are to further elucidate some of the molecular
biology of this organism, particularly with respect to important antigenic polypeptides, 
and to produce diagnostic systems for the detection of U. urealyticum from human 
clinical samples which could be commercially developed. These kits would not only be 
less time consuming, but would also allow workers outwith this field to examine
clinical samples for the presence of this organism.
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CHAPTER 2
MATERIALS AND METHODS.
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All chemicals used in this study were supplied by BDH unless otherwise stated.
2.1. ORGANISMS USED.
(a) Ureaplasma urealyticum strains: Serotypes 1 (T7), 4 (11860), 6 (12253) and 8 
(T960) were gifts from Dr. D. Taylor-Robinson (C.R.C., Harrow, U.K.). Serotypes 2 (T23), 
3 (DKF3), 5 (NIH 5), 9 (Vancouver), 10 (Western), 11 (11-JsL 2), 12 (12-JsL 5), 13 
(13-JsL 6) and 14 (14-JsL 11) were gifts from Professor J. Robertson (University of 
Alberta, Edmonton, Canada). Serotype 7 (ATCC 27819) was obtained from the American
Type Culture Collection.
(b) Ureaplasma diversum strains: Strains T44, 7860/1 and E172/1 were gifts from
Dr. G. E. Jones (Moredun Institute, Edinburgh, Scotland).
(c) Non-human ureaplasmas: Ureaplasmas isolated from canines (9255), felines 
(8638), chimpanzees (13863, 13838, 13849, 13882, 13892) and marmosets (13583) were 
also gifts from Dr. D. Taylor-Robinson.
(d) Mycoplasma hominis. Strain WHO PG21 was also donated by Dr. D.
Taylor-Robinson.
(e) Mycoplasma ovipneumoniae Strain 956/2 was a gift from Miss R. K. Spooner 
(University of St Andrews, Scotland).
(f) Proteus, Serratia and Klebsiella strains:
Proven urease-positive strains of a Proteus species, P. vulgaris, P. rettgeri, 
P. mirabilis, Serratia Hquefaciens, Klebsiella aero genes, K pneumoniae (M169), and 
Klebsiella species (SW35, SW85, SW87, ST44,and ST81 all isolated from above or below 
a sewer outfall) were gifts from Dr. D. Thirkell (University of St Andrews, Scotland).
70
2.2. MEDIUM AND CELL PRODUCTION.
Ureaplasma urealyticum, Ureaplasma diversum and the other non-human 
ureaplasmas:- ,
Except where stated, ureaplasmas were grown in medium containing 70 % (v/v)
PPLO broth (Difco), 20 % (v/'v) horse serum (NBL) and 2.5 % (w/v) fresh yeast extract, 
incorporating 0.1 % (w/v) urea, 0.005 % (w/v) phenol red and 1000 lU penicillin G ml-1 
(Glaxo), at a starting pH of 6.0. Cultures were incubated at 37° C until a pH of 7.6, 
corresponding to a cell density of 107 c.c.u. m~i was reached. Determination of 
colour-change units (c.c.u.) was performed by serial decimal dilutions of 0.2 ml 
cultures in vials containing 1.8 ml of growth medium which were incubated at 37° C 
until no further colour change of the phenol red indicator was apparent (normally 48h). 
From the highest dilution in which colour change was seen, the number of c.c.u. ml~i 
of the original inoculum was determined. The cells were harvested by centrifugation 
using a Beckman J-21 centrifuge (25000g, 20 min), the pellets washed in Dulbecco's 
phosphate buffered saline 'A' (PBS) (Dulbecco and Vogt, 1954) and the final pellet 
resuspended in PBS (1ml/ 2.5 litre culture). Unless used immediately, the pellet 
suspension was aliquoted (1OOyul aliquots) and stored at -70° C.
Mycoplasma hominis- This organism was grown as described above but 
substituting 0.2 % (w/v) arginine hydrochloride for 0.1 % (w/v) urea. initial pH was 7.0 
and the culture harvested as above when the external pH had reached 7.8. The pellet 
was resuspended in PBS as above and used immediately or aliquoted (50 yul) and
stored at -20°C.
Mycoplasma ovipneumoniae.- Cells were grown in 20 % (v/v) Brain Heart infusion 
(Oxoid), 6 % (v/v) 10 X Medium 199 (Gibco), 10 % (v/v) inactivated newborn calf serum 
(Sera-Lab), 10 % (v/v) freshly prepared yeast extract, 0.008 % (w/v) phenol red and 1 
mg ml“i Penbritin (Beecham) at a starting pH of 7.6-7.8. Cultures were grown at 37°C
71
until a pH of 6.8-7.0 was reached corresponding to 5 X 10® c.c.u. ml-1. Cells were then 
harvested and stored as described for M. hominis
Proteus, Serratia and Klebsiella strains:- 20 ml cultures were grown overnight in 
nutrient broth (Oxoid) at 37°C and used immediately.
2.3. RADIOIMMUNE ASSAY (RIA).
Nitrocellulose paper was incubated (60 min, 37°C) in a suspension of 
U. urealyticum, serotype 8, prepared as in section 2.3.8, with a protein concentration of 
10-100zUg mr1(dot-blot assay). The paper was washed in PBS, blocked with 10 % 
(w/v) Marvel (Cadbury) in PBS (30 min), and then washed several times in PBS 
containing 0.2% (v/v) Nonidet P40 (NP40) (Sigma) (PBS-N). The paper was sandwiched 
between two 96-well microtitre plates (Cell Cult) with .the lower plate containing the 
test antibodies e.g. from a mouse tail bleed or from media overlaying hybridoma cells. 
The 'sandwich' was then inverted, ensuring the test material was in contact with the 
paper, and incubated at 37° C for 1 h. The paper was then washed in PBS-N, followed 
by incubation at 20° C for a further 1h in 10-20ml PBS-N to which 50^ of 
125I—labelled Protein A (Amersham) was added. For detection of immunoglobulins of 
classes other than Ig G, the paper was incubated (60 min, 37°C) with 10-20 ml of a 
1/200 dilution of goat anti-mouse immunoglobulins (GAM) (Sigma) in PBS-N, before 
incubation in the radiolabelled Protein A. Finally the paper was washed repeatedly with 
several changes of PBS-N over a period of 30 minutes, dried and subjected to 
autoradiography (section 2.6.1).
2.4. ANTIBODY PRODUCTION.
(a) Production of Monoclonal Antibodies (Mab's):-
Monoclonal antibodies were raised from two separate fusions (Fusions A and B) 
and for a general review on methodology, see Goding, Ch 3, 1986.
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Fusion A:- This fusion was carried out by Mrs P. Braddock as described below.
Balb/C mice were immunised with Ureaplasma ueealyeicrm, serotype 8, grown and 
harvested as described in section 2.2. Washed cells (approximately 107 c.c.u. mi"1) on 
ice, were soniqated (4 X 10 second bursts with intermittent cooling) using a 0.5 cm
micropr^e on a Kerry ultrasonlcator and then alum-orncioitatnd (Mautner and Wilcox,
1974).
Initial immunisation (intraperitonnbl, (ip)) was with 0.2 ml alum“prncipItbtnd cell
extract followed by a second such injection 4 weeks later. A third injection 
(intravenous, (iv)) of 0.1 ml sonicated cell extract was given 4 weeks later, 3 days 
before the fusion. Mouse antiserum taken 2 days before fusion was screened by 
R.I.A. (section 2.3) for anti-ureaplasma antibodies using organisms grown in a medium 
with 10 % (v/v) new-born calf serum substituted for horse serum.
The spleen was removed from the mouse showing the greatest immune response 
and was gently homogenised in 5 ml PBS using a glass homogeniser in a boiling tube. 
After allowing particulate tissue material to settle, the overlying suspension containing 
the spleen cells was removed and centrifuged at 300 g for 5 min. Any red blood ceils 
present were lysed by shaking in 0.83 % (w/v) ammonium chloride and removed from 
the spleen cells by centrifugation (300g, 5 min).
Mouse myeloma cells (SP2/0), frozen in liquid nitrogen in 1ml freezing mix (1 mi 
DMSO, 3 ml new born calf serum (Sera-Lab), 6 ml Glasgow's modified minimal Eagles 
medium (Gibco) (MEM)) were thawed at 37°C and centrifuged (300g, 5 min). The 
supernatant was discarded, 10 ml fresh MEM added and the cells rnceetriOugey (300g, 
5 min). The cells were then resuspended in a further 10 ml MEM containing 10 % (v/v) 
new born calf serum (10 % MEM) and placed in 75 cm® tissue culture fiats (Cell-Cult) 
at 37°C in an atmosphere of 5 % CO2, cell suspensions were prepared by first 
replacing the spent medium with fresh and the fiats subjected to vigorous tapping.
Macrophages were prepared from sacrificed Balb/C mice by injecting 5mi of warm
73
MEM (ip). The abdomen of the mouse was then massaged gently for 2-3 min after
which a second needle was inserted into the left-hand side of the abdomen and the
fluid containing the macrophages removed. This fluid was centrifuged (300 g, 8 min) 
and any red bigod cells present were removed as described above. The macrophages
from one mouse were resuspended in 30 ml 10 % MEM and were used to seed 3 X 
96-well plates (100yil/wel).
Spleen and SP2/0 myeloma cells were counted on a haemocytometer slide and 
spleen cells (6.8 X 107) were mixed with SP2/0 myeloma cells (1.0 X 107)in a ratio of 
2:1 with respect to cell numbers and giving a total volume of 6.5 ml, which was then 
made up to 50 ml in PBS. The cells were centrifuged (300g, 5 min), resuspended in 50 
ml PBS and similarly centrifuged. The final cell pellet was resuspended in residual PBS 
by gentle tapping, 0.5 ml polyethylene glycol (PEG) added and cells were centrifuged 
at 300 g for 1-2 min to ensure close contact. These fused cells were incubated at 
37°C for 20 seconds, slowly diluted with 20 ml 10 % MEM, and again centrifuged 
(300g, 5 min). The fused cells were gently resuspended in 5 ml 10 % MEM containing 
hypoxanthine, aminopterin and thymidine (HAT) (Sigma, 50X HAT), used at final 
concentration of 1 X 10"7 M hypoxanthine, 4 X 10“7 M aminopterin, 1.6 X 10“® M 
thymidine. A further 50 ml of 10 % MEM/HAT medium was added to the 5 ml of cells 
and six 96-well plates (containing 100 /jl macrophages/well) were seeded with 36 ml 
of this cell suspension (100 jji/well). The remainder of the cells was diluted 1/2 in 10 
% MEM/HAT and a further six 96-well plates also containing 100 ql macrophages/well, 
were seeded with this cell suspension (100 ql/well as above). Outer wells were filled 
with 10 % MEM/HAT medium only, to prevent the wells containing cells from drying 
out. Mouse SP2/0 myeloma cells lack the enzyme hypoxanthine guanine 
phosphoribosyl transferase and cannot grow in minimal medium containing HAT. 
Although spleen cells do possess this enzyme they will also not survive in tissue 
culture medium for more then a few days as they are not immortal. Thus, unfused 
myeloma and spleen cells survive only a few days in HAT medium and only fused
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spleen/myeloma cells (hybridoma cells) survive and grow. After 5-7 days, the HAT 
medium was replaced with HT medium (as HAT without the aminopterin) and after a 
further 14 days the cells were placed in 10 % MEM alone.
When the wells were 50 % confluent with hybridoma cells, the medium above the
cells was tested for the presence of antibodies using RIA (section 2.3) and by 
enzyme-linked immunosorbent assay (ELISA) using a goat peroxidase-linked 
anti-mouse immunoglobulin (Sigma) as described by Precious et al. (1987). Positive 
clones were transferred to 24-well plates (previously seeded with macrophages) by 
resuspension in 200 juI of fresh 10 % MEM, retested when 50 % confluent and clones 
which were positive at this stage, were dilution cloned.
Dilution cloning: Each positive clone was resuspended in 200 ,ul of fresh 10% MEM
when 80-100% confluent and the cells first diluted 1/1000 in 10 % MEM. F’om this cell
suspension, three 5-fold dilutions were prepared in 10 % MEM (1/5000, 1/25000, 
1/125000) and all four dilutions were plated out in 96-well plates (100 z.ul/well) which 
had been previously seeded with macrophages as before.
After three days, each well was examined for the presence of a single cell and any 
wells containing more than one cell were eliminated. After six days, wells were 
re-examined for the presence of a single clone and only wells containing single 
clones were retested when 50 % confluency was reached.
Positive clones were then transferred (as above) to 24-well plates and retested 
twice and when 100 % confluent, were suspended in 500 ul MEM, centrifuged (1000 g, 
3 min) and resuspended in 500 yU MEM. Pristane-treated Balb/C mice (0.5 ml pristane 
(Sigma) injected (ip) 5-7 days previously) were Injected intraperitoneally with these 
cells and ascitic fluid removed usually between 8-14 days later. Any contaminating red 
blood cells were removed using 0.83 % (w/v) ammonium chloride and centrifuged as 
described previously, 0.1 % (w/v) sodium azide added and after aliquoting (500 jjI), 
stored at -20° C. Any hybridoma cells present were resuspended In 10 ml 10 % (v/v)
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MEM and grown to 100 % confiuency in 75 cm® fiats in an atmosphere of 5 % CO2 . 
Spent medium was removed from the cells which were then resuspended in 10 ml 
MEM, centrifuged (300g, 5 min) and finally resuspended in 1 ml freezing mix and 
placed in 2 mi plastic vials. These vials were placed in an insulated box at ~70°C for 
2-3 days before being transferred to liquid nitrogen.
Fusion B:-
Using a previously obtained Mab (UU8/1) which recognised the urease enzyme of 
U. urealyticum, serotype 8, (Precious et a/, 1987), purified urease was prepared using 
affinity chcomotgrbohy and FPLC (section 2.11; 2.18). This urease was used either as 
the native enzyme or in the denatured state (boiling 2 min) as an immunogen to 
hyoerimmunIsn two sets of six Balb/C mice following a protocol as described for
fusion A.
Three days after the final iv injections of the urease preparations, the mice were 
tail-bled and using RIA, antibody levels against the urease were determined so that 
the spleens from the mice with the highest antibody titres could be used in the
fusions.
Two fusions were carried out using standard techniques (as for Fusion A). 
Antibodies were tested by RIA as before and by using the urease catch test (section 
2.21). However the fusion performed with the spleen from the mouse immunised with 
denatured urease was not successful. Only a small number of hybriyombs grew and 
cells proved to be negative for the production of anti-urnbsn antibodies by the above 
techniques. As the other fusion was producing large numbers of antibody-producing
clones it was decided to continue with this one only.
(b) Production of Polyclonal serum:-
Polyclonal serum was produced as described by Precious et a/, (1987).
76
Briefly, rabbits were injected (0.5 ml X 2) (intramuscularly) with 5 X 10® c.c.u. ml"i 
(grown in medium containing horse serum) with a ratio of 1:1 (with respect to volume) 
of Freund's complete adjuvant followed by a series of further intramuscular injections 
in complete adjuvant at 3 week intervals for 3 months. Animals were test bled 
periodically and antisera monitored by R.i.A. (section 2.3). Further booster injections 
were given intramuscularly at 3 month intervals and the animals bled for sera as and 
when required. The serum was aliquoted and stored at -20°C.
2.5. PROTEIN ESTIMATIONS.
These were carried out using three different methods as appropriate.
(a) Using the method of Bradford (1976) where an accurate measurement was 
required:-
A standard curve was prepared using a range of 10-100 jug ml”i of bovine serum 
albumin (BSA) (Sigma) diluted in PBS. For each reaction, 10 jjl of protein solution was 
mixed with 1 ml of Bradford's reagent (0.01% (w/v) Coomassie Blue G-250 (Sigma), 8.8 
% (w/v) phosphoric acid, filtered before use) and incubated at 20°C for 4-10 min. The 
absorbance (O.D.) was read at 595 nm within 1 h on a CECiL CE 272
spectrophotometer.
(b) Dot-Blots:-
Doubling dilutions of BSA containing 10 mg - 0.078 mg protein m~i were prepared 
in PBS and 2 pi of each dilution were spotted on to nitrocellulose sheet. The sheet 
was then stained with 0.2 % (w/v) naphthalene black 12B in 10 % (v/v) acetic acid, 40 
% (v/v) methanol for 3 min and destained in 7.5 % (v/v) acetic acid, 25 % (v/v) 
methanol. Protein samples were also subjected to doubling dilutions in PBS and an 
approximation of protein concentration was made by visual comparison of the two
sets of dilutions.
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(c) Absorbance:-
The absorbance of protein samples was read at 280 nm on a Perkin-Elmer Lamda 
5 UV/Vis spectrophotometer, where 1 O.D. Is approximately equivalent to a protein
concentration of 1 mg ml
2.6. POLYACRYLAMIDE GEL (PAGE).
2.6.1. SODIUM DODECYL GEL
(SDS-PAGE).
Using 10 % or 15 % (w/v) polyacrylamide slab gels, the method of Russell and 
Blair (1977) was followed except where stated. Samples were prepared for 
electrophoresis, (i) by making to 25 % (v/v) with respect to glycerol and without any 
prior heat treatment, or (ii) by boiling for 2 min after addition of an equal volume of 
'denaturing mix' (2.5M urea, 1.75M p-mercaptoethanol (Sigma), 1 % (w/v) SDS and 0.1 
% (w/v) bromophenol blue). Staining of polypeptides was achieved either with 
Coomassie stain or with the more sensitive silver stain (Bo-Rad kit). For Coomassie 
staining, gels were fixed for 1 h in 10 % (w/v) trichloroacetic acid, 40 % (v/v) 
methanol, stained for 4 h in 0.3 % (w/v) PAGE blue 83, 46 % (v/v) methanol, 7.5 % 
(v/v) acetic acid (stain was filt^e^ed before use) and destained with 7.5 % (v/v) acetic 
acid and 25 % (v/v) methanol.
Where labelled material was electrophoresed, autoradiography was carried out as
described by Russell and Blair (1977) using x-ray film (Fuji CX) and a Philips fast
tungstate intensifying screen.
Apparent molecular masses were determined, where appropriate, by comparison 
with protein standards (Bethesda Research Laboratories).
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2.6.2. PAGE IN ABSENCE 01= SDS(NON-DENATURED PAGE).
Polyacrylamide gels (7.5 % or 10 %, w/v) were prepared as described in (a) above
without the presence of SDS in either the gel or the buffer.
2.7. IMMUNQBLOTTiNG.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose
sheets (Schleicher & Schmit) was carried out on an Ancos Model A semi-dry
electroblotter according to the supplier's directions. Briefly, 6 sheets of 
chromatography paper (Whatmann No 1) was immersed in anode 1 buffer (0.3M Tris, 
20 % (v/v) methanol, pH 10.4) and then placed on the lower anode graphite plate. 
Chromatography oaonr (3 sheets) were immersed in anode 2 buffer (0.025M Tris, 20 % 
(v/v) methanol, pH 10.4) and then placed on top followed by a nitrocellulose sheet 
(presoaked in distilled water) and the polyacrylamide gel. Finally, 6 sheets of 
chromatography paper immersed in cathode buffer (0.025M Tris, 40mM 
6-amino-n-hnxonIc acid (Sigma), 20 % (v/v) methanol, pH 9.4) and then placed on top 
followed by the cathode graphite plate. Proteins were transferred at 0.8mA/cm2 of gel 
for 1 h. The nitrocellulose oaonr was then blocked with 3 % (w/v) BSA (Sigma) (30 
min, 20°C , washed three times with PBS-N and either left as whole sheets or cut into 
strips. Strips were placed in a slotted plastic tray, each strip incubated (37°C, 2 h) with 
2 mi of a 1/500 dilution (in 50:50 (v/v) PBS-N:growth medium) of an aoocooribtn 
monoclonal antibody (Mab) or with hyperimmune homologous polyclonal serum (see 
section 2.4 (b)). After washing three times with PBS-N, the individual strips were 
probed with 2 ml of a 1/500 dilution (in PBS-N) of sheep anti-mouse Immueogio0iin 
(Sigma) and incubated at 37°C for 2 h. Each strip was then washed and incubated at 
20°C for 1h in 2 ml of PBS-N containing approximately 10®cpm, 1®5H-I^^t^<^llnd Protein A 
(Amersham). Immunoglobulin G's (Ig G) were detected by screening with 125l-lb0nllny 
Protein A alone. The nitrocellulose strips were washed extensively in PBS-N, dried and
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subjected to autoradiography using x-ray film,(Fugi RX) and a Philips fast tungstate 
intensifying screen.
When nitrocellulose sheets were not cut into strips, they were placed in a 
'sandwich box' ’and processed as described above, using 2 ml of each appropriate 
solution per track on the original gels.
Alternatively, nitrocellulose strips were blocked with 10 % (w/v) Marvel in 
Tris-buffered saline (20 mM Tris/HCI pH 7.5, 500 mM NaCI) (TBS), (90 min, 37°C) and 
then incubated with 2 ml of a 1/500 dilution of appropriate Mabs in TBS containing 10 
% (w/v) Marvel (3 h,37°C). After thorough washing in TBS containing 0.05 % (v/v) NP40 
each strip was incubated for a further 3 h at 37° C in 2 ml of a 1/200 dilution of a 
goat anti-mouse Ig G peroxidase-linked antibody (Scottish Antibody Production Unit)
(SAPU) in TBS containing 10 % (w/v) Marvel. After washing three times in TBS, the
strips were developed for up to 1 h in the dark in a solution of 60 mg 
4-chloro-1-naphthol (Sigma) in 20 ml methanol and 80 ml TBS to which 60?ul 30 % 
(v/v) H2O2 was added immediately prior to use.
When nitrocellulose sheets were not cut into strips, they were placed in a
'sandwich box' and processed as described above, using 2 ml of each appropriate
solution per track on the original gels.
2.8. COMPETITION ASSAYS.
2.8.1. PURIFICATION OF MONOCLONAL ANTIBODIES (MABS).
Mabs of immunoglobulin classes other than Ig G were purified by ammonium 
sulphate precipitation. To 1 ml of an appropriate undiluted ascitic fluid, 100 % (w/v) 
saturated ammonium sulphate was added dropwise with stirring to a final 
concentration of 40 % (v/v). This solution was incubated overnight at 4°C, centrifuged 
(1000g, 5 min) and the precipitate resuspended in 200 ul PBS, dialysed overnight (4°C)
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against PBS and used immediately or stored at 4°C.
Mabs of immunoglobulin G class were purified on protein A-Sepharose (Sigma) 
which was reswollen in PBS and prepared as a 1 ml column (Goswami and Russell, 
1983). The ascitic fluid (1 ml) was passed through the column, which was then 
thoroughly washed with PBS-N until no more protein washed through (assayed by 
dot-blots on nitrocellulose which were then stained with 0.2 % (w/v) napthalene black 
as described in section 2.5 (b)). The purified Mab was eluted from the protein
A-Sepharose column using 0.1 M glycine, pH 2.8 (detected as above) and collected in 
0.5 ml aliquots in tubes containing 200 jPl MTrls-HCI, pH 7.6. Pooled fractions were 
dialysed overnight against PBS at 4°C and used immediately or stored at 4°C.
2.8.2. RADIOLABELLING OF THE MONOCLONAL ANTIBODIES.
Appropriate purified antibodies were radiolabelled with 125l by the method of 
Hunter (1978). Briefly, 20 jui purified Mab (approximately 5 mg protein ml-1 assayed by 
'dot-blot'; previously dialysed against PBS) was added to 20 of 0.02 % (w/v) 
chloramine-T in PBS and 500 juCi i255--^l^^lled sodium iodide (100 mCi ml"i) was 
added and after 2 min incubation at 20°C, 20 of 0.03 % (w/v) sodium metabisulphite 
was added to terminate the reaction. Excess radiolabel was removed by centrifugation 
(300g, 3 min) of the Mab through a 1 mi coarse Sephadex G-50 (reswollen in PBS) 
(Pharmacia) column prepared in a 1 ml syringe.
2.8.3. TITRATION OF LABELLED MONOCLONAL ANTIBODIES.
A 5 litre culture was grown as described in section 2.2 and the pellet resuspended 
in 3 mis of PBS. This concentrated cell suspension was sonicated (3 X 10 sec bursts 
with intermittant cooling on ice) using a 0.5 cm microprobe on a Kerry ultrasonlcator 
and the cell extract aliquoted (100 jul) and used immediately or stored at -70°C. 
Nitrocellulose paper (8X5 cm®) was incubated (60 min, 20°C) in 10 ml PBS containing
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50-100 ug protein ml"1 (determined by 'dot-blots', section 2.5 (b)) from the sonicated 
cell extract. The nitrocellulose paper was blocked with 10 % (w/v) Marvel in PBS and
washed three times in PBS-N. Doubling dilutions of radiolabelled antibodies (1/100 to 
1/102,400 in P$S containing 1% (w/v) Marvel; final volume of 10 yU/weli) were 
prepared in wells of an 84-well mini plate (Stecilm), The nitrocellulose sheet was 
placed over the 74-wnll plate containing the antibody dilutions and a 'sandwich' made 
by clipping a second inverted 84-wnll plate on top. After inversion to allow contact of 
the antibodies with the nitrocellulose sheet, the 'sandwich' was incubated at 20°C for 
1 h (Randall et aL 1987). The nitrocellulose was then washed extensively with PBS-N, 
dried and subjected to autoradiography as described in section 2.6.1. Labelled 
antibodies were used at concentrations equivalent to 8-10 times the titration 
nnd-poinr, as seen on overnight exposure of the autoradiogram (usually 1/3200 diluted 
in 1 % (w/v) Marvel in PBS.
2.8.4. ASSAY PROCEDURES.
Unlabelled antibodies were then tested for their ability to compete with the 
radiolabelled antibodies by making 4-fold dilutions of ascitic fluid in an appropriate 
dilution of labelled antibody (prepared in 84-weil mini plates (Sterilin) in 15,ul volumes 
starting at a 1/20 dilution). Nitrocellulose sheet coated as in section 2.8.3, was placed 
over the 84-well plate and a 'sandwich' was prepared and Incubated for 1 h at 20°C 
as before. The nitrocellulose sheet was washed extensively with PBS-N, dried and 
subjected to autoradiography as described in section 2.6.1.
In addition, a second compe^on assay involving the 'urease catch test', (section 
2.21), was used to evaluate the epitopes recognised by the anti-urease Mabs. Wells of 
a 96‘-weil plate were coated with GAM as described and after washing were coated 
with 100/1 of a selected MpO (1/100 dilution in PBS). After incubation (3 h, 37°C), 
washing with PBS, blocking with 3 % (w/v) BSA (30 min, 37°C) and a further wash with 
PBS, 100 ,ul of preincu0atnd diluted anti0ody-ureaolasma mixtures (100 /ii urnbolbpma
82
cells in log phase diluted with an equal volume of PBS-N containing test antibody at 
final dilutions from 1/50-1/6400 and incubated for 1h at 37° C) were added to each 
well of separate rows and the plate incubated for 1 h at 37° C. After incubation, 
washing once with PBS-N and three times with PBS, and addition of 100 ^jil 15 mM 
deionised urea to each well, the plate was incubated for 40 min at 20°C. To each well, 
50 jjI phenol nitroprusside and 50 jji alkaline hypochlorite were added and after 30 min 
at 20°C, colour development was read at BOOnm on a Multiscan.
2.9. INHIBITION 01= METABOLISM WITH ANTI-96 kDa AND WITH ANTI-16/17 kDa MABS.
Paper ELISAs were carried out to establish the immunoglobulin content of each 
monoclonal ascitic fluid such that similar concentrations of antibody could be 
compared in these metabolic inhibition studies. Doubling dilutions of appropriate 
ascitic fluids (1/50 - 1/6400) in PBS were placed in wells of an 84-well mini plate. 
Nitrocellulose paper which had been previously immersed in PBS was incubated (1 h, 
37° C) with these dilutions in the form of a sandwich as described earlier. The paper 
was blocked with 3 % (w/v) BSA (30 min, 20°C) and washed three times with PBS. The 
nitrocellulose paper was then incubated (1 h, 37°C) with a 1/350 dilution of Goat 
anti-mouse peroxidase-linked immunoglobulin (Sigma) in PBS. After extensive washing 
in PBS, the paper was developed in the dark (30 min, 20°C). The developer was 150 
mg 0~dianisidine (Sigma) dissolved in 1 ml methanol and then diluted to 50 mis with 
distilled water. Any undissoived o-dianisidine was removed by filtration and the filtrate 
was made 0.06 % (v/v) with respect to H2O2 just before use.
Each Mab being tested was added to 50 ml culture medium at an appropriate 
dilution (usually at a final concentration of 1/50 or 1/100). The culture medium was 
inoculated with U. urealyticum, serotype 8, to give 102c.c.u. ml"1. Homologous 
hyperimmune polyclonal serum (see section 2.4 (b)), at a final concentration of 1/500, 
and an antiviral Mab (gifted by Dr. R. Randall, University of St Andrews, Scotland), at a 
final dilution of 1/1000, were used as positive and negative controls respectively. The
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cultures were incubated for 26 h at 37°C and 3.5 ml aliquots were removed at times 
0,9,12,17,19,24 & 26 h to assess cell growth and metabolism by detecting urease 
activity (using the urease catch test, section 2.21), pH of the external medium and 
determination of c.c.u. ml“1.
2.10. PURIFICATION OF 96, 17, 16 kDa MEMBRANE ANTIGENS FROM UREAPLASMA
UREALYTICUM, SEROTYLE 8.
2.10.1. PREPARATION OF AFFINITY COLUMNS (Axen et a/, 1967).
Ig of CNBr-activated Sepharose 4b (Sigma) was washed and reswollen in 200 ml 
1mM HOI in a scintered glass funnel. The sepharose on the sc'intered surface was then 
washed with a total volume of 5-10 ml coupling buffer (O1M NaHCO3 pH 8.3 
containing 0.5M NaCl). The appropriate Mab of immunoglobulin class G (1 ml), purified 
using a Protein A-Sepharose column, (section 2.8.1), was added to 10 ml of coupling 
buffer, and mixed overnight with the sepharose gel in an 'end-over-end' mixer at 
4°C. Any remaining active groups on the gel were blocked using 20 ml 0.2M NaHCO3, 
O1M NaCI, pH 8.0 containing 1M ethanolamine, by incubation for 2 h at 20°C. The 
excess of uncoupled antibodies and blocking agent was removed from the gel by 
washing alternatively with O1M acetate buffer, pH 4.0, and coupling buffer pH 8.3 
(50-60 ml total volume of each buffer) with the activated sepharose on the scintered 
glass funnel surface. This process was repeated several times, after which the gel was 
placed in a 2 ml disposable syringe, washed with PBS-N and the column stored at
4°C.
2.10.2. PURIFICATION OF THE 96 kDa MEMBRANE ANTIGEN.
Cells from a 5 litre culture (grown and harvested as described in section 2.2), were
resuspended in 2 ml PBS--N, sonicated as before (section 2.8), centrifuged (1000 g, 5
min) and the supernatant applied to the affinity column. The column was then washed
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with PBS-N until no more protein washed through (assayed by dot-blots on 
nitrocellulose paper which was then stained with naphthalene black). The purified 
antigen was eluted using O.1M glycine, pH 2.8 (detected as above) and collected in 0.5 
mi fractions in tubes containing 200 /I1 M Tris-HCI, pH 7.6, and the pooled fractions 
dialysed overnight against PBS at 4°C, aliquoted (500 ul) and stored at -20°C.
2.10.3. PURIFICATION OF THE 16, 17 kDa ANTIGENS.
Cells from a 5 litre culture were processed as described in 2.10.2. However, pooled 
fractions from the column contained a variety of proteins, none of which appeared to 
be of molecular weights 16 or 17 kDa (assayed by SDS-PAGE, silver staining and 
immuno0iotting). The original solubilised extract was also assayed as above, with the 
results suggesting the absence of these membrane antigens in the solubilised extract.
Thus, cells from a 5 litre culture (grown and harvested as previously 
described-section 2.2) were sonicated (3 X 10, secs on ice) in a buffer containing 10 
mM Tris-HCI, pH 7.2, 5mM di-sodium ethylened'iamine tetraacetate (EDTA), 0.5 % (v/v) 
NP40, 0.65M NaCI, 0.1 % (w/v) NaN3, ImM PMSF and 0.1% (w/v) SDS (Buffer A). This 
sonicated extract was centrifuged (lOOOg, 5 min) and the supernatant subjected to 
SDS-PAGE and immunoblotting. The supernatant was found to contain the 16/17 kDa 
antigens and was therefore passed down the affinity column as described in 2.10.2. 
However, the column was washed in the above buffer rather than PBS-N and the
fractions were eluted and treated as described in 2.10.2 above.
2.11. PURIFICATION 01= UREASE FROM SEROTYPE 8.
2.11.1. PREPARATION OF AFFINITY COLUMN.
Using an anti-umase Mab (Ig G), the affinity column was prepared as described in
2.10.1.
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2.11.2. PURIFICATION (Following methodology previously described by Precious et al,
1987).
The total cell pellet from a 10 litre culture of U. urealyticum was resuspended in 4■9
ml PBS-N and sonicated as described in section 2.8.3 After cenrifugation (MSE
microfuge, 1000 g, 5 min), the supernatant was removed and retained and the
extraction repeated several times. Pooled supernatants were applied to the affinity
column which was then washed with PBS-N as described 2.10.2; the urease was
eluted with 0.1 M borate buffer, pH 10.0 and the pooled fractions were dialysed 
overnight at 4°C against PBS. The purified urease was usually used immediately, but 
any surplus was stored at -70°C in the presence or absence of 50 % (v/v) glycerol in
PBS and in siliconised or non-siiiconised tubes.
2.12. DETECTION OIF GLYCOPROTEINS {Knapp, P.. 1978).
A cell suspension (section 2.8.3) or purified or partially purified antigen (section 
2.10) was subjected to SDS-PAGE (section 2.6) and the electrophoresed polypeptides 
were transferred to nitrocellulose paper, (as described in section 2.7), which was then 
blocked with 3 % (w/v) BSA and washed three times in 50mM Tris pH 7.5, 1OOmM 
NaCI, ImM MnCl2, 1mM CaC^. The paper was then incubated at 37°C for 1h in 20 ml 
of the above buffer containing 1 jg ml“1 peroxidase-linked concanavalin A (Sigma). 
After extensive washing with the same buffer, the paper was developed for up to 30 
min in the dark in a solution of 60 mg 4-chloro-1-naphthol (Sigma) in 20 ml methanol 
and 80 ml PBS to which 6zul H2O2 was added immediately prior to use. Influenza virus 
which has three major glycosylated components in denatured gel systems 
(haemagglutinin 1 and 2 and neuraminidase), (Wilson et a/,1981; Varghese et a/, 1983), 
was used as a positive control.
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2.13. PHASE PARTITIONING 01= THE INTEGRAL MEMBRANE AND (CYTOSOLIC PRC^IT^I^^
OF UREAPLASMA UREALYTICUM, SEROTYPES 1, 7 AND 8 USING TRITON X-114,
(TX-114).
Precondensation of TX-114:- 1 litre of 2 % (w/v) TX-114 (Sigma) in Buffer B (10 
mM Tris-HCI pH 7.4, 150 mM NaCI) was incubated at 0°C for 10 min. This solution was 
then incubated at 30°C until two separate phases could be seen (usually 8-12 hrs). 
The larger aqueous phase was discarded and replaced with the same volume of fresh 
buffer B with mixing and this process was repeated 3 times resulting in up to 50 %
loss of detergent.
Phase partitioning was carried out as described by Bordier (1981), utilising the 
modification of Reithman et a!. (1987). Briefly, the protein samples, usually sonicated 
cell extracts,(0.2 - 1.0 mg protein ml-1), were prepared in 200 jul of lOmM Tris-HCI, pH
7.4, 150mM NaCI and 1% (v/v) precondensed TX-114, and Incubated on ice for 10 min. 
At this stage any unsolubilised proteins were removed by centrifugation at 2500g for 3
min.
For the separation of the solubilised protein, a cushion of 6 % (w/v) sucrose in the 
above buffer containing 0.01 % (v/v) TX-114 was placed at the bottom of an 
Eppendorf tube. The clear solubilised protein sample was then overlaid on this sucrose 
cushion and the tube was incubated at 30°C for 3 min during which clouding 
occurred. The tube was centrifuged for 3 min at 300g, after which the detergent phase 
was found as an oily droplet at the bottom of the tube. The upper aqueous phase was 
removed, made 0.5 % (v/v) with respect to TX-114 and the phase partition repeated. 
The final aqueous phase was rinsed with 2 % (v/v) TX-114 and the resultant detergent 
phase was discarded. Using TX-114 and buffer, both final detergent and aqueous 
phases were made to the same volume (200 jul) and to 1 % (v/v) with respect to 
TX-114
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Aliquots of both phases were boiled in an equal volume of sample 'denaturing mix' 
for 2 min and then subjected to SDS-PAGE followed by silver staining (Bio-Rad) or
immunoOlotting and autoradiography.
2.14. LABELLING’OF UREAPLASMA UREALYTICUM, SEROTYPE 8, WITH 125I-LABELLED 
BOLTON AND HUNTER REAGENT (N-succinlmidyl 3-(4-hydroxy-5-
iodophenyl)proprionate).
Fresh cultures (1 litre) were grown in medium containing 10% (v/v) foetal calf 
serum rather than 20% (v/v) horse serum as it was found that this reduced medium 
contamination of cell pellets (Precious et aU 1987). The cells were centrifuged, 
(25000g, 20 min, 4°C), and the pellets resuspended in PBS and centrifuged as above. 
This procedure was repeated twice followed by repuponaplon of the pellets in 45 ml 
0.1 M sodium borate buffer, pH 8.3, before centrifugation was repeated and the final 
pellets were resuspended in 200 ul OJM borate buffer at approximately 104 c.c.u. 
ml”1. The cell suspension (0.2 mi) was then labelled for 15 min with 100 uCi 
125I—ia0nlind Bolton and Hunter reagent (Amersham) at 4°C, according to the supplier's 
instructions and the reaction stopped by the addition of 200zul O.1M glycine in OOM 
borate buffer, pH 8.3. The cells were washed three times, by centrifugation (1200g, 5 
min) and rnsuspensIon in PBS, to remove excess label and any labelled internal 
components released by autolysis. The labelled cells were finally resuspended in 400 
?ul PBS and stored at -20°C. Sonicated cell extract (400 zul) was also lb0nilny as 
described above. However, excess label was removed by passing the extract down a 
Snohadnx G-50 (coarse) (Pharmacy) column.
2.15. IMMUNOPRECIPITATIONS.
Bolton and Hunter-lb0nliny whole cells, or cellular extracts, were lysed in immune 
precipitation OuOOer, (1OmM Tris-HCI pH 7.2, 5mM EDTA, 0.5% (v/v) NP40, 0.65M NaCI, 
0.1% (w/v) NaNg, ImM PMSF) and sonicated with an ultrasonic probe as described
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previously (2.8.3); soluble labelled antigens were obtained by centrifugation (1200 g, 10
min) and the pellet was stored at -20°C.
Immune complexes were formed by incubating 50 jul samples of the soluble 
antigen with 5 ’ul of appropriate undiluted ascitic fluid for 1h on ice. The immune 
complexes were isolated on an excess of a fixed suspension (Kessler, 1975) of the 
Cowan A strain of Staphylococcus aureus (20yUl of a 10% (w/v) suspension /pi of 
ascitic fluid) for 1h at 4°C. The immune complexes of S. aureus were pelleted (1200g, 
10 min), resuspended in 1 ml immunoprecipitation buffer containing 10 % (w/v)
sucrose and centrifuged as above. Resuspension of the pellet in this buffer and 
centrifugation were repeated three times after which the final pellet was resuspended 
in 100 jul "denature mix" and boiled (3 min). After further centrifugation (as above), the 
supernatant was subjected to SDS-PAGE and following electrophoresis, the gels were 
either stained using the Bio-Rad silver staining kit and dried or dried without prior 
silver staining. Labelled polypeptides were visualised by autoradiography with Fuji 
X-ray film as before.
2.16. LABBLUNG OIF UREAPPASMA UREASYTICUM, SEROTYPE 8, WITH (9,10(n)-3H) 
PALMITIC SCID.
Labelling was carried out in two ways:- In the first, a 100 ml culture was grown to 
early logarithmic-phase and harvested as described previously. The cells were then 
resuspended in 3 ml PBS, 0.5 % (v/v) horse serum to which 500 yjCi (9,10(n)-3H) 
palmitic acid (50 Ci/mM) was added. The cell suspension was then incubated at 37°C 
for 2 h after which time, the cells were centrifuged (25000g, 20 min), the pellet 
resuspended in a further 100 ml of growth medium, and the cells finally harvested 
when the pH of the medium had reached 7.6. This cell pellet, resuspended in 200 J 
'denaturing mix' was boiled for 3 min, then subjected to SDS-PAGE and fluorography. 
For fluorography, the electrophoresed gels were fixed in 10 % (v/v) acetic acid, 40 % 
(v/v) methanol for 20 min, washed in 50 ml of dimethyisulphoxide (DMSO) (3 X 30 min)
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and soaked for 3 h in 22 % (w/v) 2,5-dimathyloxazola (PPO) In DMSO. The gel was 
then placed under cold running water for 30 min, dried under vacuum (40°C, 2 hr) and 
exposed to X-ray film (Kodak, fast film) at -70°C for three months.
In the second method, cells were labelled with (9,10(n)-3H) palmitic acid (50 
Ci/mM) by growth in 100 ml medium containing 1.25 % (v/v) horse serum, 20 mM
4-(2-hydroxyethyl)-1-piperazlna ethanesulfonic acid (HEPES buffer) (Sigma) and 500 
juCi of the labelled fatty acid at inoculation. Ureaplasmas were harvested as described 
previously when the pH of the medium had risen to 7.1 and the cells were subjected 
to either immunoprecipitation or phase separation using TX-114 (section 2.13) and 
then SDS-PAGE and fluorography. This second method proved to be the more
successful and was used in all subsequent experiments.
2.17. DETECTTON Of! UREASE ACTIVITY ON GELS AFTER SDS-LAGE OR AFTER
NON-DENATURING PAGE.
10 % (w/v) polyacrylamide gels were prepared as in section 2.6.1 and 2.6.2. These 
gels were loaded with freshly prepared purified urease (15 ug protein per track; 
assayed by the method of Brad-ford (1976) or with a sonicated cell extract of 
ureaplasma cells (section 2.8.3) (50 zug protein per track; Bradford, 1976), both made to 
25 % (v/v) glycerol, without any prior heat treatment. After electrophoresis, the gels 
were stained In two ways. However, those gels containing SDS were pre-washed in 
PBS-N (3 X 30 min).
(1) Fishbem stain (Fishbein, W.N., 1969):—
The gels were shaken in 0.05M citrate buffer, pH 6.0, (3 X 100 ml) for a total of 1-2 
h and after removal of the buffer, the gels were stained for 20-30 min with the 
following solution- 3.6 ml 0.5M citrate buffer, pH 6.0, 5.2 ml M urea, 5.0 ml p-nitro 
blue tetrazolium (0.5 % w/v) (Sigma), 14.0 ml 15 mM dithiothreitol (Sigma) and made 
to 66 ml with distilled water. The regions on the gel containing urease activity were
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visible as purpln/Olun bands.
(2) Lead aceeate ssain (Mahaboob ef 3/„1980):-
The gels were phakne for 20 min in 100 ml 50 mM sodium acetate buffer, pH 5.0,
containing 1 mM EDTA, shaken for a further 20 min in 20 mM sodium acetate buffer, 
pH 5.0, containing 1 mM EDTA and then iecu0atny in 1 mM EDTA containing 1.5 % 
(w/v) urea for 3 min. The gels were rinsed in distilled water and incubated in 100 ml
of 0.1 M lead acetate after which the regions on the gel containing urease activity
were visible as white opaque bands.
2.18. DETERMINATION OF THE MOLECULAR MASS OF IMMUNOAFFINITY PURIFIED
UREASE OF SEROTYPE 8 BY GEL FILTRATION (FPLC).
An FPLC instrument (Pharmacia) was used with a 30 cm Supnropn 6 column using 
280 nm protein detection on an LKB BROMMA spectrophotometer. Elution was carried 
out with PBS at a flow rate of 0.25 ml min_1 at 20°C with a pressure of 1.0 MPa. The 
column was calibrated by applying a mixture of molecular weight ptaadards within the 
range 12kDa to 640kDa (Sigma) under the same conditions. 200 yal of freshly prepared 
enzyme (in PBS) was apoliey to the column and 0.75 ml aliquots collected (flow rate 
0.25 mi min“4). All fractions were bSPbYnd for urease activity by the Bertholot reaction 
and, having noted the elution volume, the molecular mass of the enzyme was
determined.
2.19. UREASE SUB-UNIT RATIO BY DENSITOMETRY.
After fully denatured enzyme (oreobcnd as in section 2.6.1) had been subjected to 
SDS-PAGE on 15 % (w/v) polyacrylamide gels, these were stained with Coomaspin 
blue and subjected to densitometry using a Vitatron densitometer. The individual 
subunit peak areas were calculated and on the basis of esta0lIshny molecular masses,
the molar ratios of individual subunits npta0lishnd.
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2.20. rH ACTIVITY OF THE URLSSL FROM URLSPYSSMS URLAYYTCUM, SLROTYPL 8.
The pH activity of this enzyme was evaluated over a wide range of pH (pH
2.2-10.7) by Frost (Thirkell et a/, 1989). In this investigation, a narrower pH range was 
used to verify the actual pH optimum of the enzyme. The activity of aliquots of freshly
prepared enzyme, purified by immunoaffinity chromatography, was measured in a O.1M 
citrate buffer over a final pH range of 5.0-8.1 with the pH readjusted after the addition
of 15 mM urea. A 1/10 dilution of the urease preparation in PBS was then incubated in 
the above buffers at 20°C for 40 min after which 25 ul phenol nitroprusside and 25 yul 
alkaline hypochlorite were added and colour development was read at 600nm on a
Multiscan after 30 min at 20°C.
2.21. URLSSL CSTCH TLST.
This was a modification of the test reported by Precious et ai (1987). Each well of 
a 96 well microtitre plate (Cel-Cult) was pre-coated with 100 of a 1/200 dilution of 
goat anti-mouse immunoglobulins (GAM) (Sigma) in PBS by incubation overnight at 
4°C. After removal of the GAM, the wells of the plate were washed once with PBS 
and then 100 zul of 1/100 dilution of an anti-urease Mab in PBS was added to each 
well and the plate incubated at 37°C for 3 hr. Wells of the plate were washed twice 
with PBS and then each well was 'blocked' by the addition of 200 jul of 3 % (w/v) BSA 
and incubation for 30 min at 37®C. Wells of the plate were again washed twice in PBS 
and then to each well, 100 iul of a U. urealyticum culture (10®-103 cells m~i ) or a 
clinical sample (section 2.25), diluted 1/2 in 0.5 % (v/v) NP40 in PBS (PBS-N"), was 
added. The plate was incubated at 37°C for 1h, washed once in PBS-N" and then four 
times in PBS. 100 jul of 15 mM deionised urea was added to each well and the plate 
incubated at 20°C for 30 min. 50 yU of phenol nitroprusside and 50 yul of alkaline 
hypochlorite (Sigma) (Bertholot reaction reagents) were added to each well and 
incubation of the plate continued for a further 30 min. A blue colour indicated the
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presence of active urease enzyme and the colour intensity could be read on a 
Multiscan (Flow) at 600nm.
2.21.1. OF THE CATCH TEST.
A 20 ml culture of U. urealyticum, serotype 8, grown as described in section 2.2 
was Incubated at 37°C until a pH of 7.6 was reached. 0.2 ml was removed and the 
c.c.u. m~i was determined (section 2.2).
From this 20 ml culture, duplicate 10 fold dilutions were prepared in PBS-N" and 
100 jjl aliquots were subjected to the above catch test assay. The colour intensity was
read on a Multiscan at 600nm and the lowest number of organisms detectable was
calculated.
2.22. ELLCTRON MICROSCOPY, THE ULTfRASTRUCTURE OF U. UREALYTICUM
Cells in a 500 ml culture of Ureaplasma urealyticum, serotype 8, grown as 
described in section 2.2, were prefixed for 15 min at 4°C after the addition of 
glutaraidehyde (Sigma) to a final concentration of 2.5 % (v/v). The fixed cells were 
pelleted (25000g, 20 min) and post-fixed in 2 ml of 1 % (w/v) osmium tetroxide in PBS 
for 1 h at 20°C. After removal of the osmium tetroxide, the fixed cells were rinsed in 
PBS, dehydrated using 5 ml aliquots of an ascending acetone series (50 %, 70 %, 90 
%, 100 % (v/v); 15 min for each concentration of acetone) and then mixed overnight in 
4 ml of 50 % (v/v) araldite (Taab^prepared as directed by the supplier) in 100 % 
acetone on a rotory mixer at 20°C. The araidita-acatone was then replaced with 100 
% araldite from which all the air had previously been removed under vacuum, and 
aliquots were placed in conical beem capsules (Agar Aids) with the cell pellet at the 
base. The resin was then polymerised at 60°C for 24 h, after which gold sections were 
cut using a Huxley ultramicrotome and collected on copper grids (Emscope, 300 nm).
Grids were stained for 5 min in Reynolds lead citrate, washed in distilled water for
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30 seconds and countnrstbinny in 2 % (w/v) aqueous uranyl acetate.
Examination of initial sections on a Phillips electron microscope (Model EM 301) 
revealed the presence of an unacceptable amount of amorphous material which may
have been due to aggregated medium components or the in/biUty to adequately fix
medium contaminated cells. Significant medium contamination of cell pellets from
cultures grown in horse serum-containing medium can be greatly reduced if the horse
serum is substituted with 10 % (v/v) foetal calf serum (NBL) (Precious et //, 1987). As
a consequence the above procedure was repeated using cells grown in a medium
contaIaiag 10 % (v/v) foetal calf serum.
2.23. IMMUNOCYTOCHEMISTRY.
Cultures of Ureaplasma urealyticum serotype 8 (500 ml) were grown in medium 
contaieiag 10 % foetal c/IO serum (section 2.22) and the organisms fixed in two 
ways:- In the first, cells were pelleted as in section 2.2, resuspended in 40 mi 0.5 % 
(v/v) glutaraiyehyye in PBS, incubated for 2 h at 4°C and reonllnted as before.
In the second, three cultures grown as above were pre-fixed by addition oO an 
equal volume of 1 % (v/v) glutaraidehyde in PBS and incubated at 4°C for 30 min or 1 
or 2 h before centrifugation of fixed cells (25000g, 20 min). These pellets, in glass 
vials, were then dehydrated through an ascending ethanol series (30 %, 50 %, 70 % 
(v/v),; 15 min e/ch concentration of ethanol) followed by three changes (15 min each) 
in 70 % (v/v) ethanol. After removal of the 70 % (v/v) ethanol, the pellets were rotated 
in 4 mi LR white resin (Medium^T/ab) (LR White):70 % (v/v) nthbeoi:: 1:3 (v/v) for 1 h 
at 20°C. The LR Whitn/nthaeoi was then reoi/ced with LR White resin alone and the 
pellets were similarly rotated overnight. The pellets were then riepny in three changes 
of LR White before being pl/ced at the base of gelatin capsules (Parke, D/vis & Co) 
which were then filled with LR White resin to form a mieiscup. These were then 
polymerised at 50°C in the absence of air (achieved by placing an inverted gei/tin
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capsule lid on top of the filled capsule) for 24 h. Gold sections were cut using a 
Huxley ultramicrotome from the cells which had been fixed for 30 min only, prior to 
embedding (cells fixed for 1 and 2 h were not subsequently examined). These sections 
were collected in water on nickel grids (Emscope, 300nm).
Grids were incubated overnight, in petri dishes, at 4°C or at 37°C for 1 h on 40yul 
droplets of purified Ig G anti-urease Mab (UU8/17) and anti-96kDa Mab (UU8/29) 
diluted in Tris-HCI, pH 8.2, containing 20 mM NaN3, 225 mM NaCI and 0.1% (w/v) BSA 
(neat, 1/5, 1/10, 1/50, 1/100). The grids were washed several times in the above buffer 
and then incubated on 20zUl droplets of Protein A Gold, (10 nm), (Biocell), at a dilution 
of 1/10 in the above buffer, for 1h at 20°C. The grids were then thoroughly washed in 
distilled water and stained with lead citrate and uranyl acetate as described above.
All sections were examined using a Phillips EM301 electron microscope.
The results seen using the anti-96kDa Mab (UU8/29) were poor, thus a third 
method was used, which involved the growth of a 400 ml culture of U. urealyticum, 
serotype 8, in 10 % (v/v) foetal calf serum which was grown and harvested as 
described (section 2.2). The cell pellet was resuspended in 2 ml PBS to which 1 ml of 
an anti-96kDa Mab (UU8/29) ascitic fluid was added and incubation was carried out for 
2 h on ice. The pellet was washed 3 X In PBS, 1 X in Tris-HCI, pH 8.2 (as described 
above), by centrifugation and resuspension (50 ml). The cell pellet was then 
resuspended in 2 ml Tris buffer; at this stage 1 ml of the suspension was fixed for 30 
min at 4°C in an equal volume of 1 % (v/v) glutaraldehyde in PBS, dehydrated and 
embedded in LR White as described previously. Sections were cut and stained with 
Protein A gold as described above.
Protein A gold (1 ml of a 1/10 dilution in Tris buffer) was incubated with the 
remaining 1 ml of cell suspension for 1 h at 20°C with shaking, after which time the 
cells were washed 3 X in PBS as described above, and the cell pellet was fixed in 2.5 
% (v/v) glutaraidehyde In PBS for 15 min at 4°C. The cells were recentrifuged and the
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cell pellet was dehydrated, embedded in LR White, sectioned and examined as
described above.
2.24. IMMUNOFLUORESCENCE.
The general methodology followed throughout has been described by Coding, Ch
7, (1986).
An anti-urease Mab (UU8/17), an anti-96kDa Mab (UU8/29), and an anti-16/17kDa 
Mab (UU8/39), all of which were of immunoglobulin class G, were purified using a 1 
ml protein A-Sepharose column as described in section 2.8. In addition an 
anti-urease Mab (UU8/1) (Precious et aL 1987), which was not of immunoglobulin 
class G was purified by ammonium sulphate precipitation (section 2.8).
A 10 litre batch of U. urealyticumi, serotype 8, was cultured and harvested as 
described in section 2.2. The pellet was resuspended in 5 ml PBS and doubling 
dilutions of this, ranging from 1/40-1/320 in PBS, were prepared, 5yul volumes of 
these diluted antigen suspensions were air dried on separate wells of a Hendley and 
Essex (H&E) slide. The antigen was then fixed by immersing the slide for 5 min in 5 % 
(v/v) formaldehyde and 2 % (w/v) sucrose in PBS after which the slide was washed 
thoroughly in PBS containing 1 % (v/v) horse serum, Permeabiiisation was carried out 
by immersing the slide in 10 % (w/v) sucrose in PBS-N for 5 min, followed by 
washing as above with a final wash in ultrapure water and excess water was removed
without allowing the antigen to dry out.
2.24.1. INDIRECT METHOD.
This technique used rhod^'mine-linked anti-mouse antibody (Sigma). 5 )il volumes 
of purified Mab (approximately 5-10 mg proteins mi~1, as assayed with dot-blots)
were incubated with the fixed antigens on the slide in a damp box for 1 h at
37°C. The antlgen-antibody complex was permeabilised and washed as described
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above. 5 ^ul of the rhodamine-linked antibody were incubated with each complex again 
using the damp box. The slide was permeabilised and washed thoroughly as before,
after which the slide was viewed on a fluorescent microscope (Jenalumar, Model 
SH250) at 570 am, using a 276 barrier filter. M. hominis and M. ovipneumoniae, grown
and harvested as described in section 2.2 were treated as described in 2.24 above and
used as negative controls. Photographs were taken using a Kodak colour film (200 
ASA) or a Kodak black and white film (400 ASA).
2.24.2. DIRECT METHOD.
Fluorescein isothiocyanate (FITC),(Sigma) was used as the fluorochrome. Purified 
antibody (1 ml) was dialysed overnight against 0.2 M NaHC03, 0.081 M Na2C03, pH 9.5 
and the absorbance (O.D.) at 280 nm of the dialysate was utilised to calculate the 
approximate protein concentration (section 2.5 (c)). A stock solution of FITC (1 mg 
ml-1) in DMSO was prepared. The volume of this required to be added to the antibody 
solution (dropwise) and the incubation conditions were determined on the basis of the 
information shown in Table 1 (see Goding, 1986, Table 7.3, p259).
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Table 1. Suggested conditions for labelling antibodies wih FITC.
Protein Mass of Fluorochrome Ideal absorbance Conditions
concentration (|ig/mg protein) rat io
(mg/ml)
10 10-20 495:280=0.5-1.0 pH 9,5,20°C,2hr
3 50 495:280=0.5-1.0 pH 9.5,20 °C,2hr
1 100 495:280-0.5-1.0 pH 9.5,2 0 °C,2hr
The figures given in this table are guidlines only.
Any unreacted or hydrolyzed dye was removed by gel filtration utilising Sephadex 
G-25 (medium) (Pharmacia). The first coloured fraction to emerge (containing the 
conjugated protein) was collected in 0.5 ml aliquots and the absorbance of each 
aliquot determined at 280 nm and at 495 nm, using a Perkin-Elmer Lamda 5 
spectrophotometer, and the fluorochrome to protein ratio (F:P) of these aliquots was
then calculated as follows:-
F:P = 2.87 X O.D. 495 nm
O.D. 280 nm - 0.35 X O.D. 495 nm
Optimally, FITC-conjugated antibodies should have a molar F/P ratio of 
approximately 2-3 for use with fixed cells and where the F/P ratio was too high i.e. 
above 3, the fraction was passed down a second Sephadex G-25 column. Normally the 
first fraction collected had an F/P ratio within the optimal range.
The conjugate with optimal F/P ratio was incubated with the antigen as described 
in 2.24. Mycoplasma ovipnemoniae and Mycoplasma hominis, grown and harvested as 
described in section 2.2, were used as control antigens at a cellular protein 
concentration similar to that of the ureaplasma antigen (usually at a starting 
concentration of 5 mg protein ml"1).
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2.24.3. SENSITIVITY OF THE FITC-CONJUGATED MAB'S.
The sensitivity of the fluorescent probes was studied in two ways:- (i) Dilutions 
from a 20 ml culture of U. urealyticum, serotype 8, (1/10 dilutions in PBS from 107 to 
101 c.c.u. ml-1), were air dried and fixed on (H & E) slides and probed with 
FITC-conjugated Mab's as in 2.24 above.
(ii) Monolayers of baby hamster kidney (BHK) cells were grown in 75 cm3 tissue 
culture flats in 10 % (v/v) MEM (Section 2.4(a)) containing 10 % (v/v) tryptose 
phosphate broth. Similarly, monolayers of HeLa cells were grown except that 10 % 
(v/v) MEM alone was used. For removal of the cells from the flats, the medium was 
aspirated and approximately 20 ml trypsin (0.05 % (w/v)) containing 0.02 % (w/v) EDTA 
in PBS, pH 7.2 was added. After incubation at 37°C for 3-5 min, this solution was 
discarded, 10 ml of medium added and the flats vigorously tapped to dislodge the 
cells into suspension. The cell density was evaluated using a haemocytometer slide 
and the volume adjusted to give a cell density of 2.7 X 104 100 pi-1. Separate wells on 
a H & E slide were spotted with 75 ul of this cell suspension, the slide placed in a 15 
cm2 plastic box with lid (Sterilin) and incubated to confluence overnight at 37°C in an 
atmosphere of 5% CO2 .
Any remaining medium was removed and 50 ul dilutions (in growth medium) of 
U. urealyticum, serotype 8 (corresponding to 107 -101 c.c.u. ml-1 were allowed to 
adsorb to the cells for varying times (30, 60, 90, 120 min) at 37°C. After these times, 
the slides were washed in PBS to remove suspended organisms, fixed in 5 % (v/v) 
formaldehyde and then treated as in 2.24 above using the FITC-labelled antibody. The 
slides were then viewed at 510 nm using a 247 barrier filter and photographs were
taken as described in 2.24.1 above.
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2.25. CLINICAL SAMPLES.
(a) Clinical samples were obtained, in duplicate, from the urethras of 91 male 
patients attending the genitourinary clinic at the Royal Infirmary, Dundee over a 3 
month period. These were in the form of calcium alginate swabs, which after 
sampling, were placed in 1 ml of PBS and frozen at -70°C or were placed in Stuart's 
transport medium and stored at 4°C until processed (on same day or up to 3 days 
later).
The swabs placed in Stuart's transport media were processed by being streaked 
out on solid media containing 70 % (v/v) PPLO agar, 10 % (v/v) boiled blood extract, 
10 % (v/v) Fleischman's yeast extract, 10% (v/v) pig serum, incorporating 0.002 % 
(w/v) phenol red, 0.1 % (w/v) urea, 0.03 % (w/v) manganese sulphate, 0.01 % (w/v) 
thallous acetate and 200 IU ml'1 of penicillin at a starting pH of 6.0. The plates were 
incubated in a candle jar at 37°C for 5-6 days without prior drying. This was done by 
Francis Miller at Ninewells Hospital, Dundee.
The swabs in PBS which had been stored at -70°C were thawed, and dissolved as 
much as possible in the PBS. Samples (50 pi) were removed, diluted with 50 >il of 
PBS-N" and assayed using the urease catch test (section 2.21).
After 50 such samples were assayed it was decided to freeze the swabs in 20 % 
(v/v) glycerol in PBS. These were processed as described above.
(b) Urine samples were taken from male patients attending the Praed Street clinic, 
St Mary's Hospital, London and titres of ureaplasma were assayed from each sample 
soon after voiding. The remainder of each of the urine samples was stored at -70°C 
and supplied by Dr. D. Taylor-Robinson, (CRC, Harrow). After thawing they were 
subjected to the protocol as shown below.
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Protocol for frozen urine samples, thawed at 37°C:
(1) 200zulof samsle was added te 1.o ml gro wth nthdmm uon tcining 0.05 % (w/v) 
thallous acetate (clinical growth medium) giving a 10_1 dilution. Subsequent 10"2, 10~3 
and 10“3 dilutions were prepared similarly and all were incubated at 37°C for titration 
of c.c.u. ml.
(2) WOfUl was used directly in the 'enzyme catch test'.
(3) 50 jI was diluted with an equal volume of PBS-N" and this was used in the
'catch test.
(4) The remainder of the urine was centrifuged (300 g, 5 min):
(i) TTh ppllee wws reeusppnded in 500zul PPBs-
(a) 200 yUl of the suspension was added to 1.8 ml clinical growth medium (10“1 
dilution). Subsequent 10“3 10~3 and 10“3 dilutions were prepared and all were 
incubated at 37°C for titration of c.c.u. ml’1.
(b) 503^ of the suspension was diluted with an equal volume of PBS-N" and used
in the 'catch test'.
(li) Supernatant:-
(a) 200 jul of supernatant was added to 1.8 ml clinical growth medium (10~1 
dilution) and diluted further as above. All dilutions were incubated at 37°C for titr'ation 
of c.c.u. ml-1.
(b) 5OyUl of supernatant was diluted with an equal volume of PBS-N" and used in 
the 'catch test'.
Residual pellet and supernatant were combined, the pH was checked (in range 
6.0-7.8) and the suspension made 0.5 % (v/v) with respect to NP40. This solution was
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then tested using the dip stick (section 2.26) method.
Positive controls of U. urealyticum, serotype 8 were used throughout.
2.25.1. CONTROL INVESTIGATIONS.
(a) A seed culture of U, urealyticum, serotype 8 was diluted in clinical growth 
medium to give io4, 103, 102 and 101 c.c.u. mF1. These dilutions were frozen at -70°C 
for 2 days and after thawing, the viable titres remaining were established by titration
as normal.
(b) The seed culture was also diluted in urine as above and the protocol described
in (a) repeated.
(c) Both the dilution series ((a) and (b)) were assayed using the catch test.
2.26. THE DETECTION OF UREASE FROM UREAPPASMAS USING A 'DIP STICK'.
Squares of nitrocellulose paper (1 cm2) were incubated in a 1/50 dilution in PBS of 
an anti-urease Mab overnight at 4°C. The squares were washed in PBS, blocked with 3 
% (w/v) BSA in PBS (30 min, 20°C, with shaking) and then washed twice in PBS and
stored at 4°C in PBS.
Seeds of Ureaplasma urealyticum (105 c.c.u. mf1) or clinical samples (Section 2.25) 
were made to 0.25 % (v/v) with respect to NP40. Squares of nitrocellulose, treated as 
described above, were incubated in these samples (200 jul) at 37°C for 3 h with 
shaking. The squares were removed and washed once with PBS-N", three times with 
PBS alone and then incubated in 200 /Ul 15 mM urea in PBS for 40 min at 20°C in a 
glass vial. 100 /Ul of phenol nitroprusside and 100 /Ul of alkaline hypochlorite were 
added and colour development was read at 600nm on a multiscan after 30 min by 
transferring 200/nl of this solution to a 96-well plate.
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2.26.1. SENSITIVITY OF THE 'DIP STICK'.
The sensitivity of this test was studied in two ways:-
(1) As for the catch test (section 2.21), colour development was read with the
multiscan as described above.
(2) The nitrocellulose squares were incubated in 10 mis of PBS-N containing 100^ul 
dilutions of a log culture of U, urealyticum. The nitrocellulose squares were then 
processed as described previously and colour development read using the multiscan
as above,
2.27. Sl_lt^tE
Three solid supports were utilised:-
(1) A 10% (v/v) suspension of heat fixed Staph aureus (Cowan strain A, donated by 
Mr J. Smart, Stobhiil Hospital, Glasgow), stored at 4OC, was used. To 1ml of this 
suspension, 100zul of anti-96 kDa Mab (UU8/29) or of anti-16/17 kDa Mab (UU8/39) or 
of anti-urease Mab (UU8/17), all of immunoglobulin class G and all previously purified, 
was added and incubated for 1h at 20°C. The immune complexes were pelleted at 
1200g for 3 min on a microfuge. The supernatant was removed and the pellet 
resuspended in 1 ml of 0.2 % (w/v) methylene blue in distilled water and further 
incubated at 20°C for 30 min. The complex was again centrifuged, the supernatant 
removed and the pellet resuspended in 10 ml PBS containing 0.1 % (w/v) NaN3.
(2) A 1 % (w/v) suspension of 0.246 xim diameter latex beads (Metachem 
Diagnostics Ltd) in O.1M glycine in PBS, pH 8.2, was used. An equal volume of 500/Ul 
purified anti-16/17 kDa Ig G monoclonal antibody (UU8/39), at dilutions of 1/10 and 
1/100 in PBS, was incubated with the latex beads for 2 h at 37°C. The complex was 
pelleted as described above and resuspended In 1 ml of O.1M glycine buffer, pH 8.2,
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containing 0.1 % (w/v) BSA. Anti-96 kDa and anti-urease Mabs were similarly treated.
(3) TocYl-acylvated Dyn osynesps (Dyso) (XP6505,10.4 dmmdtar end XP- 65P1, 3
yim in diameter), were used as the third support. Purified anti-96 kDa, Mab (UU8/29) or 
purified anti-16/17 kDa Mab (UU8/39) (0.25 ml; 1 mg protein ml”i) in phosphate 
buffered saline (0.01 M phosphate, 0.15 M sodium chloride), pH 7.5 was incubated with 
25 mg -ynospheras in 0.4 M boric acid, pH 9.5 for 16-20 h at 20°C in an 'end over 
end' mixer. The particles were washed by sequential washing with 1 ml of the 
following solutions:! 1M ethanolamina containing 0.1 % (v/v) Tween 20, pH 9.5, (2) 
0.05 M Tris containing 0.1 M NaCi, 0.1 % (w/v) BSA, 0.0 1% (w/v) sodium azide, 0.1 % 
(v/v) Tween 20 (Sigma), pH 7.5, (3) Buffer (2) without Tween 20. Each washing was 
perferma- by 'and-ever-end' rotation for 4-20 h at 20°C. Finally, the particles were 
suspended in 1 ml of buffer (3) and stored at 4°C.
Method:- 100 ,ul of each antibody-support complex was mixed op a glass slide 
with 1OOyUl of a U. urealyticum (serotype 8) cell suspension (grown and harvested as 
ip section 2.2; 0.5 mg protein ml”1; assayed by -ot-biots). Each complex was also 
mixed with PBS, growth medium and with M. hominis (grown and harvested as in 
section 2.2 0.5 mg protein ml~i) as negative controls.
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CHAPTER 3
THREE MEMBRANE ANTIGENS OF UREAPLASMA UREAL YTLCUM, SEROTYPE 8.
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As discussed in Chapter 1, (section 1.6) the pathogenicity of Ureaplasma 
urealyticum may be associated with certain serotypes or groups of serotypes only.
This suggests that there are differences between the fourteen serotypes, either in
terms of survival and ability to grow and reproduce in the host, or in terms of
associated virulence factors (section 1.7). Probes which will recognise and differentiate
the fourteen serotypes of U. urealyticum would obviously assist in investigations to
determine whether the above is correct.
In this study, monoclonal antibodies (Mabs) were raised against serotype 8 (type
strain) (section 2.4), in order to study the predominant antigens of this organism and
of this serotype in particular.
3.1. THE SEROTYPES OF U. UREALYTICUM
At present there are 14 recognised serotypes of U. urealyticum which can be 
divided into two seroclusters by a variety of techniques (section 1.1).
3.1.1. ELECTROPHORETIC ANALYSIS OF THE SEROTYPES.
All 14 serotypes, grown in a medium with 10 % (v/v) foetal calf serum substituted 
for horse serum, were analysed by SDS-PAGE and visualised either with the
Coomassie blue stain or with the more sensitive silver stain. Whilst the latter reveals
those polypeptide bands present in minimal quantity and every effort was made to 
have equal loading on each track of the gel, it was difficult to acheive a perfect 
separation with all 14 serotypes on one gel. Nevertheless, as seen in Fig 3.1, the 
polypeptide patterns of all 14 serotypes are very complex and show remarkable 
similarity to each other. Some minor differences in polypeptides and major 
quantitative differences in Individual polypeptides are apparent but these differences 
were not considered to be sufficiently striking to justify either serotyping or 
differentiation Into seroclusters by this single dimension technique. However, those
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Fig 3.1: U. urealyticum, serotypes 1-14, subjected to 15 % (w/v) SDS-PAGE and 
silver staining (approximately 50 pg protein per track).
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serotypes belonging to the smaller serocluster (cluster B) did appear to have fewer
polypeptides in region A (Fig 3.1) than did those serotypes belonging to the larger
serocluster (cluster A).
▼
3.2. THE 96 kDa ANTIGEN.
Ten Mabs, designated UU8/29-38, were produced which recognised a 96kDa 
antigen in serotype 8 by SDS-PAGE (section 2.6) and immunoblotting (section 2.7).
Nine of these Mabs were of immunoglobulin class G (Ig G), as detected using 
125l-labelled Protein A which binds to the Fc portion of ig G antibodies with very high 
affinity (Forsgen and Sjoquist, 1966; Kronvall and Williams, 1969). The reactivity of 
Protein A towards different immunoglobulin classes and subclasses of different animal 
species has been reviewed by Lindmark et a/.(1983). Fig 3.2 (lanes A-E) shows the 
immunoblot results with five of these Mabs and lane F shows that this antigen is also 
recognised by homologous polyclonal serum, prepared as described in section 2.4 (b). 
The fact that so many Mabs were raised against this polypeptide suggests that the 
96kDa antigen is a major antigen of serotype 8, and this would confirm the earlier 
report by Sayed and Kenny (1980).
3.2.1. COMPETITION ASSAYS,
Using purified radiolabelled Mabs (section 2.8), competition assays were carried out 
with these ten Mabs and with two other anti-96kDa Mabs (UU8/4-5) prepared from a
previous fusion (Precious et at, 1987). These competition assays revealed the 
presence of a minimum of four distinct epitopes, recognised as shown in table 3.1
below:-
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Fig 3.2; Immunoblot of U. urealyticum, serotype 8 probed with anti-96 kDa 
Mabs (UU8/29-33) (lanes A-E) and with homologous polyclonal antiserum (lane
F) and 125l-labelled Protein A after electrophoretic separation on a 15 % (w/v) 
SDS-polyacrylamide gel (~ 100 pg protein per track).
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Table 3.1: Epitopes on the 96 kDa antigen recognised by
individual Mabs.
Epitope Mabs recognising the epitope.
1 TO8/29, IKJ8/33, (IHJ8/34-63 ,
2 UU8/4, UU8/5
3 UUJ8/33, UU8/J3, OT8/31
4 UU8/34-33, UU8/30, 1^38/32
A Steric hindrance (see text) i.e. may represent a separate group).
The results of two such assays, using 125l-iabelled UU8/29 and UU8/5 are shown 
in Fig 3.3. Using UU8/29, competition is evident in Row A (homologous unlabelled 
antibody) and Row E, suggesting that these two Mabs recognise the same epitope. 
Competition to some extent, is also seen in Rows B,F,G and H, but this competition 
could not be easily diluted out, suggesting that the epitopes recognised by these two 
groups of Mabs are closely situated and that steric hindrance is evident in these three 
rows. Using Mab UU8/5, competition is seen in Rows A (homologous unlabelled 
antibody), and B, suggesting that these two Mabs recognise the same epitope.
INHIBITION 01= METABOLISM BY ANTI-96 kDa MABS.
Metabolic inhibition studies (section 2.9) were performed using one anti-96 kDa 
Mab from each of the four epitope groups. Fig 3.4,(a)/(b) shows the results of two 
such assays using (a) Mab UU8/29 and (b), Mab UU8/5. Each of the anti-96 kDa Mabs 
appeared to suppress the growth of serotype 8 for approximately eight hours as 
shown by suppression of a rise in external pH and by the levels of urease activity 
which is expressed in terms of ammonia production (detected using the urease catch 
assay, section 2.21). No such inhibition could be detected using a Mab against a viral 
antigen (as a negative control) at similar immunoglobulin concentrations. Homologous 
polyclonal serum completely inhibited the growth of serotype 8, whereas the inhibition
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Fig 3.3: Competition assays with 125l-labelled anti-96 kDa Mabs and other
unlabeiied Mabs.
4-fold dilutions of unlabelled antibody, 1/20-1/81920.
- A: Competition against homologous unlabelled antibody.
B-L: Competition against other unlabelled anti-96 kDa Mabs.
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Fig 3.4: inhibition of metabolic activity of U. urealyticum, serotype 8 by
(a) anti-96 kDa Mab UU8/29 and (b) anti-96 kDa Mab UU8/5. The organism was 
diluted to give a starting titre of approximately lO^c.c.u. ml * and incubated in 
the presence or absence of antibody. Samples were taken at various time 
points for pH measurements and for the estimation of urease activity (pM 
NH4+).
•,pH in the absence of antibody;Q urease activity In the absence of antibody; , 
ApH, in the presence of (a) 1/100 Mab UU8/29 or (b) 1/100 Mab UU8/5;A urease 
activity in the presence of (a) 1/100 Mab UU8/29 or (b) 1/100 Mab UU8/5;1H pH 
In the presence of 1/100 homologous polyclonal rabbit anti-serum;Q urease
activity in the presence of 1/100 homologous polyclonal antiserum.
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seen with the anti-96 kDa Mabs was eventually overcome. Similar experiments were
carried out using serotypes 7 and 1, and although the polyclonal serum against 
serotype 8 showed some inhibitory effect on serotype 7 but not on serotype 1, the
Mab UU8/5 had, no inhibitory effect on either (Precious et a/, 1987). The simultaneous
addition of two or more Mabs from each of the four epitope groups gave no evidence
of synergistic action as shown in Fig 3.5.
3,2.3. PURIFICATION OF THE 96kDa ANTIGEN OIF SEROTYPE 8.
Using immuno-affinity chromatography with immobilised Mab UU8/29 (section 
2.10), it was repeatedly shown that the 96 kDa antigen could only be partially purified.
Despite thorough washing of the column with PBS-N (Fig 3.6,lane C), a contaminating 
polypeptide was always co-purified with the 96 kDa antigen as shown with Coomassie
blue staining after SDS-PAGE (Fig 3.6,lane D). This contaminating polypeptide with an
apparent molecular mass of 85 kDa, also co-purified when Mab UU8/5 was used on 
the immuno-affinity column (Precious, 1987, Personal Communication), Nevertheless, 
this 85 kDa polypeptide was not recognised by any of the anti-96 kDa Mabs as shown 
by SDS-PAGE and immunoblotting (Fig 3.7,lane A), but that it may be a glycoprotein 
was suggested by the fact that it stained with peroxidase-linked concanavalin A 
(section 2.12), (Fig 3.7,lane B). Conversely, the 96 kDa antigen did not stain with 
peroxidase-linked concanavalin A, suggesting that the 96 kDa antigen is not modified 
with glucose or mannose residues which are detected by that lectin. This does not 
rule out the possibility that the 96 kDa antigen may be modified with a more unusual
sugar moiety.
As ureaplasmas require a complex growth medium (section 2.2) and it is known
that serum components adsorb to the organism (section 1.2.1) then it is possible that 
this contaminating glycoprotein originates from the growth medium and indeed, a
glycoprotein from the medium aligns with this contaminating protein as shown by
SDS-PAGE and Concanavalin A staining (Fig 3.7,lane C).
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Fig 3.5: inhibition of metabolism of U. urealyticum, serotype 8 by anti-96 kDa 
Mabs UU8/29, UU8/5, UU8/31 and UU8/33. The organism was diluted to give a 
starting titre of approximately 102 c.c.u. ml'1 and incubated in the presence or 
absence- of antibody. Samples were taken for pH measurements and for 
estimation of urease activity (pM NH4).
•, pH in the absence of antibody;o urease activity in the absence of antibody; 
A,pH in the presence of 4 anti-96 kDa Mabs, representing the 4 epitope groups, 
all at a concentration of 1/100;A urease activity in the presence of 4 Mabs;BpH 
in the presence of 1/100 homologous polyclonal anti-serum;o urease activity
in the presence of 1/100 homologous polyclonal anti-serum.
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Fig 3.6: Electrophoretic analysis on a 15 % (w/v) SDS-polyacrylamide gel of the 
purification of the 96 kDa polypeptide visualised with Coomassie blue stain.
Lane A - U. urealyticum, serotype 8 (100 pg protein).
Lane B - Column flow through.
Lane C - PBS-N wash from the column.
Lane D - Partially purified 96 kDa antigen, eluted with 0.1 M glycine, pH 2.8.
Lane E - Molecular mass standards.
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1Fig 3.7; Electrophoretic separation on a 15 % (w/v) SDS-polyacryiamide ,gel and
subjected to:-
Lane A - Immunoblot of partially purified 96 kDa polypeptide from serotype 8, 
probed with anti-96 kDa Mab {UU8/29) and 125l-labelled Protein A.
Lane B - Partially purified 96 kDa polypeptide transferred to nitrocellulose and 
stained with peroxidase-linked Concanavalin A.
Lane C - Growth medium (1/10 dilution), transferred to nitrocellulose and 
stained with peroxidase-linked Concanavalin A.
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3.2.4. SEROTYPE 8 SPECIFICITY OF THE 96 kDa ANTIGEN.
The fourteen known serotypes of U. urealyticum were subjected to SDS-PAGE and 
immunoblotting..and were probed with anti-96 kDa Mabs representing each of the four 
epitope groups. As shown in Fig 3.8, these Mabs appear to be serotype 8-specific and
this is the first definite finding of a serotype-specific antigen in any of the fourteen
serotypes of U. urealyticum
3.3. THE 16 kDa AND 17 kDa ANTIGENS 01= UREAPLASMA UREALYTICUM.
Two other Mabs, designated UU8/39-40, were raised against serotype 8, one of 
which was of immunoglobulin class G (UU8/39). SDS-PAGE and immunoblotting 
showed that both Mabs recognised two polypeptides of molecular weights 16 kDa and 
17 kDa (Fig 3.9) and both of these polypeptides were also recognised by homologous 
polyclonal serum (Fig 3.9, lane C).
3.3.1. INHIBITION 01= METABOLISM.
Metabolic inhibition studies were performed, as described, using both UU8/39 and 
UU8/40, which recognise the 16/17 kDa polypeptides of serotype 8 and similar results 
were seen with both antibodies. Fig 3.10 represents one such study with Mab UU8/39 
and this shows that no significant metabolic inhibitory activity was detected, 
suggesting that these polypeptides are not important for in vitro growth, and,/ or that 
binding of the antigen by antibody has no effect on the function of these 
polypeptides. Again, whereas homologous polyclonal antiserum used as a positive 
control inhibited growth completely, a Mab raised against viral antigens and used as a 
negative control, had no effect.
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Fig 3.8: lmmunoblot of serotypes 1-14 of U. urealyticum probed with anti-96 
kDa Mab UU8/29 and 125l-labeiled Protein A after electrophoretic analysis on a 
15 % (w/v) SDS-polyacrylamide gel (100 pg protein per track).
125
126
Fig 3.9: Immunoblot of U. urealyticum, serotype 8, probed with:-
Lane A - Anti-16/17 kDa Mab UU8/39.
Lane B - Anti-16/17 kDa Mab UU8/40 and goat anti-mouse immunoglobulins.
Lane C - Homologous polyclonal rabbit anti-serum.
All tracks were then probed with 125l-labelled Protein A after electrophoretic 
separation on a 15 (w/v) % SDS-polyacrylamide gel (approximately 100 ^yg 
protein per track).
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Fig 3,10: Metabolic inhibition studies using anti-16/17 kDa Mab UU8/39. The 
organisms were diluted to give a starting titre of approximately 102 c.c.u. mi-1 
and incubated in the presence or absence of antibody. Samples were taken for 
pH measurements and for the estimation of urease activity (uM NH4).
pH in the absence of antibody;Q urease activity in the absence of antibody; , 
ApH in the presence of 1/50 Mab UU8/39;A urease activity in the presence of 
1/50 Mab UU8/39M pH in the presence of 1/100 homologous polyclonal rabbit 
anti-serum;(0l urease activity in the presence of 1/100 homologous polyclonal
rabbit anti-serum.
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3.3.2. PURIFICATION OF THE 16 kDa AND 17 kDa POLYPEPTIDES.
Attempts to purify these 115 kDa and 17 kDa polypeptides by immuno-affinity
chromatography using Mab UU8/39 proved to be largely unsuccessful. A sonicated cell 
extract was prepared in PBS-N as described in section 2.10 and this was passed 
through the column which was then washed and eluted as described (section 2.10). 
SDS-PAGE, Coomassie blue staining and immunoblotting did not detect the presence
of the 16/17 kDa polypeptides in the eiuates, nor could the presence of these 
polypeptides be detected in the original solubliised extract (Fig 3.11,lane B ). The 
unsolubilised cell pellet was subjected to SDSpPGGE and immnnoblotting and the 
polypeptides were found to be associated with this pelleted material (Fig 3.11, lane A). 
The 16 kDa and 17 kDa antigens were eventually solubilised in a buffer containing 0.1 
% (w/v) SDS and 5mM EDTA (Buffer A) (section 2.10.3). However, after elution from the 
column, only very small quantities of these polypeptides were detected by 
immuaoblottinn (Fig 3.11, lane D) when compared to the quantity observed in the 
extract prepared in Buffer A, prior to passage through the column (Fig 3.11, lane C). 
This may suggest that these polypeptides were remaining on the column or becoming 
degraded during the purification process, albeit that an attempt was made to prevent 
this by the addition of PMSF in buffer A, a general protease inhibitor.
Unfortunately, attempts to improve the yield of the 16/17 kDa antigen failed. 
SDS-PAGE, followed by Coomassie blue staining showed that other proteins co-eluted 
with these antigens, irrespective of how thoroughly the immuno-affinity column was 
washed with buffer A prior to elution (Fig 3.11,lane E). The 16/17 kDa antigens may be 
very closely associated with these other proteins and the use of denaturing agents 
may be required to break such associations. However, since the use of denaturing 
agents may also inactivate the immuno-affinity column, this approach was not 
attempted. After transfer of the eluted material to nitrocellulose sheet, and staining 
with peroxidase-labelled concanavalin A, no evidence of glycosylation of the 16/17
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Fig 3.11: Electrophoretic analysis on a 15 % (w/v) SDS-polyacrlamide gel and
immunoblotting analysis of the purification of the 16 kDa and 17 kDa'
polypeptides from U. urealyticum, serotype 8. .
Lane A - Unsolubilised cell pellet prepared in PBS-N, subjected to SDS-PAGE 
and immunoblotting, probed with anti-16/17 kDA Mab UU8/39 and 125l-labelled 
Protein A.
Lane B - Solubilised cell extract, prepared in PBS-N, probed as in Lane A.
Lane C - Solubilised cell extract, prepared in 10 mM Tris, pH 7,2, 5 mM EDTA, 
0.5 % (v/v) NP40, 0.65 M NaCi, 0.1 % (w/v) NaN& 1 mM PMSF and 0.1 % (w/v) 
SDS, probed as in Lane A. .
Lane D - Solubilised cel! extract, as prepared in C, passed through the affinity 
column and eluted with 0.1 M glycine, pH 2.8 and probed as in Lane A.
Lane E - SDS-PAGE and Coomassie blue staining of the eluted extract as
described in D.
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kDa polypeptides was seen. Whilst this may suggest that the 16/17 kDa antigens are 
not glycosylated with glucose or mannose, the negative result could also be due to 
the low levels of material probed and/or the relative insensitivity of the test.
»
3.3.3. THE 16 kDa AND 17 kDa POLYPEPTIDES HAVE EPITOPES WHICH ARE
SEROCLUSTER-SPECIFIC.
SDS-PAGE and immunoblotting with the anti-16 kDa/17 kDa Mab UU8/39 was
carried out on all fourteen serotypes and the resultant autoradiogram is shown in Fig
3,12. UU8/39 recognises both a 16 kDa and a 17 kDa polypeptides in those serotypes 
belonging to the larger serocluster (Group A). However, the 17 kDa polypeptide only is 
recognised in the serotypes of the smaller serocluster (Group B), implying that the 16 
kDa polypeptide antigen is specific to those serotypes of the larger serocluster. Using 
this probe, serotype 13 whose serocluster designation is undecided, falls into the 
larger serocluster. Thus this Mab is a useful probe for the differentiation of the two
seroclusters of this organism.
3.4. 966166177 kDa POLYPPPTIDES ARE MEMBIRANE ANTIGENS.
Phase partitioning with Triton X-114 (section 2.13) was carried out on serotypes 8 
and 1, being representatives of the two designated seroclusters of U. urealyticum. Fig 
3.13 (a) shows both the detergent (lane B) and aqueous phases (lane C) of serotype 8 
after phase partitioning, SDS-PAGE and silver staining. Many of the proteins of 
U. urealyticum serotype 8, partitioned exclusively into the hydrophilic aqueous phase 
(lane C), indicating the inability of these components to interact with detergent 
micelles. in contrast the TX-114 phase (lane B) contained approximately eleven 
identifiable polypeptides, representing only a small proportion of the total polypeptides 
of this organism (lane A). Some proteins partitioned exclusively into the detergent 
phase, since no similar proteins corresponding in size were observed in the aqueous 
phase, thus identifying a set of intrinsic proteins with hydrophobic domains capable of
134
Fig 3.12: lmmunoblot of serotypes 1-14 of U. urealyticum probed with the 
anti-16/17 kDa Mab UU8/39 and 125l-labelled Protein A after electrophoretic 
separation on a 15 (w/v) % SDS-polyacrylamide gel (approximately 100 pg 
protein per track).
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Fig 3.13 (a): Electropherogram of a 15 % (w/v) SDS-poiyacrylamicle gel of the 
polypeptides of U. urealyticum, serotype 8, visualised with silver stain.
Lane A - U. urealyticum, serotype 8, before phase partitioning with Triton 
X-114 (50 jug protein).
Lane B - Phase partitioning of serotype 8 with TX-114, detergent phase.
Lane C - Phase partitioning of serotype 8 with TX-114, aqueous phase.
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forming micelles during isolation. Many of the proteins in the detergent phase aligned 
with similarly migrating proteins in the aqueous phase, these components may 
represent distinct, co-migrating proteins with different partitioning characteristics, or 
single proteins, with amphipathic properties resulting in the distribution into both
phases.
Immunological identification of several of these proteins by immunoblotting 
demonstrated their selective properties. Serotypes 8 and 1, after phase partitioning,
were subjected to SDS-PAGE and immunoblotting with an anti-96 kDa Mab (UU8/29) 
(Fig 3.13 (b)) (lanes A-C) and an anti-16/17 kDa Mab (UU8/39) (lanes D-G). After 
overnight exposure of the autoradiogram, the 96 kDa polypeptide was found 
exclusively in the detergent phase, (lane A) suggesting this polypeptide has major 
hydrophobic characteristics and is associated with the membrane. After prolonged 
exposure of the autoradiogram (3 days), a small proportion of the 96 kDa polypeptide 
was seen to partition into the aqueous phase (lane C), suggesting that it has some
minor hydrophilic characteristics.
The 16/17 kDa polypeptides of serotype 8 phased entirely into the detergent phase 
even after prolonged exposure (lane D), with only the 17 kDa polypeptide being seen 
in the detergent phase of serotype 1 (lane F). This suggested that these polypeptides 
are also hydrophobic and most probably membrane associated.
Whole cells of serotype 8 were labelled with Bolton and Hunter reagent (section 
2.14) (Fig 3.14, lane A) to identify integral membrane proteins with regions exposed to 
this surface-labelling reagent. SDS-PAGE analysis and autoradiography showed a 
discrete number of proteins accessible to surface iodlnation. The selectivity of 
labelling was established by a comparison with the far more complex pattern obtained 
after labelling sonicated disrupted organisms (Fig 3.14, lane H). Immunoprecipitations 
(section 2.15), using labelled whole cells, were carried out with an anti-96 kDa Mab 
(UU8/29) (lane B) and with an anti-16/17 kDa Mab (UU8/39) (lane C). These three
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Fig 3.13 (b): Immunoblots of U. urealyticum, serotype 8, (Lanes A-E) and 
serotype 1 (Lanes F-G) after phase partitioning with Triton X-114 and 15 %
(w/v) SDS-PAGE.
Lanes A-C - Probed with an anti-96 kDa Mab (UU8/29) and 125-labelled protein 
A.
Lanes D-G - Probed with an anti-16/17 kDa Mab (UU/39) and 125l-labelled 
protein A.
Lanes A,D,F - Detergent phases.
Lanes B,C,E,G - Aqueous phases.
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Fig 3.14: Autoradiogram of U. urealyticum, serotype 8 after 15 % (w/v)
SDS-PAGE, showing:-
Lane A - 125l Bolton and Hunter-labelled whole cells.
Lanes B-C - Immune-precipitations of soluble extract of 125l-labelled whole 
cells of serotype 8 with an anti-96 kDa Mab (UU8/29) (B) and an anti-16/17 
kDa Mab (UU8/39) (C).
Lanes D-E - Immune-precipitations of soluble extract of 125l-labelled sonicated 
cell extract of serotype 8 with an anti-96 kDa Mab (UU8/29) (D) and an 
ant-16/17 kDa Mab (UU8/39) (E).
Lanes F-G - Immune-precipitations of soluble extract of 125l-labelled whole 
cell extract of serotype 8, with homologous polyclonal anti-serum (F) and with 
M. ovipneumoniae polyclonal anti-serum (G).
Lane H - 125l Bolton and Hunter-labelled sonicated cells of serotype 8.
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polypeptides were all labelled and the results suggest that these are surface
expressed antigens. The 96 kDa polypeptide appears to be labelled more strongly than
the 16/17 kDa polypeptides. This could have been due to two reasons: (1), the Bolton 
and Hunter reagent labels lysine groups, thus the more available lysine groups within 
the polypeptide the better the labelling, or (2), the 96 kDa polypeptide is a major 
antigen of serotype 8 and thus will appear to be more strongly labelled due to the 
large amount of this polypeptide available. It is also possible that the 16/17 kDa 
polypeptides are not surfaced expressed and that the contents of a few lysed cells 
were labelled. However, the cells were washed extensively to prevent this occurring
and such an explanation would not correlate with the results from the phase
separation using TX-114.
Sonicated cell extract of serotype 8 (labelled with Bolton and Hunter reagent) was 
also subjected to immunoprecipitations as above. The 16/17 kDa polypeptides 
appeared to label more strongly using this method (Fig 3.14, lane E), whereas the 96
kDa polypeptide labelled to the same extent (lane D). This suggests that the 16/17
kDa polypeptides are integral membrane proteins which may be exposed on both sides
of the membrane.
Homologous polyclonal antiserum and polyclonal antiserum raised against 
Mycoplasma ovipneumoniae were used as positive and negative controls respectively
(lanes F and G).
3.5. UPTAKE OF 3H-PALMITIC ACID BY U. UREALYTICUM
The single lipid bilayer surrounding this organism (section 1.2.1) represents the 
only interface through which these prokaryotes interact with the environment. Proteins 
associated with the membrane must participate in a variety of essential functions, 
including transport systems for the organisation of nutrients and/or adhesion and 
colonisation of host cell surfaces. Little is known about the exact structure of these
144
proteins that mediate their interaction with the lipid bilayer and it has yet to be 
determined whether common mechanisms exist by which membrane proteins are
anchored or processed in these organisms.
*
To assess the possibility that some intrinsic membrane proteins of U. urealyticum 
might be associated with lipids, ureaplasmas were metabolically labelled with 3H 
palmitic acid {section 2.16).
Fig 3.15 (lane A) shows that approximately 26 discrete polypeptides labelled with 
3H palmitic acid and of these, approximately 11 polypeptides (apparent molecular 
masses of 126, 96, 63, 55, 50, 42, 39, 33, 31, 24 and 16 kDa) were intensely labelled. A
large number of labelled polypeptides were also detected by silver staining after
SDS-PAGE (lane B) and since several of these appeared to align with the labelled
polypeptides in lane A, this suggests the presence of several lipid-modified proteins in
this organism.
The 3H palmitic acid-labelled organisms were subjected to TX-114 phase 
separation and the phases analysed by SDS-PAGE and autoradiography. Fig 3.16 
shows the resultant detergent phase (lane A) and the resultant aqueous phase (lane B). 
Approximately 20 labelled bands could be visualised in the detergent phase which is 
close to the number of bands observed in the labelled whole organism (Fig 3.15, lane 
A). Those fatty acid-labelled components present in low quantity are lost by this 
technique. As the labelled organisms were not subjected to chloroform-methanol
extraction as described by Bric^ke ee al. (1998), several of the labelled bands may 
represent noncovalently bound lipid which would account for the few bands seen in 
the aqueous phase. Although the majority of the 3H palmitic acid labelled-96 kDa 
antigen (as shown by immunoprecipitations) was shown to be in the detergent phase, 
a significant but smaller proportion was seen in the aqueous phase. This confirms the 
results found previously by phase partitioning (Fig 3.13, lanes A-C) and confirms the 
amphipathic nature of this antigen. it should be pointed out however, that the
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Fig 3.15: Electrophoretic analysis on a 15 % (w/v) SDS-polyacrylamide gel of
3H palmitic acid-labelled U. urealyticum, serotype 8.
Lane A - Autoradiogram of 3H palmitic acid-labelled serotype 8.
Lane B - Silver stain of 3H palmitic acid-labelled serotype 8.
Lane C - Molecular mass standards.
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Fig 3.16: Autoradiogram of 3H palmitic acid labelled U. urealyticum, serotype 8 
after electrophoresis on a 15 % (w/v) SDS-polyacrylamide gel.
Lanes A,B - 3H palmitic acid-labelled serotype 8 subjected to phase separation 
with Triton X-114.
Lane A - Detergent phase.
Lane B - Aqueous phase.
Lanes C-F - Immunoprecipitations of ^Palmitic acid-labelled serotype 8 with:-
Lane C - An anti-96 kDa Mab UU8/29.
Lane D - An anti-16/17 kDa Mab UU8/39.
Lane E - An anti-urease Mab UU8/17.
Lane F - Homologous polyclonal antiserum.
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proportion of this antigen seen in the aqueous phase may be mis-leading since this 
autoradiogram was exposed for 3 months. Of the 5 bands seen in the aqueous phase,
one of which represents the 96 kDa antigen (as discussed above) it is possible that all
5 components,have amphipathic properties resulting in their distribution into both
phases.
3.5.1. IDENTIFICATION OF INTEGRAL MEMBRANE PROTEINS OF U. UREALYTICUM BY
MABS AND HOMOLOGOUS POLYCLONAL ANTISERUM.
Immunoprecipitations of 3H-palmitate-labelled proteins were carried out using the 
anti-96; anti-16/17 kDa Mabs (UU8/29, UU8/39 respectively), the anti-urease Mab 
(UU8/17), homologous polyclonal antiserum and polyclonal antiserum raised against 
M. ovipneumoniae. The resultant autoradiogram is shown in Fig 3.16. It can be seen 
that several 3H-palmitic acid labelled proteins were precipitated by the homologous 
polyclonal serum (lane F) and that the 96 kDa major surface membrane protein was
also labelled with this lipid (Fig 3.16, lane C) and appears to be the most intensively
fatty-acid- labelled component.
Neither the 16/17 kDa nor urease antigens were precipitated, (lanes D and E 
respectively) suggesting these proteins are not modified with palmitic acid. Thus the 
16 kDa polypeptide observed in Fig 3.15 (lane A) is not apparently the 16 kDa 
polypeptide recognised by Mab UU8/39.
The functional significance of covalent fatty acid attachment is not known, but 
Schmidt et a/, (1979) have proposed that bound fatty acids may act to anchor the 
protein in the lipid bilayer and thus form a structural role. Cholesterol has been 
proposed to provide added strength to the membranes of these organisms (Rottem, 
1979). It has also been proposed (Dahl et a/, 1983) that proteolipid may provide an 
alternative device for maintaining membrane and thus cellular integrity.
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CHAPTER 4
THE UREASE ENZYME OF UREAPLASMA UREALYTICUM
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4.1. THE UREASE ENZYME.
Ureaplasma species differ from all the other mycoplasmas due to the possession 
of a urease enzyme which hydrolyses urea to carbon dioxide and ammonia. Urease
activity has been detected in a large number of bacteria, but the ureaplasmas are the 
only organisms known to depend on urea for growth (see section 1.4). Ureaplasma
urease appears to be a m^or constituent of the cytoplasm and has been shown to
have a considerably higher specific activity than jack bean urease (Precious et a/, 
1987). This urease enzyme is also thought to play a role in the pathogenicity of the 
organisms (section 1.6).
Despite the apparent importance of the ureaplasmal urease, knowledge of the 
structure and properties of the enzyme is fragmentary. Early attempts to characterise 
the enzyme in crude cell extracts as well as more recent efforts directed at the 
purification of the enzyme, have been problematic due to the extremely low yields of 
ureaplasmas and the high level of medium contamination of the harvested organisms.
The production of an anti-urease Mab (UU8/1) enabled this enzyme to be purified 
by immuno-affinity chromatography as described by Precious et al. (1987). This 
purified enzyme was then used as an immunogen to produce a further 18 anti-urease 
Mabs (section 2.4(a)) (discussed later, 4.7).
4.2. SUBUNIT STRUCTURE OF UREAPLASMA UREASE.
Using anti-urease Mab (UU8/1) or anti-urease Mab (UU8/17) (see 4,7), active 
purified urease was prepared by immuno-affinity chromatography, followed by dialysis 
against PBS at 4°C (section 2.11). Using the assay method of Bradford (1976) (section 
2.5(a)) it was shown that approximately 1 mg of enzyme was recovered from the cell 
pellet obtained from a 10 litre culture. SDS-PAGE of freshly purified enzyme, prepared 
in 50 % (v/v) glycerol, without prior boiling (section 2.6.1(i)), revealed two closely
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migrating protein bands when stained with either Coomassie blue stain or with the 
more sensitive silver stain (Fig 4.1, lane A). Both bands were shown to be enzYmically 
active with the Fishbein stain or with the lead acetate stain (Fig 4.1, lanes B and C)
although the band of higher molecular mass was the more intense both by staining
and in enzymic activity. As the enzyme was not denatured prior to electrophoresis,
accurate determination of molecular masses was not possible, but both bands were
within the 170-200 kDa range. To calculate the molecular mass of the enzyme more 
accurately, FPLC (section 2.18) was carried out on freshly prepared urease. A single 
major protein peak, shown by the Berthelot reaction to be the active urease, was 
eluted and when subjected to non-denaturing SDS-PAGE was shown to contain only 
the two enzymically active protein bands. By comparison of the elution volume of this 
major peak with the elution volumes of the molecular mass standards, the molecular 
mass of the single peak corresponding with urease activity was shown to be 190 kDa.
After boiling of the freshly prepared enzyme in both the presence or absence of 
denaturing agents, the samples were subjected to SDS-PAGE. All enzymic activity had 
been lost (Fig 4.1, F) and total degradation to three subunits with apparent molecular 
masses of 72 +/- 4 kDa, 14 +/- 2 kDa and 11 +/- 1 kDa (Fig 4.1, lane E) had occurred. 
However, it is noteworthy that the two smaller subunits could only be seen after 
electrophoresis on a 15 % (w/v) polyacrylamide gel. When the boiled enzyme was 
electrophoresed on a 10 % (w/v) polyacrylamide gel, these smaller subunits merged 
with the dye front (Fig 4.1, lane I). After SDS-PAGE of boiled urease prepared in 
'denature mix' (2.6.1(ii)) had been carried out, the gels were stained with coomassie 
biue and subjected to densitometry (section 2.19). The individual peak areas were 
calculated and after taking the apparent molecular mass of the subunits into 
consideration, it was shown that they were present in equimolar ratios (72 kDa:14 
kDa: 11 kDa;: 1:0.99:0.95), consistent with the native enzyme being a hexamer (72 
kDa2:14 kDa2:11 kDa2). Similar patterns were obtained with all batches of the purified
enzyme.
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Fig 4.1: Electrophoretic analysis of polypeptides associated with purified
urease.
Lane A -- 1 0 % (w/v) gel; freshly prepared urease, coomassie stain.
Lane B -- 1 1 % ('w/v) gel; freshly prepared urease, Fishbein stain.
Lane C ■- 1 1 % (w/v) gel; freshly prepared urease, Lead acetate stain.
Lane D -  15 % (w/v) gel; molecular mass standards.
Lane E -- 1 1 % ('w/v) gell urease after boiling (2 min), coomassie stain.
Lane F -- 1 5% (w/v) gell urease after boiling (2 min), Fishbein stain.
Lane G ■- 11 % (w/v) gel ; thawdd enzyme; coomssse— stain.
Lane H -  1 1 % (w/v) gel - freshly prepared urease - coomassie atn.n.
Lane 1 - 1— % (w/v) gei; urease after boiling (2 min), coomassie stain.
Lane J -- 1 1 % (w/v) gel- Molecular mass standards.
(approximately 20 jg protein per tracks)
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4.3. STABILITY OF THE ENZYME.
Storage of the purified urease at -70°C with or without added glycerol, in 
siliconised or npn-siliconised tubes, followed by thawing to 20°C, resuited in a partial
breakdown to the three subunits, and a 50-55 % loss of activity as shown using the
Berthelot reaction. The active protein bands and the subunits were visualised after
non-denaturing SDS-PAGE with coomassie stain (Fig 4.1, lane G) and no additional 
components were detected by silver-staining. Work in the laboratory by Frost also 
showed that at 20°C, the addition of urea, B-mercaptoethanol or of "denaturing mix" in 
the absence of boiling did not appear to accelerate enzyme breakdown over a period
of 20 mins (Thirkell et al 1989).
4.4. pH OPTIMA FOR ENZYME ACTIVITY.
As discussed in section 2.20, the pH activity of this enzyme was evaluated over a 
wide range of pH (pH 2.2-10.7) by Frost (Thirkell et al 1989). No enzyme activity was 
detected below pH 4.3 or above pH 8.5 and the optimum pH for activity was shown to
be pH 6.9 (Thirkell et a/, 1989). To verify the actual pH optimum of the enzyme a 
narrower pH range of pH 5.0-8.1 was used as described In section 2.20. The results 
obtained are shown in Fig 4.2. Two pH optima are apparent at pH 6.15 and pH 6.9 with
more activity at pH 6.15.
Previously reported pH optima for urease from U. urealyticum serotype 8, have 
been at pH 5-6 (Masover et al 1976), pH 7.2-7% (Eng et al 1986) and also pH 7.5 
(Blanchard et a/, 1988). However, Swanberg et al. (1978) also detected the presence of 
two pH optima at pH 5,0 and pH 7.0 with reduced enzymic activity at pH 6.0 and these 
workers suggested that the two optima may be due to the presence of different 
isoenzymes which were reported by Delisle (1977). The differences in pH optima may 
be due to the different buffer systems used, but the overall pattern reported by 
Swanberg is similar to the results reported here.
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Fig 4.2: pH activity curve for purified urease, using 0.1 M citrate buffer.
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4.5. THE UREASES OF U. UREALYTICUM!, SEROTYPES 1-14.
U. urealyticum,, serotypes 1-14 were subjected to non-denaturing PAGE (section 
2.6.2) and to denaturing SDS-PAGE (section 2.6.1). In both cases, the urease activity in 
the gels after electrophoresis was detected with lead acetate (section 2.17). In the
latter case, the SDS was removed from the gel prior to staining by thorough washing
with PBS-N since SDS has an inhibitory effect on most enzymic activity (Lacks et al 
1979). On addition of urea, the urease metabolises this to ammonia which causes a
localised increase in pH and leads to the dissociation of the lead acetate to form
soluble ammonium acetate and an insoluble white lead precipitate in the area of pH 
increase as seen in Figs 4.3 (a) and (b). After electrophoresis using the 'native' gel 
system, a single active urease band was seen in all 14 serotypes (Fig 4.3 (a)). After 
SDS-PAGE, two active bands are apparent (Fig 4.3 (b)) in the 170-190 kDa range and it 
is possible that the lower molecular weight band with less enzymic activity may
represent a slightly denatured though still active form of the urease.
The molecular masses of the urease of the 14 serotypes appear to differ 
irrespective of the gel system used and such differences may reflect minor variations
in amino-acid sequence, in structure and/or organisation of the enzyme. The ureases 
of the serotypes belonging to the small serociuster (serotypes 1,3,6 and 14) behaves 
similarly and appear to have a slightly higher molecular mass, those of serotypes 
2,5,7,8,10,11 and 12, appear to have the lowest molecular mass and those of serotypes 
4,9 and 13 appear to have a molecular mass which is between the massess of the 
above. These findings of molecular mass variations for the urease of the different 
serotypes of U. urealyticum is consistent with previously reported data (Davis et al 
1988).
159
Fig 4.3: U. urealyticum, serotypes 1-14 subjected to:-
(a) Non-denaturing (7.5 % w/v) polyacrylamide gel electrophoresis
(b) Denaturing (7.5 % w/v) SDS-PAGE,
Stained with lead acetate (100 jug protein per track).
160
1 2 3 4 9 I I I I 1 11 12 13 1
1 2 I 4 I I 7 | I I U 12 1 1
161
4 6. UREASE CATCH ASSAY.
This assay was initially reported by Precious et ai. (1987) but was subsequently
found to be unreliable with results appearing to depend upon the make of 96-well 
plate used and to vary from day-day. After trying various modifications to the assay 
system, it was found that the desired reliability and reproducibility of the assay, 
irrespective of the make of 96-well plate used, could be achieved if the wells of the 
96-well plates were pre-coated with goat anti-mouse (GAM) immunoglobulins as 
described in section 2.21. A typical assay result is shown in Fig 4.4 where anti-urease 
Mabs (UU8/1-lane 3, UU8/17-lane 10, UU8/11-lane 11) and anti-96 kDa Mabs
(UU8/29-34-lanes 4-9) as negative controls, were used in the pre-coated wells, and 
where doubling dilutions of a log culture of U. ureaiyticum, serotype 8 (1/10-1/320 
dilutions in rows A-F) provided the urease antigen. As expected, blue colour developed
only in those pre-coated wells to which anti-urease Mabs had been added (lanes 3,10 
and 11). -
4.7. ANTI-UREASE MABS.
Although one such Mab (UU8/1) was available from a previous fusion (Precious et 
aU 1987), the use of immunoaffinity-purified urease from U. ureaiyticum, serotype 8 as 
immunogen, allowed 18 further anti-urease Mabs (designated UU8/11-UU8/28) to be 
raised. Using the radioimmune assay technique, 5 of these (UU8/12-13, UU8/17-18,
UU8/26) were shown to be of immunoglobulin class G.
All 19 Mabs recognised the 'native' enzyme of serotype 8 in the catch test without
affecting enzymic activity suggesting that the epitope(s) recognised by these Mabs
was/were not on, or presumably near to, the active site of the enzyme.
Although the autoradiogram is over exposed, homologous polyclonal serum was 
seen to recognise both active bands of the purified urease after 'non-denaturing'
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Fig 4.4: Urease catch assay with doubling dilutions (1/10 - 1/320) of a 
logarithmic culture of U. urealyticum, serotype 8 (107c.c.u. ml-1) (rows A-F).
The plate was pre-coated with a 1/200 dilution of GAM in PBS.
Lane 1 - Blank (no antigen added).
Lane 3 - Wells coated with anti-urease Mab UU8/1.
Lanes 4-9 Wells coated with anti-96 kDa Mabs UU8/29-34.
Lane 10 - Wells coated with anti-urease Mab UU8/10.
Lane 11 - Wells coated with anti-urease Mab UU8/11.
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PAGE and immunoblotting (Fig 4.5, lane B), as did all 18 anti-urease Mabs. Typical
results with two of these Mabs are shown in Fig 4.5 (lanes D and F).
After SDS-PAGE and immunoblotting with denatured enzyme, it was found that the 
72 kDa sub-unit was recognised by homologous polyclonal serum (Fig 4.5,lane A) and 
reproducibly by only 6 of the 18 Mabs (UU8/12-13, UU8/17-18, UU8/26-27). Two such 
examples are seen in Fig 4.5 (lanes C and E). The two smaller sub-units of the urease 
(14 kDa and 11 kDa) were not recognised on immunoblot by homologous polyclonal 
serum or by any of the 19 anti-urease Mabs.
4.8, CROSS-REACTIONS 01= MABS WITH THE UREASE 01= THE OTHER 13 SER01TYPES 01=
U. UREALYTICUM.
It was subsequently shown (see section 4.4) that the 6 Mabs which had been
shown by SDS-PAGE and immunoblotting to recognise the 72 kDa sub-unit of the
urease of serotype 8, between them recognised three different epitopes on the
enzyme. A representative Mab from each of these different epitope groups (UU8/12,
UU8/17, UU8/26) was then used to probe the other 13 serotypes of the organism.
After PAGE and immunoblotting, all these Mabs were shown to recognise both
active bands of the native ureases (data not shown). However, after SDS-PAGE and
immunoblotting of denatured ureases from the serotypes, UU8/17 was seen to
recognise the 72 kDa sub-unit of the ureases from only 11 of the 14 serotypes. This
sub-unit was not recognised in serotypes 3,6 and 14 (Fig 4.6). Although these three 
serotypes belong to the smaller serocluster of U. urealyticum, the 72 kDa sub-unit of 
the urease from the other serotype of that smaller cluster (serotype 1), was 
recognised. After SDS-PAGE and immunoblotting of denatured ureases, the 72 kDa
sub-unit was detected in all 14 serotypes by the other two Mabs used (UU8/12, 
UU8/26) (data not shown).
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Fig 4,5: immunoblot of fresh and boiled urease of U. urealyticum, serotype 8.
Lanes A,C,E - Urease after boiling (2 min).
Lanes B,D,F - Freshly prepared urease.
Lanes A,B - Probed with homologous polyclonal serum (1/800 dilution in 50:50
(v/v) PBS-N growth medium).
Lanes C,D - Probed with anti-urease Mab (UU8/17) belonging to epitope group
A (1/500 dilution as above).
Lanes E,F - Probed with anti-urease Mab (UU8/13) belonging to epitope group 
B (1/500 dilution as above).
All tracks were probed with 125I-labelled Protein A after electrophoresis on a 
15 % (w/v) SDS-polyacrlymide gel (~ 20 2^g protein per track).
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Fig 4.6: Immunoblot of serotypes 1-14 of U. urealyticum probed with the 
anti-urease Mab (UU8/17) and 1251-labelled Protein A after electrophoretic 
separation by 15 % (w/v) SDS-PAGE (~ 100 jug protein per track).
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4.9. COMPETITION ASSAYS FOR DETERMINATION OF EPITOPES ON THE UREASE.
As described in section 2.8, these assays were carried out using two different 
techniques whtch both gave similar results. it was shown that the 19 available 
anti-urease Mabs, between them recognised at least 4 distinct epitopes on the 
enzyme. Using the catch assay system, a typical result is shown in Fig 4.7, The wells 
of both 96-well plates were pre-coated with GAM Ig and then coated with anti-urease 
Mab UU8/1. On plate 1, competition assays were carried out against UU8/1 (lane 3), 
and against UU8/11-UU8/19 (lanes 4-12). On plate 2, competition assays were carried 
out against UU8/20-UU8/28 (lanes 3-11). On plate 1, competition to varying degrees is 
evident in lanes 3 (UU8/1), 4 (UU8/11), 7 (UU8/14), 10 (UU8/17) and 11 (UU8/18) and 
on plate 2, in lanes 3-6 (UU8/20-UU8/23). This suggests that these 9 Mabs all
recognise the same epitope on the enzyme. Assays of this type were repeated three 
times in each case, initially coating the wells with a Mab which had shown no
competition in previous assays. The groupings of Mabs recognising each of four
distinct epitopes were:-
Group A; UU8/1, UU8/11, UU8/14, UU8/17-18, UU8/20-23
Group B: UU8/12-13
Group C: UU8/24-28
Group D: UU8/15-16, UU8/19.
The binding of the urease by two Mabs during these assays may have inhibited the 
activity of the enzyme, which in turn, would have given misleading results such that 
inhibition would be mistaken for competition. To ensure that this was not the case,
competition assays were carried out with Mabs from each of the four epitope groups
as follows:-
(a) the urease enzyme was incubated with both Mabs simultaneously in the wells
170
Fig 4.7: Urease competition assay using the enzyme catch test.
Plates 1 and 2 pre-coated with GAM (1/200 in PBS) and Mab UU8/1 (1/100 in
PBS).
Lane 1 - Blank (no antigen added).
Well 2 A -Positive control (no competing antibody added).
Plate 1:
Lanes 3-12 - Competition respectively with UU8/1, UU8/11-UU8/19 ( 2-fold 
dilutions from 1/50 (A) to 1/6400 (H)).
Plate 2:
Lanes 3-11 - Competition respectively with UU8/20-UU8/28 (2—fold dilutions 
from 1/50 (A) to 1/6400 (H)).
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PLATE 1
PLATE 2
of a 96-well plate (Fig 4.8, side A), and
(b) competitions assayswe re carried odt as normal, i.e. the uease wa s inc unated
with one antibody prior to incubation in the wells of the plate with the second Mab
(Fig 4.8, side B).
As shown in Fig 4.8 competition is seen only on side B of the plate (lanes 7 and 8) 
suggesting that incubation of the urease simultaneously with the two Mabs did not
inhibit the activity of the enzyme. As expected competition is only seen where both
Mabs belong to the same epitope group.
To confirm these results, the second competition assay method using purified 
radiolabelled Mabs (section 2.8) was carried out. A typical result representing Mabs 
from the four epitope groups is shown in Fig 4.9, where the anti-sraaee Mab UU8/17 
was radiolabelled. Using UU8/17 competition is evident in Row A (homologous 
un^elled antibody) and rows C,D,E and F (corresponding to Mabs UU8/11,UU8/14, 
UU8/20, UU8/22). No competition is evident in rows B,G,H,1,J and K (corresponding to
Mabs UU8/1, UU8/12, UU8/25-26, UU8/15 and UU8/19). With the exception of Mab 
UU8/1 these results confirm those observed using the urease catch assay method. 
Mab UU8/1 may or may not belong to epitope group A, however, the discrepancy seen 
here may be due to the higher affinity of Mab UU8/17 for the urease enzyme using
this method.
One Mab from each of the four epitope groups was used in the catch assay to 
probe various bacteria which were known to possess a urease enzyme (section 2.1) 
but no cross reactions were observed. Thus, the Mabs appear to be specific for
sraatlnema urease only.
4.10. CELLULAR LOCATION OF UREAPLASMA UREASE.
It has been reported previously that the urease is located in the cytoplasm of the
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Fig 4.8: Verification of the competition assay results using the urease catch
assay.
The plate was pre-coated with GAM (1/200 in PBS) and Mab UU8/17 (1/100 in 
PBS).
Lanes 1-6 - Urease incubated with two Mabs simultaneously.
Lanes 7-11 - Urease incubated with the second antibody prior to addition to
the 96-well plate.
Lanes 1 & 7 - UU8/17 and UU8/17 (both from epitope group A).
Lanes 2 & 8 - UU8/17 and UU8/1 (both from epitope group A).
Lanes 3 & 9 - UU8/17 and UU8/13 (from epitope groups A & B respectively).
Lanes 4 8t 10 - UU8/17 and UU8/26 (from epitope groups A & C respectively).
Lanes 5 & 11 - UU8/17 and UU8/16 (from epitope groups A & D respectively).
(2-fold dilutions from 1/50 (A) to 1/6400 (H)).
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Fig 4.9: Competition assays with 125l-labelled anti-urease Mab UU8/17 and 
other unlabeiied anti-urease Mabs.
4-fold dilutions of unlabelled antibody, 1/20-1/81920.
A: Competition against homologous unlabelled antibody.
B-L: Competition against other unlabelled anti-urease Mabs.
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cell (Vinther, 1976; Masover et al, 1977a). To confirm this, U. urealyticum, serotype 8, 
was first subjected to phase partitioning with Triton X-114 (section 2.13). The resultant 
detergent and aqueous phase were subjected to SDS-PAGE and immunoblotting with 
the anti-urease, Mab UU8/17. In Fig 4.10 (lane A (detergent phase); lane B (aqueous 
phase)), it is seen that the 72 kDa sub-unit of the urease partitioned exclusively into
the hydrophilic aqueous phase. Subsequently, both whole cells (Fig 4.10, lane C) and 
sonicated cell ex-tract (Fig 4.10, lane F) were labelled with 125l using the Bolton and 
Hunter reagent (section 2.14) and it is obvious that many more proteins are labelled In 
the latter preparation. The 125l-labelled whole cells and the 125l-labelled sonicated 
cell ex-tract were then subjected to Immunoprecipitations with the anti-urease Mab 
UU8/17. Using this technique, none of the three urease sub-units were detected in the 
surface labelled whole cells (lane E), but both the 72 kDa and the 14 kDa sub-units 
were detected in the labelled sonicated cell extract (lane H). Again, when 
immunoprecipitations of these two 125l—labelled preparations were carried out using 
homologous polyclonal serum, no urease sub-units were detected in the labelled 
whole cells (lane D) but both the above mentioned sub-units were again detected in 
the labelled sonicated cell extract (lane G).
All of these findings are consistent with the cytosolic location of the urease and 
this was confirmed further by the use of immunogold labelling (chapter 5).
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Fig 4.10: Use of immunoblotting and immunoprecipitation to establish the 
cellular location of the urease of U. urealyticum, serotype 8.
Lanes A & B - Autoradiogram of immunoblots probed with the anti-urease
Mab UU8/17 of the detergent (A) and aqueous phases (B) after phase 
partitioning with Triton X-114 and SDS-PAGE on a 15 % (w/v) polyacrylamide
gel.
Lanes C & F - Autoradiogram of 125l-labelled whole cells (C) and of 
125l-labelled sonicated cell ex-tract (F) after SDS-PAGE (as above).
Lanes E & H - Autoradiogram of immunoprecipitations, using Mab UU8/17 with 
i25l-labelled whole cells (E) and with i25l-labelled sonicated cell extract (H)
after SDS-PAGE (as above).
Lanes D & G - Autoradiogram of immunoprecipitations, using homologous
polyclonal serum, with i25l-labelled whole cells (D) and with i25l-labelled
sonicated cell ex-tract (G) after SDS-PAGE (as above).
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CHAPTER 5
THE ULTRA-STRUCTURE OF UREAPLASMA UREALYTICUM, SEROTYPE 8.
181
5.1. THE ULTRASTRUCTURE OF U. UREALYTICUM, SEROTYPE 8.
The ultrastructure of U. urealyticum was examined by electron microscopy (section 
2.22) using cell? grown and harvested as described in section 2.2, i.e. in the presence 
of 20 % horse serum. Cells were prefixed before centrifugation as recommended by 
Maniloff et al. (1965), but it should be noted that Anderson and Barile (1965) did not 
find that prefixing Mycoplasma hominis cells before centrifugation had any advantage. 
Indeed, Whitescarver and Furness (1975) reported that centrifugation of ureaplasma
cells at 14000 g for 30 minutes did not distort or lyse the cells as shown by light
microscopy.
As discussed previously (section 1.2(i)), serum components from the medium are 
known to adsorb to the cells and this caused severe problems as can be seen in Fig 
5.1 (a-d). Much of the material examined had an amorphous appearance as shown in 
Fig 5.1 (c), and the presence of recognisable organisms as shown in a,b and d was
rare.
This problem was previously reported by Black et aL (1972) who replaced horse
serum with PPLO fraction after the observation of an accumulation of extracellular
material which obscured the electron micrographs.
In agreement with Whitescarver and Furness (1975), the cells were mostly seen as 
spherical or ovoid. Rod-shaped or filamentous structures as reported by Black et al. 
(1972), were not seen. The size of the majority of cells observed here ranged from 0.4 
yum to 0.8 urn in diameter though occasionaly smaller (0.1-0.2 /urn) structures were 
observed. Whether these smaller structures represent viable ureaplasmas is unknown. 
Larger (1.4 jjum) cells were also observed, these cells were mostly empty and probably 
represent lysed, dead cells. The diameter of the amorphous material observed was 
within the 0.4 yum-0.8 |im size range and may therefore represent badly fixed 
organisms.
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Fig 5.1: Culture cf U. urealyticum, serotype 3 grown in a medium containing 20 
% (v/v) horse serum, pre-fixed with 2.5 % (v/v) glutaraldehyde in PBS and 
post-fixed in 1 % (w/v) osmium tetroxide in PBS. Bar represents 0.2 /jm.
(a) Several recognisable ureaplasmas, a large organism absent of cytoplasmic 
material, and other amorphous structures can be seen (X 34,000).
(b) Field showing only one recognisable ureaplasma organism, surrounded by 
other amorphous material (X 74,000).
(c) A field showing only amorphous structures (X 34,000).
(d) Two ureaplasmas surrounded by a 'fuzzy' layer which obscures the fine 
structure of the membrane (X 95,000).
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As reported by Black et at. (1972), the smaller cells (0.4 jum) were more electron 
dense and filled with homogenous cytoplasmic material compared to the larger cells.
These authors claimed that this electron dense material represented ribosomes, either 
in randomly distributed or partly arranged in closely square-packed groups which 
were arranged to form corn-cob like patterns.
The presence of a tripled layered membrane could be seen surrounding most cells, 
although some organisms appeared to be covered with a 'fuzzy' layer (Fig 5.1, (d)), 
which obscured the fine structure of the membrane. This layer may represent the 
hair-like structures reported by Black e al. (1972) and Williams (1967) (see section
1.2.1), and?/ or may be the ruthenium red-staining capsule reported by Robertson and 
Smook (1976). Alternatively, it may of course represent medium components adsorbed
to the cell.
Black et al. (1972) also reported the presence of delicate filaments within the 
cytoplasm which were later identified as DNA but these were not seen here.
As reported previously (Precious et al., 1987), growth of ureaplasmas in medium 
containing foetal calf serum removes most of the medium contamination. Cells were
grown in this way, prefixed as before and the resultant electron micrographs can be 
seen in Fig 5.2. The cells observed were almost identical to those seen previously 
except the amorphous material was no longer present and many many more 
organisms could be found. Whitescarver and Furness (1975) reported the presence of 
budding ureaplasmas and what appears to be budding ureaplasmas can be seen in Fig 
5.2(a). The presence of a 'fuzzy' layer was still observed on many cells suggesting that
this layer is not composed of medium contaminants.
Occasionally, what appears to be short chains of very small (0.1 yjm) ureaplasmas 
were seen (Fig 5.2 (b)), these may be real or they may have been artifacts.
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Fig 5.2: Culture of U. urealyticum, serotype 8 grown in a medium containing 10 
% (v/v) foetal calf serum, pre-fixed in 0.5 % (v/v) glutaraldehyde in PBS (30 
min), and embedded in LR White resin. Bar represents 0.2 jum.
(a) Large number of ureaplasmas, with densely packed cytoplasm and several 
of what appear to be budding ureaplasmas (arrows) (X 32,000).
(b) Ureaplasmas and chains of smaller coccoid structures (arrows) (X 28,000).
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5.2. IMMUNOCYTOCHEMISTRY.
Previous work (chapters 3 and 4) has indicated that the 96 kDa, 16 kDa and 17 kDa 
polypeptides are integral membrane antigens of U. urealyticum, serotype 8, whereas 
the urease enzyme is cytosolic. To confirm the location of these antigens, 
immunocytochemistry (section 2.23) was carried out using LR White resin and Protein
A gold.
LR White resin has several advantages over traditional araldite resins which can be
exploited for the localisation of antigens in sections of fixed and embedded tissue 
under the electron microscope. This resin is hydrophilic and allows the passage 
through ultrathin sections of aqueous solutions such as antibodies. Both membrane 
and cytosolic structures are stable within this resin, even without prior fixation with 
osmium which often destroys antigenicity. This resin also tolerates rapid, partial 
dehydration, accepting tissues from 70 % (v/v) ethanol and thus these tissues have 
improved antigenicity compared to those tissues which have been fully dehydrated.
Glutaraidehyde, which was used previously for the examination of the
ultrastructure of this organism, was again used here as this fixative has a greater
power to cross-link proteins than does formaldehyde, but as this may reduce
antigenicity the concentration used and the fixation times given were very low. As 
fixation with osmium was avoided, the cells were more prone to distortion, thus after
dehydration, the cells were placed in LR White diluted in ethanol as this prevents
tissue shrinkage.
Cells were first probed with an anti-urease Mab (UU8/17) and 10 nm Protein A
gold; the resultant electron micrographs can be seen in Fig 5.3. In most cases, cells 
were cytoplasmically labelled but on occasions, gold particles could be seen 
associated with other material. The smaller, more densly packed cells were more
intensely labelled than the larger emptier cells. This may suggest that the urease
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Fig 5.3: Electron micrographs of ultrathin sections of U. urealyticum, serotype 
8, prepared as for Fig 5.2. Stained with an anti-urease Mab UU8/17 and Protein 
A gold (10 nm). Bars represent 0.2 pm.
(a) X 115,000; (b) X 49,000; (c) X 125,000; (d) X 141,0-00; (e) X 79,000; (f) X
58,000; (g) X 68,000.
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enzyme is lost from the cell as it ages and looses integrity and this may explain why 
gold particles were seen outwith the cytoplasm. The presence of urease outwith the
cytoplasm was also confirmed using the urease catch test with whole cells, i.e. no 
PBS-N was included. Negative controls, either excluding antibody or Protein A gold,
were also examined and one such example can be seen in Fig 5.4 (a). Some of the 
cells appeared to be poorly labelled (Fig 5.3 (f)) and this could be due to several 
reasons, such as the antigenicity of the urease being destroyed by the fixation and/or 
the polymerisation methods used. In addition, the antibodies may not satisfactorily
penetrate the sections unless they are ultrathin.
The 96 kDa antigen was not satisfactorily labelled using the above method as only 
a small proportion of the cell membrane was labelled (Fig 5.5), and this is not
indicative of this polypeptide being a major membrane antigen. Thus a second method
of labelling was carried out (section 2.23) which was suitable for labelling
surface-expressed antigens only.
This second approach was very successful and the majority of all cell membranes 
were intensively labelled with gold particles (Fig 5.6). As labelling was only successful 
prior to fixation, this may suggest that this antigen was destroyed by the
glutaraidehyde fixative or that this antigen was inaccessible to the Mab due to the 
cross-linking caused by the fixative. Controls were performed as for the urease
labelling and an example can be seen in Fig 5.4 (b).
This method was also carried out using Mab UU8/39 which recognises the 16/17 
kDa polypeptides In order to confirm that these antigens were also membrane 
associated. Using this method, no labelling of the cells could be seen, but the results 
of the Bolton and Hunter labelling had suggested these antigens may be located on 
both the internal and external surfaces of the membrane and results from the 
purification of these antigens suggested that they are intimately associated with other 
cellular proteins such that they are available to the antibody only after sonication or
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Fig 5.4: Electron micrographs showing negative controls. Bars represent 0.2
pm.
(a) Negative control for the anti-urease Mab; U. urealyticum, stained with
Protein A gold only (X 25,000).
(b) Negative control for the anti-96 kDa Mab; U. urealyticum, stained with
Protein A gold only (X 43,000).
(c) Negative control for the anti-16/17 kDa Mab; U. urealyticum, permeabilised 
with PBS-N prior to staining with Protein A gold (X 50,000).
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Fig 5.5: Electron micrograph of an ultrathin section of U. urealyticum, serotype 
8, prepared as in Fig 5.2 and stained with the anti-96 kDa Mab UU8/29 and 
Protein A gold (X 112,000). Bar represents 0.2 ;um.
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Fig 5.6: Electron micrographs of U. urealyticum, serotype 8, stained with an 
anti-86 kDa Mab UU8/29 and Protein A gold prior to fixation with 0.5 % (v/v) 
gluteraldehyde in PBS. Bar represents 0.2 jjm.
(a) and (e) X 82,000; (b) and (f) X 38,000; (c) X 100,000; (d) X 50,000.
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denaturation. The difficulties in purifying this antigen may imply that these 
polypeptides are integral to the membrane. Thus, cells were gently permeablised with 
PBS-N as described (section 2.23) and then labelled as for the 96 kDa antigen, i.e. 
prior to fixation. The resultant electron micrographs can be seen in Fig 5.7 (a~f). The 
majority of the cells appeared empty, suggesting that the membrane was 
permeablised. However, the majority of membrane 'shells' were very efficiently
labelled. Occasionally, whole cells were observed but these were not labelled. The
membranes were mosdy iabblled on what appeared to be the external surface,
although labelling did occcru on the inner membaane to some extent. This may
suggest that the antigenic determinant is surface-expressed but it is not available to 
the Mab prior to denatu^im, sonica^on or permeabiisation, perhaps due to the close
association of other membrane proteins.
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Fig 5.7; Electron micrographs of U. urealyticum, serotype 8, permeabilised with 
PBS-N, stained with an anti-16/17 kDa Mab UU8/39 and Protein A gold, prior
to fixation with 0.5 % (v/v) glutaraidehyde. Bar represents 0.2 pm.
(a) aad (e) X 49,000; (b) X 35,000; (c) X 42,000; (c^) X 41,000;'(f) x 88,000.
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CHAPTER 6
A COMPARISON OF HUMAN AND NON-HUMAN UREAPLASMAS.
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Ureaplasmas have been isolated from many non-human species, with those from 
cattle {U. diversurni receiving the most attention. Those studied here were isolated
from chimpanzees (5 strains), cattle (strain T44 used in all tests, 2 other strains used 
in selected tests only) and from dog, cat and marmoset (1 strain each) (section 2.1). 
Since all five chimpanzee strains behaved similarity, only one representative strain is
shown in the following figures. This was also the case for the three U. diversum 
strains (where all used), and again only one example is shown in each figure.
6.1. THE POLYPEPTIDE PATTERN AS SHOWN BY SDS-PAGE.
The non-human ureaplasmas and U. urealyticum, serotypes 1 and 8 were grown
and harvested as described in section 2.2. The resultant pellets were sonicated in
buffer A (described in section 2.15) and centrifuged at 300 g for 3 minutes to remove
the majority of the medium contamination. The resultant eiectrophoretogram is shown
in Fig 6.1 and shows the similarity between both the non-human and human strains
with respect to their polypeptide maps. However, the bovine, canine and feline strains
were distinct from the human, chimpanzee and marmoset isolates with major
differences in region A. It was noteworthy that the canine isolate (lane g) also appears 
to possess a polypeptide of apparent 96 kDa molecular mass similar to that seen in U.
urealyticum, serotype 8 (lane c). The canine isolate also appears to have two major 
antigens of apparent 21 kDa and 18 kDa molecular mass which are not apparent in
either the human or other non-human isolates. The feline and canine isolates both
appear to have two common polypeptides of molecular masses 40 kDa and 37 kDa.
6.2. THE 96 kDa ANTIGEN.
As discussed in chapter 3, the use of the anti-96 kDa Mabs had shown that so far 
as U. urealyticum was concerned, this 96 kDa antigen is serotype 8-specific. In order 
to determine whether this antigen was expressed in any of the non-human 
ureaplasma isolates, these were subjected to SDS-PAGE and immunoblotting where
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Fig 6.1: Electrophoretogram of a 15 % (w/v) SDS-polyacrylamide gel of
non-human and human isolates stained with Coomassie blue stain ( — 100 yug 
protein.per track).
Lane A -- Molecular mass standards.
Lane B -• U. diversum
Lane C -- U. urealyticum, serotype 8 (representative of serocluster A).
Lane D -- U. ureaiyticum, serotype 1 (representative of serocluster 8).
Lanes E-H - Ureaplasmas isolated from a:
Lane E -• chimpanzee.
Lane F -• marmoset.
Lane G -- dog.
Lane H -- cat.
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the blots were probed with anti-96 kDa Mabs which recognised each of the four 
known epitopes. One such autoradiogram is seen in Fig 6.2 which shows that the 96 
kDa antigen was not detected in any of the non-human ureaplasmas, giving further
evidence that the 96 kDa antigen is U. urealyticum, serotype 8-specific.
6.3. THE 16 kDa AND 17 kDa ANTIGENS.
The anti-16/17 kDa Mabs and their cross-reactions with the fourteen serotypes of
U. urealyticum have been documented in chapter 3.
The non-human ureaplasmas and U. urealyticum serotypes 8 and 1 (representative 
of the two seroclusters) were subjected to SDS-PAGE and immunobiotting with the 
anti-16/17 kDa Mab (UU8/39). This Mab reacted in an interesting manner, as shown in 
Fig 6.3. It should be remembered that both the 16/17 kDa polypeptides are recognised 
in the large serocluster of the human ureaplasmas (lane A) and that the 17 kDa 
polypeptide only, is recognised in the small serocluster (lane B). As for the human 
ureaplasmas from the large serocluster, both the 16 kDa and the 17 kDa polypeptides 
were recognised in the five chimpanzee isolates (lane C). Two polypeptides were also 
recognised in the ureaplasma isolated from the canine (lane D), but these had 
modified molecular masses of 16.5 and 17.5 kDa. In the marmoset species (lane E) the 
17 kDa polypeptide only was recognised, whereas in the bovine (lane F) and feline 
species (lane G) of ureaplasmas studied, the 16 kDa polypeptide only was recognised. 
Thus it would appear that the 16 kDa and 17 kDa polypeptides, either together, singly, 
or in a slightly modified state, are conserved across all the ureaplasma species 
studied here and this may suggest an important role for these polypeptides. The 
metabolic inhibition studies however, suggest that these polypeptides are not 
important in the metabolism of this organism (chapter 3). Thus, they may perform a 
structural role in the membrane. However, due to the apparent inaccessabiiity of these 
antigens to the Mabs (chapter 3) the results from the metabolic inhibition studies may 
be misleading.
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Fig 6.2: Immunoblot of five non-human ureaplasmas and 
serotype 8, probed with an an'ti-96 kDa Mab {UU8/29) after 
separation on a 15 % (w/v) SDS^d'acrylamide gel ( — 100
track).
Lane A - U. urealyticum^, serotype 8.
Lane B - U. diversum.
Lanes C-F - Ureaplasmas isolated from a:-
Lane C - Chimpanzee.
Lane D - Marmoset.
Lane E - Dog.
Lane F - Cat.
U. urealyticum,
electrophoretic
jag protein per
»
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Fig 6.3: lmmunoblot of
Lane A - U. urealyticum, serotype 8.
Lane B - LJ. urealyticum, serotype 1.
Lanes C-G - Ureaplasmas isolated from a:-
Lane C - Chimpanzee.
Lane D - Dog.
Lane E - Marmoset.
Lane F - Cow, i.e. U. diversum
Lane G - Cat.
AH tracks were probed with an anti-16/17 kDa Mab (UU8/39) and 1251—labelled 
protein A after electrophoretic separation on a 15 % (w/v) SDS-polyacrylamide 
gel (~ 100 jug protein per track).
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It was noteworthy that the results from the chimpanzee isolates and the marmoset
isolates were similar to the large serocluster and the small serocluster of
U. urealyticum respectively.
♦
Whether these polypeptides are two separate polypeptides with a common epitope
or are related by modification is unknown.
6.4. THE UREEXSE ENZYME.
Like the human ureaplasmas, the non-human ureaplasmas have a requirement for 
urea and possess a urease enzyme; this enzyme has been discussed in detail in
chapter 4. The urease enzymes of the non-human strains and their cross-reaction
with the anti-urease Mabs, raised against serotype 8, were studied.
6.4.1. GEL ELECTROPHORESIS.
U. urealyticum, serotypes 1, 5, 9 and 13, being representatives of the human 
ureaplasmas, and the non-human strains were subjected to non-denaturing PAGE 
(section 2.6.2) (Fig 6.4 (a)) and to denaturing SDS-PAGE (section 2.6.1), (Fig 6.4 (b)), 
prior to staining with lead acetate (section 2.17 (2)) (as discussed previously, section
4.5). Again whereas both gels show a similar pattern , the ureases appear as two
active bands on the SDS-denaturing gel compared to only one active band on the 
'native' gel system. Similarly, it is possible that the lower molecular weight band 
showing the least activity represents a slightly denatured form of the urease
As described for the ureases of the human serotypes (section 4.5) the molecular 
masses of the ureases from the non-human strains also display molecular mass
variation.
The non-human ureaplasmas were also probed with the anti-urease Mab (UU8/17) 
after SDS-PAGE and semi-dry blotting to nitrocellulose. The resultant autoradiogram
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Fig 6.4: Non-human and human ureaplasmas subjected to:-
(a) Non-denaturing (7.5 % w/v) polyacrylamide gel electrophoresis.
(b) Denaturing (7.5 % w/v) polyacrylamide gel electrophoresis.
Stained with lead acetate (~100 ug protein per track).
A: Lane a - Ureaplasma isolated from a cat.
Lane b - U. diversum.
Lane c - Ureaplasma isolated from a dog.
Lane d - Ureaplasma isolated from a marmoset.
Lane e - Ureaplasma isolated from a chimpanzee.
L,anes f-i - U. urealyticum, serotypes 9,13,1 & 5 respectively.
B: Lane a - U. urealyticum, serotype 5.
Lane b - Ureaplasma isolated from a chimpanzee.
Lane c - Ureaplasma isolated from a marmoset.
Lane d - Ureaplasma isolated from a dog.
Lane e - U. diversum
Lane f - Ureaplasma isolated from a cat.
Lanes g-i - U. urealyticum, serotype 1,13 & 9 respectively.
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Fig 6.5: Electrophoretic and immunobiot analysis on a 15 % (w/v)
SD^-poiyacrylamide gel of denatured urease, probed with anti-urease Mab
UU8/17.
Lane a - urealyticum, serotype 8.
Lane b - U. diversum
Lanes c-f - Ureaplasmas isolated from az-
Lane c - ca-t.
Lane d - deg.
Lane e - marmoset
Lane f - chimpanzee.
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(Fig 6.5) shows that the inactive 72 kDa subunit of the urease was recognised in the 
feline, marmoset and chimpanzee isolates but not in those from the bovine or canine
isolates. It should be remembered that this subunit is also not detected on
immunoblots of, U. urealyticum, serotypes 3, 6 and 14 with this Mab (see chapter 4).
As discussed previously, Mabs were raised which recognised at least four, perhaps 
five, distinct epitopes on the urease enzyme of serotype 8 (chapter 4). However, using
the urease 'catch test' (section 2.21) and U. diversum strains, the results suggested
that the anti-urease Mab (UU8/1), which may have belonged to epitope group A 
(chapter 4), behaved differently, in that the Mab did not recognise the urease from U. 
diversum, unlike the other anti-urease Mabs in this group. This therefore suggests the 
presence of at least five epitope groups on the enzyme, and agrees with the results 
obtained using the second competition assay method. Presumably all these epitopes 
are away from the active site since binding of any of these Mabs does not inhibit 
enzymic activity.
The wells of a 96-well plate were coated with an anti-urease Mab from each of 
the five epitope groups and the catch assay was carried out with each of the
neon-human strains and with U. urealyticum,, serotypes, 1-14. The results of this assay 
are shown in Fig 6.6 and are tabulated below in Table 6.1.
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Fig 6.6: Urease catch assay using logarithmic cultures ( ~ 107 c.c.u. ml-1) of:-
Row A: U. urealyticum, serotype 8.
Rows B-E: Ureaplasmas isolated from a:-
Lane B - marmoset.
Lane C - chimpanzee.
Lane D - dog.
Lane E - cat.
Lane F - U. diversum.
The plate was precoated with a 1/200 dilution of GAM in PBS.
Lane 1 - Blank (no antigen added).
Lanes 3-12 - coated with anti-urease Mabs from the five different epitope
groups.
Lanes 3 + 4 - UU8/17.
Lanes 5 + 6 - UU8/16.
Lanes 7 + 8 - UU8/12.
Lanes 9 + 10 - UU8/25.
Lanes 11 + 12 - UU8/1.
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Table 6.1: Summary of urease catch test results.
Source of urease Urease epitope groups 1-5 
UU8/17 UU8/16 UU8/12
represented
UU8/25
by:-
UU8/1
A U. urealyticum 
(serotypes 1-14)
+++ +++ +++ +++ +++
B Marmoset +++ +++ + +++ -
C Chimpanzee 
(strains 1-5)
+++ +++ +++ +++
D Canine +++ + ++ -
E Feline +++ +++ - -
F U. diversum +++ ++ + + + + —
(strains 1-3)
+++ - represents strong colour reaction (Absorbance between 1.2-1.99 at 600nm)
++ - represents medium colour reaction (Absorbance between 0.6-1.2 at 600nm)
+ - represents weak colour reaction (Absorbance between 0.1-0.6 at 600nm)
- - represents no colour reaction (Absorbance less than 0.1 at 600nm)
It can be seen that only the chimpanzee isolates behave similarly to the human 
serotypes, suggesting that the chimpanzee urease possesses and has available, the 
five epitopes of the U. urealyticum urease. Whereas the ureases of the ureaplasmas
isolated from cattle and marmoset reacted similarly in this test this is not true for any
of the other studies with the urease enzyme.
The different reactions of the non-human ureaplasmas with the anti-urease Mabs
confirm that there are differences in the structure and/or organisation of the urease 
from different strains such that epitopes are altered or are unavailable for binding and
this confirms the results from the lead acetate-stained gels.
Many workers feel that the chimpanzee may be the only natural animal model for 
the study of U. urealyticum pathogenicity and it is interesting to note that with the 
exception of the 96 kDa antigen, the five chimpanzee strains alone gave identical 
results to those serotypes of U. urealyticum belonging to the larger serocluster. This
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confirms the view of Mooches et at. (1981), who suggest that ureaplasmas of the 
chimpanzee are more closely related to U. urealyticum serocluster A than any other
animal ureaplasmas.
With the exception of the 'urease catch test' results, the marmoset strains gave
similar results to those U. urealyticum serotypes belonging to the small serocluster.
Mouches et al. (1981) also suggested that marmoset ureaplasmas were distinct from
those of other animal species.
219
CHAPTER 7 
DIAGNOSTIC TESTS.
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As discussed in chapter 1, ureaplasmas are not screened for routinely in most
laboratories because the majority of tests require the growth of the organism either
on solid or in liquid media, which is time consuming and costly. Growth in liquid
media is quicker and is usually more sensitive (Taylor-Robinson et aL1969), but 
growth on solid media is often required to confirm the results as many of the tests 
employed (section 1.1) (e.g. immunofluorescence) require the growth of the organism
on solid media.
Diagnostic tests which are sensitive, easy to perform and which do not require the
growth of these fastidious organisms would greatly improve the situation in terms of 
rapid diagnosis, of defining the role of U. urealyticum in the pathogenicity of man and
also in terms of patient treatment. This chapter discusses the development of four
such tests.
7.1. FLUORESCENCE TECHNIQUES.
7.1.1. INDIRECT METHOD.
The main advantage of this method is that only one fluorescent probe which
recognises the primary antibody is required.
U. urealyticum, serotype 8, was probed with an anti-96 kDa Mab (UU8/29) and a 
rhodamine-linked goat anti-mouse immunoglobulin, as described in section 2.24.1. 
U. urealyticum, serotype 7, M hominis and M. ovipneumoniae probed as above and U. 
urealyticum, serotype 8, probed with an anti-viral Mab were used as negative controls. 
Using this technique, bright red fluorescence was seen with serotype 8 and Mab 
UU8/29, but background fluorescence was observed with the negative controls, even 
after thorough washing and pre-adsorption of the rhodamine conjugate with sonicated 
ureaplasma cell extract.
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7.1.2. DIRECT METHOD.
This method of staining (section 2.24.2) was elected for further study because of
the problems of background fluoresence discussed above.
Mabs which recognise the urease, the 96 kDa and the 16/17 kDa antigens were 
purified (section 2.10) and labelled with fluoroscein isothiocyanate (FITC) as described 
(section 2.24.2).
7.1.3. ANT-96 kDa AND ANTI-16/17 kDa MABS.
The anti-96 kDa and anti-16/17 kDa Mabs have been described in detail in
chapters 3 and 5. Results suggest that these Mabs recognise surface expressed 
membrane antigens, but that the 16/17 kDa antigens were more readily available to
the Mab after denaturation, sonication or permeablisation; thus, cell extracts were
permeablised with PBS-N prior to staining (section 2.24)).
For comparison of immunofluorescence staining, black and white photographs are 
shown, as the tone in the colour photographs tended to vary due to problems with
exposure. Negative controls were as described above.
Fig 7.1 (A,C) shows U. urealyticum, serotype 8 (A - 0.5 mg protein ml"1; C -0.1 mg 
protein ml~i), probed with the FITCTinked anti-96 kDa Mab (UU8/29). Fig 7.1 (B,D) 
shows the equivalent dilutions with M. hominis, probed as above, and although
material could be seen on the slide, this did not fluoresce. Cell extracts of
M. ovipneumoniae and U. urea/yticum, serotype 7 gave similar results to those seen 
with M. hominis (results not shown), again confirming the serotype 8-specificity of the
anti-96 kDa Mabs.
Fig 7.2 (A), shows U. urea/yticum, serotype 8 (0.5 mg protein ml"i), probed with the 
FITC linked anti-16/17 kDa Mab (UU8/39) and a similar result was seen with serotype
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Fig 7.1: A/C - U. urealyticum, serotype 8 probed with an FITC -anti 96 kDa Mab
UU8/29.
B/D - M. hominis probed as for A/C.
A.B ~ 0.5 mg protein ml’1.
C,D - 0.1 mg protein ml-1.
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Fig 7.2 (A): U. urealyticum, serotype 8 (0.5 mg protein ml 1) probed with 
FITC-anti-16/17 kDa Mab UU8/39.
(B): M. hominis (0.5 mg protein ml probed as in (A).
I
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7. M. hominis (0.5 mg protein mf1) probed as described above is shown in Fig 7,2 (B) 
and Fig 7.3 (A,B) shows the colour equivalent of Fig 7.2 (A,B).
Bright green fluorescence (Fig 7.3 (A)) was seen with both FITC-linked Mabs and 
the appropriate’antigen. However, the staining observed with the anti-96 kDa Mab was 
more intense than that seen with the anti-16/17 kDa Mab, which may reflect the 
number of molecules of the 96 kDa antigen available for binding of the Mab, again 
suggesting this antigen is a major antigen of serotype 8. The 16/17 kDa antigen may
be present in the same molar ratio but may be unavailable to the Mab as discussed 
previously, even though permeablisation was carried out to try and overcome this
problem.
7.1.4. SENSITIVITY OF THE FITC-CONJUGATED MABS.
The sensitivity of these probes was tested in two ways as described in section
2.24.3. ,
(1) Results from a 10-fold dilution series from a log culture of U. urealyticum, 
serotype 8 suggested that each Mab could detect down to 10* c.c.u. ml’1 i.e. 10* 
organisms. However, it was difficult to differentiate this fluorescence from small 'dots' 
of background fluorescence, thus a second method was studied to confirm these
results.
(2) Both baby hamster kidney (BHK) and HeLa cells were incubated with 
U. ureaiyticumi, serotype 8 as described (section 2.24.3). No fluorescence was seen 
associated with the BHK cells, suggesting that ureaplasmas cannot adsorb to these 
cells. Fluorescence was however, seen associated with the HeLa cells and this 
technique also suggested that these probes could detect organisms from a culture 
containing 103 c.c.u. ml”1, i.e. 50 organisms (as 50 jjl samples were used instead of 
the normal 10 ul samples).
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Fig 7.3 (A + 8): As described for Fig 7.2,
I
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7.1.5. ANTI--UREASE MABS.
The urease enzyme and the anti-urease Mabs have been described in detail in
chapter 4 and it should be remembered that this enzyme is localised in the cytoplasm9 '
of the organism.
U. urealyticum, serotypes 8 and 7 {0.5 mg protein ml'"1) were probed with 
FITC-linked anti-urease Mabs UU8/17 and UU8/1 as described in section 2.24.2 and 
one such result is shown in Fig 7.4 (A). M. hominis (005 mg protein ml-1), probed as 
above is shown in Fig 7.4 (B), aa a negative countol, where no fluoresence was
observed and a similar result was seen with M. ovipneumoniae
The fluoresence observed with both anti-urease Mabs was not as bright or as
intense as that seen with the anti-96 kDa or anti-16/17 kDa Mabs and this may be
because the urease is cytosolic and may not have been readily available to the Mab 
even after permeablisation. Also, as the urease is soluble, it is possible that the
majority of the enzyme was removed during washing procedures.
7.2. THE UlREEAiSIE CATCH ASSAY.
This assay has been discussed in chapter 4 and section 2.21and several assays are
shown in chapter 4. in the laboratory, using log cultures of U. ureaiyticum, this test 
was shown to have a sensitivity down to 103 c.c.u. ml"1 (section 2.21), i.e. detection of
102 organisms
Urethral clinical samples, in duplicate, were made aeniiaSie from Ninewells Hospital 
in the form of calcium alginate swabs (section 2.25). One of each pair of these swabs 
was placed in Stuart's transport medium and processed as described in section 2.22 
by the Ninewells staff and the following results were obtained:
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Fig 7.4 (A): £/. urealyticum, serotype 8 probed with FITC-anti-urease Mab 
UU8/17 (0.5 mg protein ml"1).
(B): M. hominis (0.5 mg protein ml b probed as in (A).
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Total number of samples examined 91
Total number of ureaplasma isolations 8
Dual isolation of ureaplasma////. hominis 1
Thus in total, urgnpiasmbs were only isolated in 9.9 % of cases which was much
lower than expected as the majority of these patients were male and aged under 50 
where the expected isolation rate was at least 21 % (chapter 1). This low isolation rate
could be due to several reasons:-
(1) it has been suggested that calcium alginate swabs may contain inhibitors for
u^ap^i^as and they should be agitated in the transport medium and immediately
removed (Taylor-Robinson, 1983b); this was not done.
(2) Stuart's transport medium is not the ideal medium for transportation of
ureaplasmas and more organisms may have survived had growth medium minus urea,
been used.
(3) Samples should be processed as soon as possible and within 24 hours during 
which time they should be stored at 4°C. In many cases this did not occur as samples 
taken on a Friday were often left until Monday before being cultured. In three cases, 
samples were stored at 37°C for several hours before being processed.
(4) The solid medium used (section 2.25) contained thallous acetate to which 
ureaplasmas are sensitive (Lee et 3/,1972) and this may have at least partially inhibited 
the growth of these organisms.
Duplicate swabs were frozen in PBS at -70°C and processed as described (section 
2.25), but all were negative when assayed using the catch test. The calcium alginate
swabs which were used should have dissolved which would have increased the
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chances of detecting this organism. However, the swabs only partially dissolved to 
form a thick jelly-like substance which was very difficult to handle and any 
ureaplasmas caught in the matrix of the swab would not have been sampled.
Unfortunately, no quantitative data was available for these samples and low
numbers of organisms may also have contributed to the negative results. As this test
does not require viable organisms, the presence of any inhibitors to the organism but
not to the urease in the swab should not have affected the results. This was studied
when dilutions of ureaplasma seed cultures prepared in the laboratory in the presence 
of aiginate swabs gave comparable positive results to samples prepared in the
absence of swabs.
Frozen urine samples (section 2.25 (b)) were processed as described and negative 
results were again obtained with the catch assay. Attempts were also made to culture 
these samples in liquid growth medium but these were also negative.
Quantitative data for these 48 samples were obtained from Dr. D. Taylor-Robinson
(CRC, Harrow) and these data are shown below:-
31Total number of negative urine samples
Number of urine samples initially shown to contain:-
101 U. urealyticum c.c.u. ml"3 7
102 U. urealyticum c.c.u. ml"1 6
103 U. urealyticum c.c.u. ml~3 3
104 U. urealyticum c.c.u. ml"3 1
Total urine samples positive for U. urealyticum (35 %)
The isolation rate of 35 % was much higher than expected (see previously) but this 
may have been due to the fact that these samples were cultured immediately they
were available.
234
Tarr et al. (1976) have suggested that ureaplasmas are isolated less frequently
from urine samples than from urethral swabs, but this was not shown here. However, 
direct comparison cannot be made since the urethral and urine samples were cultured
in/on different media. As discussed above, liquid medium is thought to be more
sensitive and, the higher isolation rate seen with the urine samples may be due to the
fact that they were cultured in such a liquid medium.
Since the catch assay has a sensitivity of 103 c.c.u. ml “1, i.e.102 organisms one
would have expected that positive results would have been seen with at least 4 of the
48 urine samples. However, freezing the organisms in urine was found to reduce the
urease activity at least 10 fold and in addition, freezing the organisms in urine was
shown to reduce the viability of the organisms 100 fold and these factors would
explain the negative results on culture.
7.3. DIP-STICK
This test (described in section 2.26 ) is very similar to the urease catch assay in
that it also "catches" the urease enzyme of U. urealyticum and after metabolism of the
urea to ammonia, this is detected by the Berthelot reaction.
However, using 100 ul samples of diluted seed culture, the test was shown to be
10-fold less sensitive i.e. the lowest seed dilution from which a positive result was 
obtained was one containing 102 c.c.u. ml"1 or 102 organisms. Nevertheless, whereas 
the urease catch test assay can use only 100 ,ul of test sample, the dip-stick can be 
placed in any volume of sample and if urease is present, it will bind to the Mab and 
be detected as described above. However, contrary to expectation, when 102 
organisms were diluted in 20 mis of PBS-N, no positive result was obtained. On 
dilution to this much larger volume, the minimum detection limit with the dip-stick 
was found to be 104 organisms. This may be a reflection of the ability of the small 
surface area of the coated nitrocellulose relative to the total volume to bind all the
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urease within a reasonable time period.
The urine samples described in section 7.2 were also tested using the dip-stick,
but unfortunately these results were again negative. This may have been due to the
decrease in urease activity caused by freezing in urine, as observed in the control
investigations.
7.4. SLIDE AGGLUTINATION.
Slide agglutination tests make use of a solid matrix to which a specific anti-serum 
is adsorbed. When this Ab-matrix is mixed with a suspension of homologous antigen,
a lattice is formed which causes agglutination to occur which can be observed
visually without the use of a microscope. This reaction usually occurs within minutes
and thus this test is very simple and easy to carry out.
The most common solid matrix used is Staphylococcus aureus (Cowan strain), 
which is formaldehyde and heat-treated to inactivate the enzymes which cause 
autolysis (Kroevbli, 1973). The cell wall of Staphylococcus aureus contains Protein A 
which has a high affinity for the Fc portion of immunoglobulin G (Forsgnen and 
Sjoquist, 1966) and thus the Fab structure of the antibody is orientated outwards and 
available for binding of the antigen. This test is used routinely, for example, using 
anti-serum raised against Streptococcus pneumoniae to successfully type 
pneumococci isolates (K^ionvall, 1973; Christiansen et al., 1973).
Mabs, both in a purified and non-purified state and at various dilutions, which 
recognise the urease, the 96kOa and the 16/17 kOa antigens (described in chapters 3 
and 4) were successfully adsorbed to a suspension of Staphylococcus aureus as 
described in section 2.27 as shown by SDS-PAGE and coomassie blue staining which 
revealed the presence of both light and heavy immunoglobulin chains (data not 
shown).
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The suspension of Staphylococcus aureus, without the presence of antibody was
mixed as follows:-
(1) on its own, (2) with PBS, (3) with growth medium and (4) with a cellular extract 
of U. urealyticum, serotype 8 (1 mg protein mi'1) and the results are shown in Fig 7.5 
A (a). Whilst the suspension of Staphylococcus aureus did not co-agglutlnate on its 
own or in the presence of PBS ( 1&2), in the presence of growth medium or 
ureaplasma cell extract (3&4) some signs of agglutination were apparent.
The results using the Staphylococcus a/reAianti-urease Mab (UU8/17) and the
Staphylococcus <af/rez.s‘-anti-16/17 kDa Mab (UU8/39) complexes alone and with the 
above three treatments are shown in Fig 7,5 A {b and c respectively). Again, no 
agglutination was seen with the conjugates on their own or with PBS, but 
agglutination was seen with growth medium and with ureaplasma cell ex-tract. Similar 
results were seen when using Staphylocous aureus- anti-96 kDa Mab complexes.
Due to the agglutination observed with the growth medium and Staphylococcus
aureus complexes, a different solid matrix, latex beads, was studied.
7.5. DATE BEADS.
After ensuring no self-agglutination occurred with these beads (results not shown), 
the Mabs, in a purified state, and at various dilutions were adsorbed to the particles as
described in section 2.27 and that this had been acheived successfully was checked 
using SDS-PAGE and coomassie blue staining. Each Mab-latex reagent was treated as 
for the Staphylococcus aureus complexes and the results are shown in Fig 7.5 B (a - 
d). No agglutination was seen using an anti-16/17 kDa Mab at a dilution of 1/10 (a) or 
at 1/100 (b), nor was any seen using an anti-96 kDa Mab (UU8/29) undiluted (5mg 
protein per ml)(c) or using a 1/10 dilution of an anti-urease Mab (UU8/17)(d). The 
reasons for this are unknown but the SDS-PAGE and coomassie blue staining 
suggested that only a small amount of antibody adsorbed to these particles which
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Fig 7.5 (A): Slide Agglutinations using Staphylococcus aureus complexed:
(a) alone.
(b) with an anti-urease Mab (UU8/17).
(c) with an anti-16/17 Mab (UU8/39).
Treated as follows:-
(1) mixed alone, (2) mixed with PBS, (3) mixed with growth medium and (4) 
with a cellular extract of U. urealyticum, serotype 8(1 mg protein ml-1).
Fig 7.5 (B): Slide agglutinations using latex beads (0.2 jjm in diameter) 
complexed:-
(a) with 1/10 dilution in PBS of anti-16/17 kDa Mab UU8/39.
(b) with 1/100 dilution in PBS of anti-16/17 kDa Mab UU8/39.
(c) with undiluted anti-96 kDa Mab UU8/29.
(d) with 1/10 dilution in PBS of an anti-urease Mab UU8/17.
Treated 1-4 as in Fig 7.5 (A).
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could be due to the small size (0.2 yum) of these particles. If only one or two 
antibodies bound to each particle then the formation of a lattice would be
unfavourable. It should also be noted that if, as reported here and elsewhere (chapters
4 and 5) that the urease is cytosolic, then no agglutination would be expected to
occur using an anti-urease Mab.
7.6. DYNOSPHERES.
A third type of matrix was used which was a gift from Roy Edwards of Dyno
Particles. These particles have a core and shell structure and the shell is composed of
an acrylic co-polymer which can be activated for the covalent coupling of proteins 
such as antibodies (see section 2.27). These particles were supplied in two sizes, 10.4 
yum and 3 yim.
Fig 7.6 A (a,b) shows the results obtained with 10.4 zum dynospheres both on their 
own (a) and coupled to the anti-16/17 kDa Mab (UU8/39) (b), treated 1-4 as above. 
Unfortunately, due to the large size of these particles they settled out during gentle
aggitation and were thus unsuitable for such a test procedure.
Fig 7.6 B (a,b) shows results obtained with the 3 ,um dynospheres, both on their 
own (a) and coupled to the anti-16/17 kDa Mab (b). Although these particles did not 
settle out, neither did they agglutinate. However, when these particles were coupled to 
an anti-96 kDa Mab (UU8/29) good specific agglutination was observed (Fig 7.7). To 
ensure this agglutination was specific for U. urealyticum, M. hominis was also tested 
as described above and no agglutination was observed as shown in Fig 7.7 (b).
A log culture of U. urea/yticum, serotype 8 was used to test the sensitivity of this 
test but even at a titre of 10® c.c.u. ml“i no agglutination was seen suggesting that 
either the test is of low sensitivity or that aggregates of organisms had occurred 
during pelleting and resuspension of the test culture which enabled visualisation of
the lattice.
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Fig 7.6 (A); Slide agglutinations using dYeosphergs (10.4 yim in diameter)
complexed:-
(a) alone.
(b) with an afti —16/17 kDa Mab DU8/39.
Treated 1-4 as before.
Fig 7.6 (B): Slide agglutinations using dYeosphgrgs (3 pm
complexed:-
(a) alone.
(b) with an anti-16/17 kDa Mab UU8/39.
Treated 1-4 as before.
diameter)
1
241
A Treatments
1 2 3 4 1 2 3 4
B Treatments
1 2 3 4 1 2 3 4
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Fig 7.7: Slide agglutinations using dynospheres (3 ,um in diameter) cornplexed 
with an anti—96 kDa Mab UU8/29.
(a) mixed with 10-fold dilutions of U. urealyticum, serotype 8, in PBS at a 
starting concentration of 10 mg protein ml 1.
(b) mixed with 10-fold dilutions of M. hominis in PBS at a starting 
concentration of 10 mg protein ml \
I
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The fact that no agglutination was observed using the anti-16/17 kDa Mab 
suggests that either these antigens are not accessible to the Mab without prior 
sonication or permeabilisation or are present at low copy number.
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CHAPTER 8 
DISCUSSION.
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After SDS-PAGE, a minimum of 35-40 polypeptides were clearly visualised in all 14 
serotypes of U. urealyticum using the sensitive silver stain. In general, the patterns
were very similar but some differences were seen both with respect to individual
polypeptides which may be serotype-specific, and with respect to the quantitative
amounts of individual polypeptides. The problem of protein contamination from the 
growth medium was reduced by growing the organisms in a medium containing foetal 
calf serum (Precious et aH 1987). Howard et ai. (1981) and Mouches et ai. (1981) 
circumvented this problem by labelling the organisms with 35S-labelled methionine, 
but work in this laboratory suggested only poor incorporation was achieved (Precious, 
personal communication). It is possible that the conditions used by Precious were
sub-optimal for incorporation. Again, approximately 40 polypeptides were visualised
but it should be noted that some polypeptides may be devoid of this amino acid.
The close similarities shown among the serotypes indicate that they are very
closely related and that the original decision, based on genetic homogeneity, to divide
these organisms into types rather than species was probably correct.
As noted by Sayed and Kenny (1980), of the 35-40 polypeptides visualised, most
strains had at least one unique major polypeptide. Whether these unique polypeptides
correlate with the antigenic determinant responsible for serotype differences remains
to be elucidated. Using this single dimension electrophoretic technique it was not
possible to substantiate the claim of Mouches ef ai. (1981) that from the differences in 
polypeptide patterns, it is possible to divide the 14 serotypes into the 2 seroclusters.
However, whether this can be acheived using 2-dimensional gel electrophoresis, as
reported by Swenson et ai. (1983), was not studied here.
The predominance of Mabs against the 96 kDa polypeptide is consistent with it 
being a major polypeptide antigen in serotype 8 and confirms the earlier observations 
of Sayed and Kenny (1986) and of Precious et ai. (1987).
Competition assays with these anti-96 kDa Mabs revealed the presence of at least
247
4 epitopes and representative Mabs from each of these 4 groups did not show any
cross-reactions with any of the other 13 serotypes, suggesting that this 96 kDa 
antigen is serotype 8-specific. This is the first definite finding of a serotype-specific 
antigen in any of the 14-serotypes of U. urealyticum. This finding disagrees with that 
of Horowitz et ai. (1986), who suggested that serotype specificty may be due to 
quantitative rather than qualitative differences or that non-protein antigens are 
involved. The anti-96 kDa Mabs thus affords an equivocable differentiation of serotype 
8 from the other serotypes and such species-specific probes for all serotypes would 
allow a better evaluation of the association of individual serotypes in disease
processes.
The suppressive effect of an anti-96 kDa Mab on the metabolism of U. urealyticum, 
serotype 8 has been reported previously (Precious et ai, 1987). Mabs recognising each
of the 4 epi-tope groups suppressed metabolism of this organism in a similar manner,
but multiple epitope binding as determined with combinations of Mabs was not 
significantly synergistic. The exact role played by this 96 kDa antigen in respect of 
the growth and metabolism of serotype 8 remains to be elucidated.
Attempts to purify this 96 kDa antigen by immuno-affinity chromatography, 
co-purified a distinct glycosylated 85 kDa protein, which may be an associated 
membrane protein in this serotype or could originate from the growth medium. Lin 
(1982) reported mycoplasmacidal activity of control anti-serum prepared against 
uninfected growth medium and suggested that medium components were becoming
intimately associated with the cell surface and it could be that the 85 kDa protein is
one such component. in addition, these medium components may give rise to the 
extracellular ruthenium-red staining layer observed by Robertson and Smook (1976). 
Furthermore, if the 85 kDa glycosylated protein were shown to be of medium origin, 
this could suggest that the 96 kDa antigen may be involved in adherence to epithelial 
cells through association with a glycosylated component. Again this aspect would 
merit further investigation.
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The 96 kDa antigen would appear to be a surface-expressed, hydrophobic
membrane protein with minor hydrophilic characteristics as shown by Bolton and
Hunter surface labelling and phase separation with Triton X-114 respectively. It is
possible that this minor hydrophilic characteristic is due to the intimate association of
glycosylated medium components as described previously, or to a localised domain of 
hydrophilic components which would allow for easy interaction of the protein with 
external aqueous environments.
Two Mabs (UU8/39-40), prepared against serotype 8, were shown to recognise two
polypeptides of molecular mass 16 and 17 KDa. Unlike the anti-96 kDa Mabs, these
had no significant suppressive effect on the metabolism of serotype 8 which suggests 
that these antigens play a role other than a metabolic one. Difficulties experienced in 
the purification of these antigens may suggest that in vivo these antigens form a 
close association with other proteins which may make them inaccessible to the Mabs, 
and so explain the lack of metabolic inhibition. They may also be dependent upon a 
lipid 'halo' in the membrane such that close association with lipid also restricts 
binding on the Mab. It is also possible that these antigens play a structural role, as 
results from phase partitioning suggest that they are exclusively hydrophobic and are 
most probably integral membrane proteins. Purification of these antigens suggested 
the close association of other proteins which may suggest these antigens are integral
trans-membrane proteins.
Probes which will differentiate the seroclusters of U. ureaiyticum, whilst useful in 
their own right, would, in addition, obviously assist in investigations to determine
whether specific seroclusters predominate in disease processes.
Mab UU8/39 was shown to cross-react with the other 13 serotypes in an 
interesting manner. The 16 and 17 kDa polypeptides were recognised in all of the 
serotypes of the large serocluster A, but the 17 kDa polypeptide only was recognised 
in the serotypes on the smaller serocluster B. On the basis of binding with serotype
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13, the latter would appear to be placed in the larger serocluster A. This Mab is the 
first reported probe which will differentiate the two seroclusters of this organism and
to place serotype 13 within one of the seroclusters. Whether the 16 and 17 kDa
polypeptides are two separate gene products, one of which has been lost in the
smaller eorocluster, or whether in the larger seroclteter two fairly similar sized 
polypeptides exist which share a common epitope or whether in the larger serouluster, 
the 16 kDa polypeptide is derived from the larger is uncertain (see discussion on
non-human strains).
Labelling of serotype 8 with S^^labelleU palmitic acid revealed approximately 26 
discrete components, of which 11 weee inteesively labelled. Similarly, although
approximately 25 membrane proteins of M. capricolum (Dahl et ah 1983) and 20 
proteins of M. hyorhinis (Bricker et ah 1988) were labelled with this fatty acid, only 4
proteins of M. hyopneumoniae and Kim, 1987) were so labelled.
It has been reported that fatty acids in the growth medium are utilised primarily
for phospholipid synthesis in mycoplasmas and do mot serve as substrates for energy 
production (Dahl, 1988). In M. capricolum the major phospholipids are 
phosphatidyiglyuorol and uardidlipin and it has been shown that both fatty acid uptake
and utilisation in this organism are influenced by the structure of the 
membrane-associated sterols (Dahl et ah 1981). Since uptake involves both transport
and utilisation of the fatty acid, the rate-limiting step for this process in mycoplasmas 
could be any one in the pathway leading to the end product, phdsphatidylglyteool. 
Current models for fatty acid transport in other prokaryotes suggest that it is protein
mediated. In £ coii, fatty acid transport is dependent on an outor-mombraso protein 
that binds long chain fatty acid (Black et a/, 1987). The fatty acid is then translocated 
by an unknown mechanism to the cytosolic surface of the inner membrane where it is 
activated by acyl coenzyme A synthetase. The pathway for phosphaeidylglyuordl 
synthesis in £ coH proceeds via the dual acylation of glycerol^-phosphate to yield 
phosphati^c acid which eventually forms CDP-diglytoriUe; this is the direct precursor
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for glvcerolipid synthesis, it is thought that a similar pathway for phospholipid 
synthesis functions in mycoplasmas (Smith, 1979), but whether this is true for
ureaplasmas is unknown.
Of these 26 labelled components, one could be differentaited by immune- 
precipitation as the 96 kDa antigen. However, several of these proteins were clearly 
immunogenic as shown by immune-precipitations with homologous polyclonal serum.
The functions of these modified proteins has yet to be determined, although it is 
clear from this study and from others (Wise and Kim, 1987; Riethman et al. 1987), that
they can represent important antigenic structures mediating immune responses as
well as possibly playing a structural role in terms of anchorage of membrane proteins
(Schimdt et ah 1979) or in determining membrane integrity.
Lipid-modified proteins have been detected in other Moilicutes including 
Acholeplasma and Spiroplasma species (Wise and Kim, 1987). in both cases, the 
proteins were identified as being apparently-surface expressed and this would agree 
with the surface location of the 96 kDa antigen (as discussed).
The apparent prevalence of lipid-modified proteins among members of the 
Moilicutes may indeed reflect a general mechanism for the processing and anchorage 
of critical membrane proteins.
Boyer and Wise (1989) have suggested that these modified proteins are a powerful 
mechanism for generating antigenic diversity due to the discovery of size-variant
lipid-modified antigens in species of M. hyorhinis which may be similar to the 
Streptococcal M proteins. Lipid modification of membrane proteins may also play an 
important role in dictating intraspecies differences in surface antigenic structure and 
host interactions and thus may play a role in the pathogenicity of the organism. 
Whether this is true for ureaplasmas is unknown and the labelling of several other 
serotypes with fatty acids may be useful to this end.
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Active ureaplasma urease was efficiently purified using immuno-affinity 
chromatography and each preparation, as judged by SDS-PAGE and silver-staining or 
by urease activity staining, revealed a consistent pattern.
Non-denatufing electrophoresis of purified urease revealed two active bands with 
apparent molecular weights between 170-200 kDa but it must be recognised that 
molecular weights cannot be accurately determined in such a system. The use of 
FPLC, a more definitive technique, suggested a molecular mass for the enzyme of 190 
kDa. Previously, various molecular masses have been reported for this enzyme and 
these include 380 kDa from native gel electrophoresis (Eng et aH 1987; Stemke et aH
1987), 210 kDa (Blanchard et aH 1988), two active bands of around 130 and 180 kDa
(Precious et a/, 1987) and after treatment with B-mercaptoethanol and SDS, 179 kDa 
(Eng et aH 1986). Similarily, bacterial ureases from Brevibacterium ammoniagenes 
(Nakano et aH 1984), Proteus mirabiiis (Jones and Mobley, 1988), Kiebsieiia aerogenes 
(Todd and Hausinger, 1987) and Providencia stuartii (Mulrooney st aH 1988) are
reported to all have apparent molecular masses between 200-230 kDa.
Of the two active protein bands observed after SDS-PAGE, that of higher mass 
was always more active. The band of apparently lower mass probably represents a
slightly denatured and hence different confirmational state where the sub-units remain
associated and enzyme activity retained.
Whilst a partial breakdown of the enzyme into sub-units with associated loss of 
enzymic activity was seen after freezing of urease preparations at -70° C followed by 
thawing to 20° C, complete denaturation and total loss of activity was acheived by 
boiling, even in the absence of denaturing agents. SDS-PAGE of freeze-thawed or of
fully denatured enzyme revealed the presence of three sub-units with apparent 
molecular masses of 72, 14 and 11 kDa. Previous electrophoretic studies on the 
composistion of ureaplasma urease under denaturing conditions (Kenny, 1983; Stemke 
et aH 1987; Precious st aH 1987; Blanchard et aH 1988) have indicated a polypeptides
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of molecular masses variously quoted as being between 64-76 kDa. Whereas this is
the first study to demonstrate the presence of the two smaller sub-units, Blanchard et
at. (1988) have reported the presence of both a 70 kDa and a possible 17 kDa
sub-unit.
The three sub-units reported here are similar in mass to the 72, 11 and 9 kDa
sub-units reported for the urease from K. aerogenes (Todd and Hausinger, 1987), the
73, 10 and 8 kDa sub-units reported for the urease from P. mirabilis (Jones and
Mobley, 1988) and the 73, 10 and 9 kDa sub-units reported for P. stuartii (Mulrooney
et ah 1988). The similarity of the urease in both 'native' molecular mass and sub-unit 
structure between U. urealyticum and P. stuartii is reflected at the genome level, such 
that DNA sequences from U. urealyticum posses homology with the urease gene from 
P. stuartii as reported by Blanchard and Barile (1988).
On the basis of densitometry, results suggest a hexamer of 82, b£, C2 for the 
ureaplasma urease, whereas Todd and Hausinger (1987) suggested an 82, b4, C4 
complex for Klebsiella urease and Mulrooney et al. (1988) suggested an (a-, b2, 002)2 for 
P. stuartii. Studies on the genetic organisation of the urease gene(s) from P. mirabilis 
(Jones and Mobley, 1988) and from P. stuartii (Mulrooney et ah 1988) suggest the 
urease peptides are encoded on adjacent DNA sequences and transcribed as a 
poiycistronic mRNA in the order c,b and then a. Whether this is the case for
U. urealyticum is as yet unknown. it is noteworthy that the urease of 
B. ammoniagenes appears to exist as a trimer of three identical 67 kDa sub-units and 
that jack bean urease appears to exist as a hexamer of six identical 96.6 kDa
sub-units.
Work in this laboratory confirmed that the urease is a nickel containing enzyme
with the nickel associated with the 72 kDa sub-unit (Thirkell et ah 1989). This finding 
is consistent with those for other ureases such as jack bean (Dixon et ah 1975), 
soybean, K. aerogenes, B. ammoniagenes and Bacillus pasteurl (Todd and Hausinger,
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1987) and Selenomonas ruminatium (Hausinger, 1986).
The enzyme was shown to have two pH optima of 6.9 and 6.15. These values are 
not significantly different from pH optima reported by others (Masoeor et ah 1977; 
Swanberg et ah 1978) and it is possible that they reflect the two active forms of the 
enzyme soos after native gel e!uctfopdoresis. It ws s dotieeabl e that the pH oo the 
buffers was lowered after the addition of substrate and this may account for the
minor variations in reported values. Although the enzyme is inactivated at pH 8,5 and
above, this is reversible since on elution from the affinity column at pH 10.0, followed
by dialysis to neutrality, an active preparation is obtained. Dialysis from pH 4.0 to 
neutrality however, Udoe noo rooonstitute aative enzymei This irreversible loss of 
activity has also been observed for jack bean urease and for ureases from Arthobacter 
oxydans and K. aerogenes (Todd and Hausinger, 1987).
Kenny (1983) showed that inhibition of urease activity inhibited the growth of 
U. urealyticum Whereas soso of the anti-urease Mabs available inhibited the enzyme
or the growth of the organism, it is apparently inactivated by homologous polyclonal
antiserum. In addition, Romano et al. (1986) reported that ATP production by the cells 
requires the concomitant activity of both the urease and a membrane bound ATPase.
It Is unlikely that the cytosolic urease is sensitive to external pH, however, it was
noti'cable that during batch culture, the external pH rises to and stabilises at around 
pH 8.1 (Fig 1.1) which is close to the upper limit for enzyme activity. It is also 
noteworthy that at this pH a plateau is reached and the culture enters a steep lytic 
decline phase. Thus the enzyme activity may be directly or indirectly related to the 
extracellular pH, perhaps as a fuuntiod of the topology of the complex and its 
relationship to the cell membrane.
After isoelectric focussing of urease stored at 4° C for 48 h, three distinct bands 
with PI values of 4.60, 4.68 and 4.73 were seen on eileor-steinisg, together with other 
very minor bands. SDS-PAGE of this preparation showed, with Codmassio stain, the
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two active enzyme bands together with the 72 kDa sub-unit (the amount of the two
small sub-units present would almost certainly be less than the detection limit of the
stain). Fully denatured enzyme preparation, containing the three sub-units only, was
shown to have three bands with Pi values of 4.68, 4.81 and 4.87. Presumably
therefore, the two active enzyme bands have PI values of 4.60 and 4.73, the 72 kDa
sub-unit, 4.68 and the two smaller sub-units PI values of 4.81 and 4.87. Whereas Eng 
et aL (1986) have also reported bands with several PI values from their urease
preparations, the major of these had PI values between 5.0 and 5.2.
Lead acetate staining of the 'native' ureases from the 14 serotypes suggested that
minor variations in molecular mass exist between the serotypes which allowed 
sub-division into three separate groups. Serocluster A divided into two groups(1:- 
2,5,7,8,10,11 & 12; 2:- 4,9 & 13), whilst serocluster B formed a single group. Such 
variation in the molecular mass of these ureases has been reported previously (Davis
et aH 1988).
By two different techniques, competition assays revealed that the urease of 
serotype 8 possess at least four and possibly five, distinct epitopes, all presumably 
away from the active site of the enzyme since binding of any of the anti-urease Mabs 
did not inhibit enzymic activity. In addition, the enzyme was shown to be uninhibited 
by homologous polyclonal serum at a dilution which had been shown to inhibit the 
growth of the ureaplasmas (Chapter 3). The unavailability of the active site to the 
Mabs may suggest that it is protected in a cleft or pocket within the enzyme complex. 
Against this however, Eng et ai. (1987) described an antiserum which to varying 
degrees, inhibited urease activity of several ureaplasma species but which did not 
inhibit the urease of jack bean or the ureases of several walled bacteria. They argued 
that the inhibition observed could either be due to the antibody binding directly to the 
active site, or that the antibody binding induces conformational changes such that the 
enzyme substrate (urea), albeit of low molecular weight, can no longer react with the
enzyme.
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Although all 19 anti-urease Mabs bound to the active urease of serotype 8, only 6 
of these (recognising three separate epitope groups) consistently recognised the
inactive 72 kDa sub-unit. On the other hand, the two smaller sub-units were not
recognised by any of the 19 Mabs. Their apparent lack of antigenicity may suggest 
that they internal within the enzyme complex.
Whilst the 19 anti-urease Mabs also recognised the native ureases of the other 13
serotypes, their 72 kDa sub-units were only recognised by Mabs binding to two of the
three above mentioned specific epitopes. The Mabs recognising the third epitope
referred to above, did not bind to the 72 kDa inactive sub-units of the ureases of
serotypes 3, 6 or 14. This may reflect minor differences in amino acid composition
and/or conformation of this sub-unit between the serotypes of U. urealyticum.
The hydrophilic nature of the urease enzyme was shown by phase partitioning with
Triton X-114 and this is consistent with the cytoplasmic location reported by Vinther 
(1976) and Masover (1977b). This was confirmed by both Bolton and Hunter labelling
and immunogold staining. The staining shown with the latter was similar to that
reported by Vinther who used a urea-manganese reagent which in the presence of 
urease, forms electron dense MnO2. Shepard and Howard (1970) suggested that older 
colonies of ureaplasmas lost urease activity as shown by the urease spot test, and the
lack of gold particles within older organisms shown here, would confirm this. The 
presence of gold particles outwith the cells suggests that this loss of activity is due 
either to leakage of enzyme from the cells and/or to the release of urease on cell
lysis.
Electron microscopic examination of cells grown in a medium containing horse 
serum revealed large amounts of amorphous material which was not seen when cells 
grown in a medium containing foetal calf serum were so examined. it is therefore
possible that this amorphous material represented inadequately fixed organisms due to
the presence of horse serum components adsorbed to the cell surface which may
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interfere with the fixation process.
The cells observed ranged in diameter from 0.4 to O,3yum although occasionally, 
much smaller (0.1 am) and much larger (1.-4;um) uelle were soos and such a diameter 
range is in agreement with the 0.1 - 1.0yum range published previously (Wltitesuarver 
and Furness, 1975). Also as reported previously (Black et ah 1972; Whitescereor and 
Furness, 1975; Robertson and Smook, 1976), tho cells were mostly ovoid or spherical 
as might be expected for a wall-loss microorganism, and they were surrounded by a 
trilaminar membrane often obscured by a ififuzy' I aaer. Thh latter maa rep^^sset thh
hair-like structures (Black et ai., 1972) and/or the tutheniumorddestaining capsule
(Robertson and Smook, 1976) which have bees destribpd. Robertson asd Smook (1976) 
suggested that the hair-like strecturpe may be a site of adhprpncp for the material
stained with ruthenium red. The extra membranous layer has bees shown to bind
tonuasavelin A (Robertson and Smook, 1976) which has specificity for glucose and
mannose carbohydrate moieties but whether as Lin (1982) has suggested, it originates 
from tho growth medium, remains to be seen. Tho ability of U. urealyticum to bind 
carbohydrate residuee in vitro may reflect an in vivo affinity for the glycocalyx of 
epithelial cells of the genital mucosa. It is also possible that only pathogenic strains of
ereaplasmae have what may bo an adhorenup virulence factor as variations in this
adherence ability have been reported. A bovino strain which when grown undor normal
in vitro conditions, failed to bind ruthenium-rod (Robertson and Smook, 1976). 
Adsorption of uarbohYdrate-containing material to tho exterior of the organism could 
also play a rolo in evading the host immune responses If tho carbohydrate moiety 
(presumably from the host) adsorbs to conceal the suofaue~exprpssed antigenic
Uptprmisants.
The modo of roproduution is unclear but many workers (reviewed by Maniloff and 
Morawitz, 1972) believo thth thehe organisms pepraeuee by bmary fission. 
Alternatively, Shepard and Mesdeor (1979) suggested that the basic mdUo of 
multiplication of U. urealyticum was a simple budding prapssy and others
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(Whitescarver and Furness, 1975) claimed that two or more buds may appear
simultaneously. Here, evidence suggested that these organisms do have the ability to
form buds and such a process could explain the short chains of organisms which 
were observed. It could also be that budding only occurs under certain conditions. 
Although filamentous reproduction has also been suggested (Black et aH 1972) no
evidence for this was seen.
The use of Protein A-gold labelling enabled confirmation of some of the results
which have already been discussed. The cytosolic location of the urease was seen and
evidence was gained to again suggest that as the cell ages, this important enzyme is
lost from the cell. The membrane location of the 96 kDa antigen was confirmed and
that the cells were intensly labelled is in agreement with the notion that this is indeed
a major antigen of serotype 8. However, this 96 kDa antigen was not accessible to
the anti-96 kDa Mabs after fixation with gluteraldehyde and/or polymerisation. It is
more likely that this problem is the result of the known cross-linking of components
caused by gluteraldehyde fixation but alternatively, it may be that loss of certain 
epitopes is caused by the polymerisation process. Immunogold labelling also
confirmed the membrane location of the 16 and 17 kDa antigens but these were
labelled successfully only after permeabilisation of the cells. This suggests that either
the epitopes are located on the inside of the membrane or that in the in vitro state,
these polypeptides are wholly or partly inaccessible because of intimate associations
with other membrane components. Were the latter to be the case, this would 
presumably explain the difficulties experienced when attempts were made to purify 
these antigens by immuno-affinity chromatography. Treatment with PBS-N would then
presumably 'loosen' any such associations to allow recognition of the epitopes by the
Mabs and consequently the Protein A-gold.
A similar technique, using anti-rabbit Ig G gold has been used to localise the
spiralin and p55 fibrilin protein of spiroplasma cells (Townsend and Plaskitt, 1985).
258
With the exception of strains of chimpanzee or bovine origin, only a single
ureaplasma strain from the cat, dog and marmoset was compared with human
U. urealyticum serotypes. in general terms, there was a high degree of homogeneity
with respect to polypeptide profiles but certain conclusions could be drawn, viz. the9
bovine, canine and feline strains were distinct from the human, chimpanzee and 
marmoset strains. Howard et ah 1981 has also claimed 11 bovine strains examined by 
SDS-PAGE could be distinguished from 8 serotypes of U. urealyticum. There were
recognisable differences in the polypeptide profiles particularly with respect to
polypeptides with apparent molecular weights in the 34-48 kDa range, and there were
significant differences in the quantitative amounts of certain polypeptides, most
notably those with apparent molecular weights of 166, 60, 28, 25 8t 23 kDa.
The canine strain possessed 2 unique polypeptides (21 and 18 kDa) but was
otherwise very similar to the feline strain. Although the canine strain had a
polypeptide of approximate 96 kDa mass, this polypeptide was not recognised by any
of the anti-96 kDa Mabs suggesting that it is unrelated to the 96 kDa antigen of
serotype 8. it is possible that this polypeptide plays a similar role to that of the 96
kDa antigen and it would be of interest to discover whether this was a membrane
antigen and whether it too was acylated with palmitic acid. Thus the 96 kDa antigen of
serotype 8 possesses epitopes which are not expressed in any of the non-human
strains examined.
The anti-16/17 kDa Mabs raised against U. urealyticum serotype 8 cross-reacted
with all of the non-human strains. However, these two polypeptides, as recognised in 
the serotypes belonging to the larger serocluster of U. urealyticum were only 
recognised as such in all of the chimpanzee strains. Two polypeptides were 
recognised in the canine strain but these had modified molecular weights of 16.5 and 
17.5 kDa. The 17 kDa polypeptide only was recognised in the marmoset strain (similar 
to the situation with the smaller serocluster of U. urealyticum serotypes) whilst the 
16 kDa polypeptide only was recognised in the bovine and feline strains. The fact that
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one or both of these polypetides appears to be conserved in all ureaplasmas
examined suggests that they play an important role, maybe a structural one as
discussed earlier. These findings would also tend to suggest that these are two
distinct polypeptides which share a common epitope rather than the 16 kDa
polypeptide being a modified product of the 17 kDa polypeptide. Were the latter to be 
true, it is difficult to explain why even a small amount of the 17 kDa polypeptide was
not detected in the bovine and feline strains.
The native urease was detected in all ureaplasmas by gel electrophoresis carried
out both in the presence and absence of SDS. Variations in apparent molecular mass
may reflect minor variations in amino acid sequence which in turn may alter the
structure and/or the conformation of this important enzyme. It was noteworthy that
the 72 kDa inactive sub-unit of the urease was recognised in only the chimpanzee,
marmoset and feline isolates. It should be reiterated that this sub-unit is not identified
on immunoblots of denatured urease from U. urealyticum serotypes 3, 6 and 14 with 
this anti-urease Mab (UU8/17).
The use of the enzyme 'catch test' with anti-urease Mabs recognising five distinct
epitopes on the urease appears to confirm that there are differences in the structure
and/or conformation of ureases from different species such that certain epitopes are 
not expressed or are unavailable for binding due to a change in conformational
structure.
Many workers feel that the chimpanzee may provide the most appropriate animal 
model for the study of U. urealyticum pathogenicity and with the exception of the 96 
kDa antigen (unique to serotype 8), the chimpanzee strains alone gave results similar 
to those given by the serotypes of U. urealyticum of the larger serocluster. This would 
confirm the view of Mouches et al. (1981). With the exception of the results from the 
catch test, it was also noteworthy that the marmoset strain gave similar results to 
those given by the serotypes of U. urealyticum of the small serocluster.
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Although any conclusions would be tonsoliUateU by examining a greater number of
urpaplasme strains from eeue of the non-human species, there is sufficient eviUencp
to suggest that tho use of immunoblotting with tho Mab probes and the catch test
enables tho species of origin of a uoeaplasme strain to be determined.
*
At the present time, ureaplesmae aro studied and diagnosed mainly by those
workers in this specialised field. As a consequence, this organism tends to bo studied
only with rospect to Its association with certain disease states. Due to the apparent 
complexities of this organism's pathogenicity, it would bo boneUiuiel if these organisms
were strooned for on a routino /e'^-to-/ey basis especially In tho area of uro-genital 
infections (and more perticulerlb with respect to ndn-gonococtal urethritis) and 
respiratory infections of pre-torm low birth weight infants.. Although its role in most 
of these diseases is so longer disputed, just how important this organism is in those 
tdsditions remains to be fully explored. A few yoare ago, a similar situation existed for 
chlamydia, but due to tho devoldpmont of enzyme-linked immunoassays and 
fluorescein-labelled Mabs (Wingorson, 1983),' tho full extent of this organism's 
pathogenicity has now been rpelispd. It is now thought that C. trachomatis is the 
single most important causo of pelvic inflammatory disease and its resulting infertility.
Some advesuee in tho production of diagsostic tests for ureeplasmae have taken 
place recently. Within the last fow months a urogenital diagnostic kit has boon 
marketed by D.B.V. Production, France which is based on the Metabolic Inhibition test. 
It is as yot unprovos but roUes upon tho growth of the strain isolated from a patient 
(which if not successful can bo replaced with freeze-dried antigen) and tho patient's 
own serum to inhibit the growth of tho organism. A major drawback to the tost is the 
fact that it remains to be prdepn that infection with uroeplesma is always eesduieted 
with a good humoral immune response (other drawbacks to this tost have boon 
discussed previously in section 1.1). ELISA systems have boon doeelopod (seo section 
1.1) but those too havo drawbacks duo to background colour Upeolopment, prosumably 
/up to Improper statUardisation and cross-reactions among tho 14 serotypos. Thus, in
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general terms, tests for the diagnosis of ureaplasmas are available only in those
laboratories with access to specialised media and reagents and even then, many such
tests give arbitary results and are not quantitative (section 1.1). Any tests applied
should be quantitative since only in this way may low-level commensal carriage be
distinguished from disease states where larger numbers are thought to be involved
(section 1.6).
Due to the success of the fluorescent probes for the diagnosis of chlamydia, an
attempt was made to develop such a fluorescent test for ureaplasmas using examples
of the three available Mabs linked to FITC as probes.
The probe made with the anti-96 kDa Mab gave good intense specific fluorescence 
but since the 96 kDa antigen is serotype 8-specific, such a probe would not be of use 
for preliminary screening of clinical samples. However, such a probe would be useful 
in secondary screening procedures were serotyping may be important in defining
serotypes more specifically implicated with given disease states.
The probe with the anti-16/17 kDa Mab also gave good fluorescence and as either 
both of these antigens or the 17 kDa antigen alone is present in all 14 serotypes of 
U. urealyticum, the probes with further development could be particularly useful for
preliminary screening of clinical samples.
Urease is also present in ail serotypes but is both soluble and cytosolic. The 
FITC-linked probe produced gave much less intense fluorescence with the test 
material and as a result, difficulties would almost certainly be encountered if this 
probe were to be tested on clinical material as other components present may mask
the low fluorescence seen.
In general, the probes were shown to be both highly specific and sensitive.
Unfortunately, no suitable positive clinical samples were available on which the 
above probes could be evaluated but there is no reason to suggest that this test
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would prove less successful than that for chlamydia. It may also be possible to design 
a dual probe such that the presence of both ureaplasmas and of chlamydia could be 
tested for on the same slide using just one sample by tagging the appropriate Mabs
with different fluorochromes.
During these studies it was noted that U. urealyticum adsorbed specifically to HeLa
cells. This adsorption has been reported previously (Manchee and Taylor-Robertson, 
1969) where the cells could not be removed by vigorous washing. It is noteworthy
that both simian and canine strains of ureaplasmas did not adsorb to these cells. This
again indicates the ability of U. urealyticum to adsorb to human cells -and may or may 
not play a role in the pathogenicity of disease. Clearly this adsorption to tissue culture 
cells may provide a suitable model system to study ureaplasma adherance.
The urease catch test, using a plate pre-coated with GAM, proved to be both a 
simple and reliable test in the laboratory using logarithmic phase cultures of 
U. urealyticum Unfortunately, the testing of clinical samples was unsuccessful due to 
the unavailability of either fresh swabs or fresh urine samples. It is obvious from the 
work here that meaningful clinical trials of the catch test would be dependant upon 
the immediate use of fresh clinical samples. Attendance at the genito-urinary clinic at 
the Royal Hospital in Dundee proved pointless as so few appropriate samples were 
made available during the day.
It would appear that although the catch test is of adequate sensitivity and would 
not give a positive result in cases of low-level, presumably commensal carriage, urine 
samples with little or no sediment are unsuitable for testing. However, using the 
modified dip-stick test, urine samples with little or no sediment could be tested. Both 
96-well plates or dip-sticks precoated with GAM and with anti-urease Mab had a 
shelf-life of at (east 4 months but blocking of the plates or dip-sticks with BSA was 
found to reduce this shelf-life to approximately 2 months.
Slide agglutination tests have the advantage of being quick, easy to read and do
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not require reagents other than the Ab-solid matrix tonjegetp. It appears that the 
choice of antibody or of antibody combinations is important since only the conjugate
with tho anti-96 kDa Mab was found to bo succoseful. Even then, the sensitivity was
much lower than that auhoiep/, for example, with the catch test in that positive 
results could not be athpiepd with logarithmic phase cultures of the organism. The 
larger numbors of tplle required to give a positive rosult may bo a tdsspquonup of the 
small size of the urpaplasma cells. In this uesp, if urpaplasmas do adhere to cells of 
the genital mucosa, it is possible that an appropriate slide agglutination test could be 
developed which would give good positive results with urethral scrapings.
Tho fact that the 16/17 kDa Mabs did not give positive agglutisation may again 
suggest that teosp antigens are trans-membrane proteins and unavailable to the Mabs. 
No agglutination would be expected with a conjugate involving the anti-urease Mabs 
since tho enzyme is cytosolic and would not be available for binding.
Until fresh clinical samples are readily available, the exact suutpee of these various 
diagnostic tests cannot bo thoroughly aeepssp/. There is good reason to believo that 
at least ono of tepep diagnostic tests, most probably the catch test and the dip-stick
test, will be useful asd would merit commercial exploitation.
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